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Abstract 
 
During the course of this PhD, a new one-pot thermal Overman rearrangement 
and ring-closing metathesis process was developed for the preparation of 
polycyclic compounds. In this method, commercially available phenols and anilines 
were converted to alkene derived allylic alcohols and then transformed via a one-
pot process into 5-amino 2,5-dihydro-1-benzoxepines and 5-amino 2,5-dihydro-
1H-benzazepines. The synthetic utility of these compounds was explored with the 
preparation of highly substituted hydroxylated analogues as well as a highly active 
hypotensive agent.  
 
A novel one-pot process was also developed for the synthesis of allylic amide 
derived 2H-chromenes. The key substrates, propargyloxy cinnamyl alcohols were 
rapidly prepared from readily available salicylaldehydes. One-pot thermal 
Overman rearrangement of the corresponding allylic trichloroacetimidates, 
followed by a gold(I)-catalysed hydroarylation gave the 2H-chromenes in high 
yields. A mild chemoselective method for the oxidation of the 2H-chromenes to 
give coumarins was also discovered.  
 
 
3 
 
Contents 
Abstract          2 
Acknowledgements        6 
Author’s Declaration        7 
Abbreviations         8 
 
1.0 Introduction         12 
1.1 Claisen rearrangement        12 
1.2 Aza-Claisen rearrangement       12 
1.3 Overman rearrangement       13 
1.3.1 Thermal Overman rearrangement      14 
1.3.2 Metal-catalysed Overman rearrangement     17 
1.3.3 Asymmetric Overman rearrangement     21 
1.3.3.1 Chiral Pd(II)-catalysed stereoselective Overman rearrangement 21 
1.3.3.2 Chiral substrate-directed Pd(II)-catalysed Overman  
             rearrangement        23 
1.3.4 Applications of the Overman rearrangement    26 
1.3.5 Conclusions          33 
1.4 Ring-closing metathesis (RCM)      34 
1.4.1 Olefin metathesis        34 
1.4.2 Ring-closing metathesis       36 
1.4.3 Catalysis of the ring-closing metathesis (well-defined catalyst  
         systems)         38  
1.4.4 Scope of the ring-closing metathesis reaction    42 
1.4.5 Applications of the ring-closing metathesis reaction   48 
1.4.6 Conclusions         59 
1.5 One-pot multi-reaction processes      60 
1.5.1 General concepts        60 
1.5.2 Types of one-pot processes       60 
1.5.2.1 Domino reactions        61 
4 
 
1.5.2.2 Cascade reactions        61 
1.5.2.3 Tandem reactions        62 
1.5.2.4 One-pot multi-reaction processes     63  
1.5.3 Application of the one-pot multi-reaction process    65 
1.5.4 Conclusions         69 
 
2.0 Results and discussion       70 
2.1 Synthesis of 5-amino-substituted 2,5-dihydro-1-benzoxepines 70 
2.1.1 Previous work within the Sutherland group    70 
2.1.2 Aims          74 
2.1.3 Synthesis of allylic alcohols       76 
2.1.4 The one-pot multi-reaction synthesis of 1-benzoxepines  79 
2.1.5 Synthesis of 8-chloro-5-guanidino-2,3,4,5-tetrahydro-1-benzoxepine 82 
2.1.6 Dihydroxylation of 5-amino-substituted 2,5-dihydro-1-benzoxepines 85 
2.1.6.1 Synthesis of cis-3,4-diols of 5-amino-1-benzoxepines   86 
2.1.6.2 Synthesis of trans-3,4-diols of 5-amino-1-benzoxepines  88 
2.1.7 Conclusions          90 
2.2 Synthesis of 5-amino-substituted 2,5-dihydro-1H-benzazepines 91 
2.2.1 Aims          91 
2.2.2 Synthesis of allylic alcohols       92 
2.2.3 Optimisation of one-pot multi-reaction process for 1H-benzazepines 103 
2.2.4 Synthesis of 5-amino-substituted 2,5-dihydro-1H-benzazepines  105 
2.2.5 Formal synthesis of mozavaptan      107 
2.2.6 Conclusions          111 
2.3 Synthesis of 2H-chromenes       112 
2.3.1 Introduction         112 
2.3.2 Cycloisomerisation        113 
2.3.3 Aims          114 
2.3.4 Synthesis of allylic alcohols       115 
2.3.5 Investigation of the key steps of the one-pot process   116 
5 
 
2.3.5.1 Optimisation of the Overman rearrangement    116 
2.3.5.2 Optimisation of the hydroarylation reaction    118 
2.3.6 Stepwise gold(I)-catalysed synthesis of 2H-chromenes   120 
2.3.7 Optimisation of one-pot synthesis of 2H-chromenes   122 
2.3.8 One-pot gold(I)-catalysed synthesis of 2H-chromenes   123 
2.3.9 Optimisation of the Pd(II)-catalysed Overman rearrangement  125 
2.3.10 Optimisation of the one-pot palladium(II)-catalysed Overman  
             rearrangement and gold(I)-catalysed hydroarylation process 126 
2.3.11 Chemoselective oxidation of 2H-chromenes to coumarins  127 
 
2.3.12 Conclusions          128 
2.3.13 Synthesis of 6-amino-substituted 6,11-dihydrodibenz[b,e]oxepines  129 
2.3.13.1 Previous work within the Sutherland group     129 
2.3.13.2 Aims          130 
2.3.13.3 Investigation of the one-pot multi-reaction process    132 
2.3.13.3.1 Optimisation of ring-closing enyne metathesis step   132 
2.3.13.3.2 Optimisation of Diels-Alder reaction      133 
 
3.0 Future work         134 
3.1 Synthesis of 11-amino-substituted 5,11-dihydro-1-benzoxepino,  
      benzazepino, and benzthiapino[4,3-b]pyridines     134 
3.2 Coumarin derived α-amino acids      136 
 
4.0 Experimental         138 
 
5.0 References         223 
 
 
 
 
 
 
6 
 
Acknowledgements 
First of all, Praise and Thank be to Allah, Lord of the Worlds. 
I would like to express my sincere thanks to my supervisor, Dr. Andrew 
Sutherland, for giving me the opportunity to undertake this PhD programme within 
his research group. I greatly appreciate his guidance, encouragement, patience, 
support and help during my PhD study. 
Thanks to my previous second supervisor Dr. Rudi Marquez and my present 
second supervisor Dr. Goetz Bucher. Thanks also to the academic and technical 
staff for their appreciated assistance throughout my PhD period: David (NMR), Jim 
and Harry (MS), Stuart and Arlene (IT), Ted, Bruce and Paul (Stores).  
Thanks to all the past and present members of the Sutherland research group: 
Ahmed, Mark, Adele, Ewen, Filip, Alex, Nikki, Mohamed, Kerry, Tomas, Tim, 
Réka, and Jonathan for the good times and working together in this team. Thanks 
to summer students: Marie and Fábio. Thanks to members of the Hartley group.  
I would like to express my deepest appreciation and love to my parents: my father, 
Ahmad, who passed away before seeing this work, and my mother Aisha, who 
always has been praying for me and for her love. I would like to express my 
deepest gratitude to my family: my wife, Seham, for her love, patience, prayers, 
and support for me, and also for my kids: Taqwa, Talia, and Ahmad, who have 
spent a lot of time away from me and whose smiles and laughs always make life 
more hopeful. I would like to thank my brothers and sisters for their 
encouragement, support and help, in particular, my brothers Hamza and 
Abdulhakim. I would like to thank my wife’s family, in particular, my mother-in-law, 
Soad for her help and prayers, and my brothers-in-law and my sisters-in-law for 
their support and help.  
Finally, the Libyan government and University of Benghazi are gratefully 
acknowledged for financial funding and support. Also, thanks to the School of 
Chemistry and the University of Glasgow for additional financial support (William 
Hamilton Award). 
7 
 
Author’s Declaration 
 
I declare that this thesis represents the original work of Salaheddin A. I. Sharif 
unless otherwise referred to in the text and has not been submitted for any other 
degree at the University of Glasgow or any other institution. The work upon which 
it is based was carried out at the University of Glasgow in the Loudon Laboratory 
under the supervision of Dr. Andrew Sutherland between June 2013 and May 
2016. Aspects of the work described herein have previously been published 
elsewhere as stated below. 
 
 
E. D. D. Calder, S. A. I. Sharif, F. I. McGonagle and A. Sutherland, One-Pot 
Synthesis of 5‑Amino-2,5-dihydro-1-benzoxepines: Access to Pharmacologically 
Active Heterocyclic Scaffolds, J. Org. Chem., 2015, 80, 4683. 
 
D. T. Racy, S. A. I. Sharif, S. L. Pimlott, and A. Sutherland, Silver(I)-Catalyzed 
Iodination of Arenes: Tuning the Lewis Acidity of N‑Iodosuccinimide Activation, J. 
Org. Chem., 2016, 81, 772. 
 
S. A. I. Sharif, E. D. D. Calder, F. G. Delolo, and A. Sutherland, Synthesis of 
5‑Amino-2,5-dihydro‑1H‑benzo[b]azepines Using a One-Pot Multibond Forming 
Process, J. Org. Chem., 2016, 81, 6697. 
 
S. A. I. Sharif, E. D. D. Calder, A. H. Harkiss, M. Maduro, and A. Sutherland, 
Synthesis of Allylic Amide Functionalized 2H‑Chromenes and Coumarins Using a 
One-Pot Overman Rearrangement and Gold(I)-Catalyzed Hydroarylation, J. Org. 
Chem., 2016, 81, 9810. 
 
Signature   _____________________________ 
Printed Name  _____________________________ 
8 
 
Abbreviations 
Δ   Reflux 
ACAT  Acyl-CoA, Cholesterol O-Acyl Transferase 
aq.  Aqueous 
BHT   3,5-Di-tert-butyl-4-hydroxytoluene  
Boc  tert-Butyloxycarbonyl 
br  Broad 
tBu   tert-Butyl  
cat  Catalyst 
Cbz   Carboxybenzyl 
CI  Chemical Ionisation 
CM   Cross Metathesis  
COP   Cobalt Oxazoline Palladacycle 
Cy  Cyclohexyl 
d  Doublet 
DCE  Dichloroethane 
DCDMH 1,3-Dichloro-5,5-dimethylhydantoin 
DBU   1,8-Diazabicyclo[5.4.0]undec-7-ene 
DIBAL-H  Diisobutylaluminium Hydride 
DIPEA N,N-Diisopropylethylamine 
DMAP  4-Dimethylaminopyridine 
DME  Dimethoxyethane 
9 
 
DMF  N,N-Dimethylformamide 
DMSO  Dimethyl Sulfoxide 
DNA  Deoxyribonucleic Acid 
dr  Diastereomeric Ratio 
EDDA  Ethylenediammounium Diacetate 
ee  Enantiomeric Excess 
EI   Electron Impact 
endo  Endocyclic 
eq  Equivalents 
exo  Exocyclic 
Hex Hexyl 
HIV   Human Immunodeficiency Virus 
HPLC  High Performance Liquid Chromatography 
HWE   Horner-Wadsworth-Emmons 
IR   Infrared 
J   NMR Spectra Coupling Constant 
LiHMDS   Lithium Hexamethyldisilazide  
m-   meta- 
m   Multiplet 
MBH   Morita-Baylis-Hillman  
m-CPBA meta-Chloroperbenzoic Acid 
Mes  Mesityl 
10 
 
MS  Molecular Sieves 
MOM   Methoxymethyl 
mp   Melting Point 
MW   Microwave 
NBS   N-Bromosuccinimide 
NCS   N-Chlorosuccinimide 
NIS   N-Iodosuccinimide 
NMR   Nuclear Magnetic Resonance 
NOE   Nuclear Overhauser Effect Spectroscopy 
OM  Olefin Metathesis 
o-   ortho- 
p-   para- 
BQ   p-Benzoquinone 
PDC   Pyridinium Dichromate  
ppm   Parts Per Million 
py   Pyridine 
q  Quartet 
RCEYM Ring-Closing Enyne Metathesis 
RCM  Ring-Closing Metathesis 
ROM   Ring-Opening Metathesis  
ROMP  Ring-Opening Metathesis Polymerisation  
quant.  Quantitative  
11 
 
rt  Room Temperature 
s  Singlet 
t  Triplet 
TBAF  Tetrabutylammonium Fluoride 
TBDMS tert-Butyldimethylsilyl  
TBDPS  tert-Butyldiphenylsilyl 
TBTU  O-(Benzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium Tetrafluoroborate 
TEMPO  (2,2,6,6-Tetramethylpiperidin-1-yl)oxyl 
TEPA   Triethyl Phosphonoacetate 
tert   Tertiary 
Tf   Triflate 
TFA   Trifluoroacetic Acid  
THF   Tetrahydrofuran 
TLC   Thin Layer Chromatography 
TMEDA N,N,N′,N′-Tetramethylethylenediamine 
TMS   Trimethysilyl 
Ts  p-Toluenesulfonyl 
 
 
 
 
 
12 
 
1.0  Introduction 
1.1 Claisen Rearrangement  
Sigmatropic rearrangements as a class of pericyclic reactions are powerful and 
useful tools in organic synthesis in which a new C-C bond is formed due to an 
intramolecular process. Claisen, Cope and Carroll rearrangements which follow a 
[3,3]-sigmatropic rearrangement are the most common and widely used types of 
sigmatropic reactions. The Claisen rearrangement was first discovered by Ludwig 
Claisen in 19121 where he reported “the thermal isomerisation of an allyl vinyl 
ether 1 - or of its nitrogen or sulfur containing analogue derivatives - to afford a 
bifunctionalised molecule 2,” and since then it has found widespread applications 
in organic chemistry (Scheme 1).2  
 
Scheme 1: Claisen rearrangement. 
In that report, Claisen described the first formation of α-allyl acetoacetate 4 from 
the distilled O-allylated ethyl acetoacetate 3 in the presence of NH4Cl via a [3,3]-
sigmatropic rearrangement which was known later as the Claisen rearrangement 
(Scheme 2).1,2  
 
Scheme 2: The first aliphatic Claisen rearrangement. 
 
1.2 Aza-Claisen Rearrangement  
In 1937, Mumm and Möller reported that an allylic imidate can be rearranged 
thermally to give an amide in a [3,3]-sigmatropic rearrangement process which is 
called an aza-Claisen rearrangement and since then it has been utilised as a new 
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alternative route in the synthesis of amino compounds (Scheme 3).3 This reaction 
requires harsher conditions than that required for the Claisen rearrangement for 
both aliphatic and aromatic molecules.2  
 
Scheme 3: Aza-Claisen rearrangement. 
 
1.3 Overman Rearrangement  
The first report of a thermal allylic trichloroacetimidate rearrangement was 
published by Overman in 1974.4,5 Overman also showed the first use of a 
transition metal complex, mercuric trifluoroacetate, to catalyse this transformation. 
Formally, the Overman rearrangement represents the conversion of a 1,3-allylic 
alcohol 7 to an allylic amine 10. This can be achieved thermally or using a metal 
catalyst (Scheme 4).6  
 
Scheme 4: Allylic trichloroacetimidate “Overman” rearrangement. 
As a potential tool for synthetic organic chemistry and due to the recent 
developments in catalysts, the Overman rearrangement has found widespread 
application and uses in the construction of naturally occurring and unnatural 
nitrogen-containing products with enhancement in the yield and control of the 
stereoselectivity.6,7,8  
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1.3.1 Thermal Overman Rearrangement  
Many factors of the Overman rearrangement have been studied extensively, such 
as steric effects, substitution effect, thermodynamic parameters, solvents, 
additives, regioselectivity and stereoselectivity.6 The thermal Overman 
rearrangement as a [3,3]-sigmatropic process occurs via a concerted suprafacial 
mechanism and this hypothesis is in accordance with Woodward-Hoffmann rules.9 
The reaction pathways progress via a highly ordered chair-like transition state that 
allows complete chirality transfer to the product with transposition of the allylic 
alcohol to the amide functional group (Scheme 5).4–6 
 
Scheme 5: Transfer of chirality in the thermal Overman rearrangement. 
This reaction proceeds for a wide variety of allylic alcohols and follows first-order 
kinetics where primary allylic alcohols react slower than secondary and tertiary 
alcohols. Due to a postulation of a partially charged transition state, the reaction 
rate enhancement was observed in changing the solvent system form xylene, a 
non-polar solvent, to nitrobenzene, a polar solvent.4,5 Allylic trichloroacetimidates 
can be rearranged at a range of temperatures from 0–140 °C under reflux. For 
example, some cinnamyl imidates rearrange in refluxing xylenes to afford 
moderate to high yields, while using chloroform, toluene or THF is unsuitable due 
to their low boiling points (Scheme 6).10  
 
Scheme 6: Solvent effects in the thermal Overman rearrangement. 
Addition of a small amount of sodium or potassium carbonate has a positive effect 
on the reaction. This addition prevents the acid-catalysed decomposition of the 
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imidate during the rearrangement process and consequently increases the 
products yield (Scheme 7).11  
 
Scheme 7: Additive effect in the thermal Overman rearrangement. 
Steric hindrance has an effect on the outcome of the thermal Overman 
rearrangement. For example, the yields of the rearrangement of ortho- and para-
substitution of the cinnamyl imidates 11 were significantly different. While the 
ortho-substituted imidate rearranged in 30% yield after 24 hours from the 
corresponding allylic alcohol, the para-substituted imidate formed in 82% yield in 
just 12 hours (Scheme 8).10  
 
Scheme 8: Steric hindrance effect in the thermal Overman rearrangement. 
Presence of substituents attached to the double bond at C-2 and C-3 of the allylic 
trichloroacetimidates such as oxygen atom has a significant effect on the thermal 
Overman rearrangement. For example, allylic alcohol 13 with 3-position oxygen 
atom undergoes the Overman rearrangement smoothly at 0 °C to give the 
produced amide 14 in 78% yield directly without observing the intermediate 
(Scheme 9).12  
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Scheme 9: Substituent effects of the thermal Overman rearrangement. 
 
Regioselectivity of the thermal Overman rearrangement is generally not high. For 
example, the rearrangement of 15 leads to two regioisomers in a 60:40 ratio 
(Scheme 10).5  
 
Scheme 10: Regioselectivity in the thermal Overman rearrangement. 
 
Although the thermal Overman rearrangement has a high degree of 
stereoselectivity due to the complete chirality transfer observed, the 
diastereoselectivity is affected by the temperature required for the reaction 
(Scheme 11).13  
 
 
Scheme 11: Diastereoselectivity in the thermal Overman rearrangement. 
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1.3.2 Metal-Catalysed Overman Rearrangement 
Since the first report introduced by Overman4 using mercury(II) salt to catalyse the 
[3,3]-sigmatropic rearrangement of allylic trichloroacetimidates, a variety of 
transitional metals including palladium, platinum, gold, and nickel have been 
examined for catalysing the allylic trichloroacetimidate rearrangement. Overman 
reported the general requirements for metal-catalysed rearrangements,4 which 
were applied in the construction of a broad spectrum of organic compounds and 
contributed to the expansion and development of the [3,3]-sigmatropic 
rearrangement.5,6,14–17   
While the thermal Overman rearrangement proceeds at high temperatures, the 
metal-catalysed Overman rearrangement takes place at room temperature under 
milder conditions to give the products in enhanced yields. Employment of catalysts 
not only allows milder conditions, but also better control of stereoselectivity and 
regioselectivity.4,5,15,18–20 
Although the first used metal in the Overman rearrangement was a Hg(II) 
catalyst,4 the Pd(II) catalysts are considered the most effective and useful.19 
Palladium(II)-catalysts react easily and rapidly with substrates at low temperature 
and low loading. Palladium(II)-catalysts can also react cleanly with substrates 
forming the products in high yields and with high stereoselectivity.15,20–23   
According to previous extensive mechanistic studies of the metal-catalysed [3,3]-
sigmatropic rearrangement by the Henry, Overman, Schoop, Ikariya and Bosnich 
research groups,5,15,19,21,23–25 the metal-catalysed Overman rearrangement 
proceeds via a cyclisation-induced rearrangement mechanism. The cyclisation-
induced mechanism of the Pd(II)-catalysed Overman rearrangement, which 
proceeds via a stepwise pathway, begins with Pd(II)-coordination to the π-system 
of the allylic substrate forming the intermediate-palladium complex 16. This 
intermediate undergoes cyclisation via an anti-intramolecular nucleophilic attack 
by the nitrogen atom to form cyclic carbocation intermediate 17. Finally, reductive 
elimination leads to the amide product and regeneration of the catalyst PdX2 
through an irreversible step due to the driving force of amide formation (Scheme 
12).  
18 
 
 
Scheme 12: Mechanism of the Pd(II)-catalysed Overman rearrangement. 
More importantly, Ikariya and Bosnich groups, from their study of the Pd(II)- and 
Pd(0)-catalysed [3,3]-sigmatropic rearrangements, showed that the Pd(II)-catalysts  
mainly give a [3,3]-product (Claisen product), while Pd(0)-catalysts form a [1,3]-
product (anti-Claisen product).23,25 Ikariya also reported that Pd(0) can rearrange 
allylic N-phenylformimidates and N-phenylbenzimidates to Claisen and anti-
Claisen products via the [3,3]- and [1,3]-sigmatropic rearrangements, respectively 
(Scheme 13).25 In 1997, Overman and co-workers reported the formation of both 
the Claisen and the anti-Claisen products by utilising the Pd(II)-catalyst.19,26  
 
 
Scheme 13: Formation of [3,3]- and [1,3]-products via Pd(0)-catalysed            
 aza-Claisen rearrangement. 
 
Sutherland and co-workers suggested that the formation of these (Overman and 
anti-Overman) products was due to the presence of the two species, Pd(II) and 
Pd(0), during the rearrangement process. They overcame this problem by adding 
a catalytic amount of re-oxidant such as p-benzoquinone (BQ), which is widely 
used to re-oxidise the Pd(0)-species to the Pd(II)-species. This prevents the 
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formation of the [1,3]-product and increases the yield of the [3,3]-product (Scheme 
14).20  
 
 
Scheme 14: Oxidant effect on the formation of [1,3]- and [3,3]-Overman 
rearrangement products. 
 
Based on the previous observations, Sutherland and co-workers stated that “1,3-
product is formed via a Pd(0)-catalysed allylic substitution reaction and that the 
Pd(0) likely arises by a competing β-elimination process during the slow Pd(II)-
catalysed rearrangement of allylic imidate” (Scheme 15).20  
 
 
 
Scheme 15: Pd(0)-catalysed formation of 1,3-anti-Overman product (anti-
Claisen). 
 
Interestingly, in 1998, Spilling and co-workers reported that halogenation reagents 
such as N-bromosuccinimide (NBS) or N-iodosuccinimide (NIS) can catalyse the 
Overman rearrangement if there is an electron withdrawing group R1 attached to 
the trichloroacetimidate (R1 is phosphonate or cyano groups) (Scheme 16).27  
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Scheme 16: Metal-free catalysed Overman rearrangement. 
Recently, Tang and co-workers reported that the Overman rearrangement can be 
carried out from allylic imidates of primary allylic alcohols within a one-pot reaction 
process using the halogenation reagents (NCS, NBS or NIS) or in the presence of 
1,3-dichloro-5,5-dimethylhydantoin (DCDMH) (Scheme 17).28  
 
Scheme 17: Metal-free catalysed Overman rearrangement from primary 
alcohols. 
 
Gold-catalysed Overman rearrangements have drawn attention for some research 
groups and these studies showed that this transformation can be efficiently 
performed utilising Au(I) and Au(III) salts.29–32 More recently, Yang and Xing 
reported highly efficient gold(I)-catalysed Overman rearrangements in water.33 
They showed that the gold(I)-catalysed Overman rearrangement proceeds very 
cleanly in water under very mild conditions leading to the formation of allylic 
trichloroacetamides in high yields (67–96%) during short reaction times (2–6 h) 
and this transformation can also be performed on a gram-scale. For example, 
conversion of allylic trichloroacetimidate 22 to the corresponding amide 23 utilising 
a catalytic amount of gold(I) chloride finished in 2 hours giving the product in high 
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yield (Scheme 18). This exact yield is also observed in the case of a gram-scale 
reaction during the same reaction time.  
 
Scheme 18: Gold-catalysed Overman rearrangement in water. 
 
1.3.3 Asymmetric Overman Rearrangement 
The Pd(II)-catalysed Overman rearrangement has attracted attention from many 
research groups for the development of asymmetric catalysis toward the 
successful synthetic applications of the Overman rearrangement through design of 
new chiral catalysts. Moreover, chiral-substrate Pd(II)-catalysed Overman 
rearrangement has also been studied and supports the development of 
asymmetric catalysis. The palladium-catalysed stereoselective Overman 
rearrangement can be divided into two approaches, the chiral Pd(II)-catalysed 
stereoselective Overman rearrangement, which is mainly used in enantioselective 
synthesis, and the chiral-substrate Pd(II)-catalysed stereoselective Overman 
rearrangement, which leads to the preparation of diastereomers. 
 
1.3.3.1 Chiral Pd(II)-Catalysed Stereoselective Overman Rearrangement 
A new era of asymmetric catalysis of the Overman rearrangement was established 
by the first report from Overman and co-workers in 1997,19 in which they described 
the first enantioselective Pd(II)-catalysed aza-Claisen rearrangement of allylic 
imidates to allylic amides. Based on the available studies and observations of 
palladium catalysis, further efforts reported by the research groups of Overman, 
Hayashi, Zhang, Williams, Kang, and List8,17,26,34–43 have contributed in the 
development of the asymmetric Pd(II)-catalysed [3,3]-sigmatropic rearrangement 
of allylic imidates including, in particular, the Overman rearrangement.  
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The development of the palladium-catalysed enantioselective rearrangement of 
allylic imidates was initially based on a detailed understanding of the 
enantioselective step.35 The first class of catalysts was the cationic catalysts which 
are formed utilising oxazoline ligands or diamine ligands (Figure 1). The second 
generation of the chiral catalysts is the neutral catalysts which are formed using 
ferrocenyl amine ligands, ferrocenyl imine ligands, ferrocenyl oxazoline ligands, or 
chromium tricarbonyl arylimine ligands.35 The development of the second 
generation of catalysts led to an improvement in the enantioselectivity of the 
formed products in addition to an increase in the yield.  
 
Figure 1: Structure of some catalysts. 
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The monomeric cobalt oxazoline palladacycle (COP) catalysts, such as (S)-COP-
Cl 24 and (R)-COP-Cl 25 are the most effective catalysts that can achieve the 
Overman rearrangement to form chiral allylic amines from prochiral allylic alcohols 
in high yield and excellent enatiomeric excess (Figure 2).8,39 These results were 
supported by a detailed kinetic and computational analysis of the Pd(II)-catalysed 
asymmetric Overman rearrangement.8 
   
 
Figure 2: Cobalt oxazoline palladacycle catalysts. 
 
For example, the asymmetric Overman rearrangement of 26 utilising chiral Pd(II) 
catalyst (S)-COP-Cl 24 leads to the formation of chiral Overman product 27 in 93% 
yield and 93% ee (Scheme 19).39 
 
Scheme 19: Use of the chiral COP-Cl catalyst 24 for the asymmetric 
Overman rearrangement. 
 
1.3.3.2 Chiral Substrate-Directed Pd(II)-Catalysed Overman Rearrangement 
The chiral substrate-directed Pd(II)-catalysed Overman rearrangement represents 
the second approach for performing asymmetric reactions. Employment of chiral 
directing-groups on the allylic trichloroacetimidates effectively encourages the 
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catalysis to occur on one face of the π-system of the allylic imidate leading to high 
diastereoselectivity. Although the preparation of diastereomers from chiral 
substrates was reported by the research groups of Schoop and Larchevêque  in 
1992,21,44 this type of asymmetric transformation was further developed in 1993 
when Bellûs and co-workers reported the synthesis of diamines from chiral allylic 
alcohols via the diastereoselective Overman rearrangement utilising the effect of a 
chiral amino group to orient the catalyst addition (Scheme 20).13 The highly 
observed selectivity (dr >99:1) was explained using a chair-like conformer 30.  
 
Scheme 20: Chiral amine-directed Pd(II)-catalysed asymmetric Overman 
rearrangement. 
 
In 2005, the Sutherland group reported a chiral ether-directing substrate for the 
Pd(II)-catalysed asymmetric Overman rearrangement.45 Among different ether 
groups, the MOM group was the most effective. The study showed the 
effectiveness of the MOM ether group in directing the facial coordination of the 
Pd(II) catalyst to the allylic double bond during the Overman rearrangement 
process to afford an excellent diastereoselectivity of the product (Scheme 21). 
Steric factors associated with ether groups had a significant effect on the minor 
diastereomer yield where more bulky ethers increase the chance of coordination of 
the palladium catalyst to the less bulky face of the double bond causing an 
increase of its yield. The authors also described that changing the MOM group 
with a carbon analogue showed a significant decrease of diastereoselectivity to 
2:1. 
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Scheme 21: Chiral ether-directed Pd(II)-catalysed asymmetric Overman 
rearrangement. 
 
Sutherland and co-workers reported further improvement of the MOM-ether 
directing effect on the yield and diastereoselectivity.20 The authors developed a 
new method for a highly diastereoselective synthesis of (2S,3S)-β-hydroxy-α-
amino acids from enantiopure α-hydroxy acids using the chiral MOM-ether-
directed Pd(II)-catalysed asymmetric Overman rearrangement. This efficient 
process led to a significant diastereoselectivity up to 14:1 along with increase of 
the yield. Further work in the Sutherland group showed the bulky side-chains 
during the MOM-ether directed rearrangement caused side-reactions, formation of 
Pd(0) and subsequent production of the 1,3-product. This problem was overcome 
by the addition of re-oxidant, in particular p-benzoquinone, to oxidise the Pd(0)-
catalyst back to the Pd(II)-catalyst. This modification led to the sole formation of 
the desired 3,3-product (Scheme 14). 
More recently, Sutherland and co-workers expanded the scope and limitations of 
the ether-directed Pd(II)-catalysed stereoselective Overman rearrangement via the 
study of non-coordinating solvents,30,46  and understanding the origin of the 
directing effect.47 Those improvements have been utilised in stereoselective 
syntheses of a number of natural products such as β-hydroxy-α-amino acids,31 
alkaloids,48,49 anti-vicinal amino alcohols50 and the first total synthesis of 
clavaminols.51  
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1.3.4 Applications of the Overman Rearrangement 
Overman rearrangements are commonly used as the key step of many synthetic 
organic routes in widespread applications to simply and efficiently access naturally 
occurring and unnatural nitrogen-containing products.  
In 2002, Chida and co-workers reported a total synthesis of sphingofungin E 39 
from D-glucose via the thermal Overman rearrangement as a key step.52 
Diacetone-D-glucose 34 was converted to 1,2-O-isopropylidene-3-O-
methoxymethyl-α-D-glucofuranose in two steps in 90% yield followed by selective 
benzylation to give 35 in 95% yield (Scheme 22). The glucofuranose 35 was 
subjected to Swern oxidation and Wittig reaction and gave the corresponding ester 
in 95% over two steps. A DIBAL-H reduction was carried out on the resulting ester, 
followed by subsequent chromatographic separation which led to (Z)-allyl alcohol 
36 in 71% yield and 13% yield of its (E)-isomer. The (Z)-isomer was allowed to 
react with trichloroacetonitrile and a catalytic amount of DBU, followed by 
Overman rearrangement conditions which led to 37 and its C-5 epimer 38 in 60% 
and 14% yields from 36, respectively. Further transformations were carried out on 
Overman product 37 that led to the sphingofungin E 39.        
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Scheme 22: Total synthesis of sphingofungin E 39. 
In 2004, Sutherland and co-workers reported the first enantioselective synthesis of 
the amino acid, (2S,3S,4R)- -hydroxyisoleucine 46 using a palladium(II)-catalysed 
Overman rearrangement.18 The route started with the conversion of poly (R)-
hydroxybutanoate 40 to allylic trichloroacetimidate 41 in seven separate steps 
(Scheme 23). Using the thermal Overman rearrangement gave a 3:2 ratio of 
diastereomers 42 and 43, while the Pd(II)-catalysed Overman rearrangement of 41 
gave the desired product 43 in higher yield and an improved selectivity (1:7 ratio).  
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Entry Conditions Ratio (42:43) Yield (%) 
1 p-xylene, Δ, 24 h 3:2 54 
2 PdCl2(MeCN)2, rt, 3 h 1:6 65 
3 PdCl2(PhCN)2, rt, 3 h 1:7 71 
 
Scheme 23: Overman rearrangement of trichloroacetimidate 41.18 
Ozonolysis of the 1:7 diastereomeric mixture in an alcoholic base gave the 
corresponding esters 44 and 45, which were separated using column 
chromatography (Scheme 24). Deprotection under acidic conditions and ion 
exchange chromatography gave the desired product 46 in high yield.   
 
Scheme 24: Synthesis of amino acid 46. 
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Synthesis of α-alkylidene-β-lactam derivatives in high yields and excellent 
enantioselectivity was carried out utilising optically active α-alkylidene-β-amino 
esters via the thermal Overman rearrangement as a key step.53 (Z)-β-Iodo Morita-
Baylis-Hillman (MBH) esters have been formed using highly enantioselective and 
(Z)-stereocontrolled three-component coupling of acetylenic esters, aldehydes, 
and trimethylsilyl iodide (TMSI) in the presence of chiral cationic oxazaborolidinium 
catalyst in good to excellent yield and enantioselectivity (Scheme 25). Then, a 
metal-catalysed cross-coupling reaction was carried out on these esters to give β-
branched MBH esters in highly enantioselectivity, up to 96% ee. In the second 
stage, the resulting allylic alcohols were subjected to the thermal Overman 
rearrangement conditions to form the corresponding α-alkylidene-β-amino esters 
in moderate to quantitative yields and highly (E)-enantioselectivity (E/Z, up to 
>99/1). These precursors were converted to α-alkylidene-β-lactams. For instance, 
basic hydrolysis of the Overman products 47 using water/ethanol system gave the 
corresponding amino acid 48. Treatment of 48 with 2,2′-dipyridyldisulfide and 
triphenylphosphine (PPh3) led to the formation of the α-alkylidene-β-lactam 
derivative 49 in 85% yield.  
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Scheme 25: Synthesis of α-alkylidene-β-lactam derivative 49.  
 
The use of a palladium(II)-catalysed MOM-ether directed Overman rearrangement 
was recently reported as an alternative method for the stereoselective synthesis of 
the bicyclic guanidine alkaloid (+)-monanchorin 63.49 The key step of this route is 
the formation of a second stereogenic centre via the Overman rearrangement. 
First, preparation of the required allylic alcohol 51 for the Overman rearrangement 
begins with using the commercially available (R)-glycidol 50 utilising a sequence of 
reactions (Scheme 26). In the second stage, allylic alcohol 51 was transformed to 
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the corresponding allylic trichloroacetimidate 52 using trichloroacetonitrile in the 
presence of a catalytic amount of DBU at room temperature, followed by the 
MOM-ether directed Pd(II)-catalysed Overman rearrangement to give two 
diastereomers 54 and 55 in a 12:1 ratio, in addition to a trace amount of the 1,3-
product 56. The addition of a catalytic amount of p-benzoquinone (BQ) to the 
rearrangement step inhibited the formation of the 1,3-product and increased the 
yield of 54 to 84%.  
 
Scheme 26: Diastereoselective synthesis of 54 via the Overman 
rearrangement key step.  
 
In the last stage, exchanging the trichloroacetyl protecting group of the desired 
Overman product 54 with the Cbz-protecting group was necessary. This 
transformation was carried out via basic hydrolysis, using sodium hydroxide, 
followed by the addition of benzyl chloroformate in a one-pot reaction to form the 
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carbamate 57 in 81% yield (Scheme 27). This carbamate was transformed to 59 
through cross metathesis utilising a catalytic amount of Grubbs 2nd generation 
catalyst (10 mol%) and 2-vinyl-1,3-dioxolane 58 to form the product 59 in 87% 
yield. Hydrogenation of the double bond and removal of the Cbz-group using 
palladium on carbon under an atmosphere of hydrogen gave the corresponding 
amine 60. This was reacted with the commercially available N,N’-bis(tert-
butoxycarbonyl)-1H-pyrazole-1-carboxamidine 61 in the presence of Hünig’s base 
leading to the formation of guanidine 62 in 87% yield. Completion of the route was 
achieved by reaction of 62 with trifluoroacetic acid (TFA) to produce the natural 
alkaloid 63 in 75% yield. 
 
 
Scheme 27: Synthesis of the natural product (+)-monanchorin 63.  
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1.3.5 Conclusions 
The Overman rearrangement is considered as an effective and powerful 
transformation that has been utilised as a key step in synthetic organic chemistry 
for the construction of a wide spectrum of nitrogen-containing compounds. This 
transformation can proceed thermally or catalytically via a number of soft metal 
catalysts such as Hg(II), Pd(II), Pt(II) and Au(I) under milder conditions.  
Further developments of Pd(II)-catalysts have led to the synthesis of some useful 
and efficient highly enantioselective asymmetric catalysts such as the COP family 
which have become commercially available catalysts.  Those catalysts have found 
widespread synthetic applications and significantly contributed to the synthesis of 
natural products.  
More recently, the highly diastereoselective chiral group-directing substrate 
Overman rearrangement, in particular using the MOM-directing group, has been 
developed and provided an alternative approach for the construction of naturally 
occurring and unnatural products.  
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1.4 Ring-Closing Metathesis (RCM) 
1.4.1 Olefin Metathesis 
Olefin metathesis (OM) is a transition metal alkylidene-catalysed transposition 
process of two olefin groups to form a new carbon-carbon double bond.54–64 The 
first use of this Greek term, which means change of the olefin position, was in 
1967 by Calderon and co-workers.65 Olefin metathesis emerged as a useful and 
effective approach in synthetic organic chemistry. This methodology has played a 
remarkable role in construction of highly substituted alkenes and synthesis of 
natural products and contributed significantly to the development of polymer 
chemistry. Since the mid-1950s, when this reaction was first reported, till the early 
1980s, the olefin metathesis was promoted by ill-defined multi-component catalyst 
systems. Tungsten, molybdenum and rhenium catalysts compromised the most 
used catalysts at that stage. For example, tungsten(VI) chloride/tetrabutyltin 
(WCl6/Bu4Sn), molybdenum(VI) oxide/silicon dioxide (MoO3/SiO2) and rhenium(VII) 
oxide/aluminium oxide (Re2O7/Al2O3) were commercially available, but had some 
limitations. Utilising these catalysts required harsh conditions and strong Lewis 
acids making them incompatible with most functional groups. Further 
improvements on the design of catalysts and detailed mechanistic studies led to 
the first use of single-component catalysts in olefin metathesis processes, such as 
diphenylcarbene(pentacarbonyl)tungsten(0) ((CO)5W=CPh2) which was reported 
by Katz and co-workers.66 
Olefin metathesis includes ring-closing metathesis (RCM), ring-opening 
metathesis polymerisation (ROMP), cross-metathesis (CM), ring-opening 
metathesis (ROM) and acyclic diene metathesis polymerisation (ADMET) (Figure 
3). The most used of these processes is the ROMP, which is exclusively used in 
polymer chemistry, and the RCM, which is widely used in preparation of different 
ring sizes of carbo- and heterocyclic compounds in organic syntheses.54–64,67  
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Figure 3: Olefin metathesis reactions. 
 
Olefin metathesis proceeds according to the Chauvin mechanism (Scheme 28).55–
58,68–70 First, an olefin substrate reacts with a metal alkylidene complex to form a 
metallacyclobutane intermediate via a [2+2] cycloaddition process. Then, a [2+2] 
cycloreversion transformation leads to an olefin metathesis product and a new 
metal alkylidene complex. This mechanism appears to be the same for all 
catalysts and proceeds under thermodynamic control.  
 
Scheme 28: Mechanism of olefin metathesis. 
 
 
36 
 
1.4.2 Ring-Closing Metathesis 
The first use of the ring-closing metathesis (RCM) reaction in organic synthesis 
was reported by Tsuji and Villemin in 1980.71,72 For example, the ring-closing 
metathesis reaction of oleyl oleate 64 using WCl6 and Cp2TiMe2 as a co-catalyst 
gave metathesis product 65 in 18% yield (Scheme 29).71 The ester 64 was readily 
prepared from oleic acid and oleyl alcohol. Conduction of this reaction, separation 
of the product and recovery of the starting material were all easy. The authors 
expected that this transformation would be a promising technique when they wrote 
“therefore, this method may be a good synthetic method of macrolides by further 
improvement.” This cyclisation by intramolecular metathesis is well-known as 
macrocyclisation in the ring-closing metathesis perspective. 
 
Scheme 29: First reaction of ring-closing metathesis. 
In the last three decades, the ring-closing metathesis reaction has attracted great 
attention as a versatile carbon-carbon double bond forming method. Further 
comprehensive studies reported mainly by the Schrock, Grubbs, Hoveyda and 
other research groups on well-defined catalyst systems led to a dramatic 
development of the ring-closing metathesis approach.54–58 This unique strategy 
was considered as an effective method in synthetic organic chemistry and 
provided unprecedented route to cyclic compounds that were difficult to form or 
inaccessible by any other methods. Further advances in catalyst design made the 
RCM reaction successfully used in widespread applications in different chemistry 
fields. It was efficiently used on acyclic dienes, enynes, and dienynes precursors 
with high tolerance to many functional groups for the synthesis of medium rings 
and macrocyclic molecules. Molybdenum- and ruthenium-based alkylidene 
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catalysts are the most common, useful and effective catalysts in RCM reactions 
(Figure 4).  
 
Figure 4: The ring-closing metathesis well-defined catalyst systems. 
According to detailed mechanistic studies and experimental observations,68–70,73–76  
the catalytic ring-closing metathesis mechanism proceeds via two general steps, 
an initiation step and a propagation step (Scheme 30).61 In the initiation step, a 
generated active carbene- or alkylidene-metal catalyst complex reacts via cross 
metathesis with one side of olefin substrate 73 to give metallacyclobutane 74 in 
presumably a reversible step. While in path A the olefin substrate might be 
regenerated, in path B two σ-bonds are supposedly cleaved to form a new active 
metal complex intermediate 75 with liberated ethylene. Thereafter, this 
intermediate cross-metathesises to give new metallacyclobutane 76 which 
dissociates into metathesis product 77 and new M=C intermediate 78. The 
catalytic cycle is then completed and the last formed active metal complex 78 
initiates a new catalytic cycle through the propagation step. The reaction driving 
force is that metathesis product 77 does not react via ring-opening metathesis with 
active metal catalyst complex 78.   
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Scheme 30: Mechanism of the ring-closing metathesis reaction. 
 
1.4.3 Catalysis of the Ring-Closing Metathesis (Well-Defined Catalyst 
Systems)  
The 1990s was the most important decade with regard to contribution to the 
development of ring-closing metathesis chemistry. Development of molybdenum 
and ruthenium catalyst systems, in particular the well-defined ruthenium-based 
catalysts, has made ring-closing metathesis to be a common, efficient and 
powerful methodology in organic synthesis.  
The first synthesis of an effective catalyst (Schrock catalyst 66) for initiation of the 
ring-closing metathesis reaction was reported in 1987 by Schrock and co-workers 
(Figure 4).77 This catalyst was utilised later by Grubbs and co-worker for synthesis 
of oxygen and nitrogen heterocycles via ring-closing metathesis reaction (Table 
1).78,79 In addition, synthesis of cycloalkenes was easily and efficiently accessible 
via the ring-closing metathesis of dienes and carbonyl olefination using the Mo-
based catalyst 66.80 
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Table 1: Synthesis of cyclic olefins via RCM using Schrock catalyst 66.80 
Although the Schrock catalyst exhibited high activity for the RCM reaction, looking 
for more efficient catalyst systems was required to increase activity, functional 
group tolerance, higher thermal stability and air and moisture stability. On the 
basis of detailed mechanistic studies, ligand design provided more effective 
molybdenum and ruthenium alkylidene complex systems. In 1992, the Grubbs 
research group reported the synthesis of the first well-defined ruthenium-based 
olefin metathesis catalyst 68.81 This ruthenium carbene complex was used by 
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Grubbs and co-workers to initiate the ring-closing metathesis reaction of 
functionalised dienes for preparing functionalised heterocyclic alkenes and 
dienynes that were used for construction of fused bicyclic rings.82,83 For example, 
cyclisation of dienes via the RCM reaction utilising the ruthenium carbene catalyst 
68 (2–4 mol%) at room temperature gave a range of functionalised heterocycles in 
high yields (Table 2).82 Five-, six-, and seven-membered rings were efficiently 
synthesised. The cyclisation of the substrate in entry 3 failed using the 
molybdenum alkylidene catalyst.78   
 
Table 2: Cyclisation of dienes via the RCM reaction using Ru catalyst 68.82 
In addition, the construction of fused bicyclic rings was efficiently performed using 
the ruthenium alkylidene catalyst 68. For example, acyclic dienynes with 
unsymmetrical diene tethers gave bicyclo[4.4.0] and bicyclo[5.3.0] rings, as sole 
products, in 83% and 78% yields, respectively (Table 3).83 
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Table 3: Construction of fused bicyclic rings via the RCM reaction using Ru 
catalyst 68.83 
The catalyst 68 also showed stability to air and moisture, and more functional 
group tolerance than Schrock catalyst 66. Consequently, the Grubbs research 
group also reported cyclisation of a variety of conformationally constrained amino 
acids and peptides utilising the same catalyst 68.84  
Later, ruthenium alkylidene catalyst 68 was used as precursor for synthesis of 
Grubbs first-generation catalyst 69. This development led to discovery of a more 
active catalyst (Grubbs second-generation catalyst) 70 in 1999 (Figure 4).85,86 
Although ruthenium benzylidene complex (Grubbs I catalyst) 69 possessed some 
advantages over the alkoxy-imido molybdenum complex (Schrock catalyst) 66, 
Grubbs II catalyst 70 exhibited an increased ring-closing metathesis activity at 
elevated temperature and low catalyst loading could be used. Furthermore, the 
Schrock and Grubbs research groups have reported the synthesis of a series of 
Mo- and Ru-based catalyst systems and supported these syntheses with detailed 
mechanistic investigations and a variety of applications.57,58,67,87–89 Meanwhile, 
Hoveyda and co-workers have contributed to the development of molybdenum and 
ruthenium catalyst systems for the ring-closing metathesis reaction. As a result, 
they reported synthesis of Hoveyda first- and second-generation catalysts 71 and 
72, respectively, in addition to Schrock-Hoveyda catalyst 67.90–92 These active 
catalysts were easily obtained and exhibited high stability to air and moisture. 
Furthermore, their studies showed that these catalysts can be recycled in high 
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yield by silica gel column chromatography, which is considered as a unique 
property. Hoveyda second-generation catalyst 72 also exhibited the ability to 
synthesise tetrasubstituted olefins through the ring-closing metathesis reaction 
(Table 4).91  
 
Table 4: Synthesis of tetrasubstituted olefins via RCM using Ru catalyst 72.91 
 
1.4.4 Scope of the Ring-Closing Metathesis Reaction 
The ring-closing metathesis reaction attracted the attention of many research 
groups as a useful and powerful reaction in synthetic organic chemistry. In 
addition, development of the well-defined, stable molybdenum and ruthenium 
catalyst systems has made them commercially available. These active catalysts 
contributed to the expansion of the scope of olefin metathesis and its 
subcategories. In particular, the RCM reaction showed significantly high flexibility 
and tolerance to functional group, ring size, reaction conditions and 
stereochemistry of molecules. The catalytic ring-closing metathesis reaction was 
carried out on dienes, enynes and dienynes and employed efficiently in synthesis 
of tri- and tetrasubstituted cyclic olefins.54–56,93 Tandem (ROM/RCM) catalysis,68,93–
97 macrocyclisation,68,94,98–101 ring expansion,102 and peptide chemistry68  were also 
initiated by the well-defined catalyst complexes. High enantioselectivity via 
asymmetric ring-closing metathesis (ARCM) using chiral catalysts,68,103–114 
construction of heterocycles,115,116 natural product synthesis117 and synthesis of 
aromatic compounds59,118,119 were also efficiently performed.  
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The Grubbs first-generation catalyst 69, for example, was utilised in the tandem 
ring opening-ring closing metathesis reaction of strained cyclic olefins. 
Consequently, this method was applied for the construction of four- to eight-
membered rings of diene substrates (Table 5). The metathesis products were 
obtained in good to high yields.94 
 
Table 5: Tandem ring opening-ring closing metathesis reaction using the 
ruthenium alkylidene catalyst 69.94 
Furthermore, a range of macrocycles were generated for cycloalkenes and acyclic 
dienes by a ring-expansion method using Grubbs second-generation catalyst 
70.102 This new approach combined three metathesis transformations; ring-
opening, cross, and ring-closing metathesis reactions. The authors showed that for 
the ring expansion to be efficiently performed, several conditions had to be 
considered. “The cycloalkenes must be able to undergo the ring-opening reaction. 
Once opened, they must react selectively with the acyclic diene for CM and RCM 
to minimise side products. In addition, the acyclic diene should not undergo 
reactions with itself such as cyclisation or cross metathesis.” For example, bis-
acrylate substrates were expanded via the ring-expansion metathesis process. 
These transformations gave the macrocycles in moderate yields using the catalyst 
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70 (5 mol%) under reflux conditions, in dichloromethane (5 mM) (Table 6). Also, 
the ring sizes were adjusted by using a range of readily available cyclic alkenes. 
 
Table 6: Ring-expansion via olefin metathesis using the ruthenium 
alkylidene catalyst 69.102 
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Prevention of undesirable isomerisation during olefin metathesis117 and 
recyclability90,91,121 of some of these catalysts added other unique 
characterisations of this methodology. In addition, the well-defined catalyst 
systems were used to efficiently initiate the RCM reaction as a key step in one-pot 
reaction processes.122–123 Some additives, in particular 1,4-benzoquinones, 
showed significant efficiency for the prevention of undesirable olefin isomerisation 
of a number of olefins.120 For example, the RCM reaction of diallyl ether using the 
ruthenium catalyst 70 gave the corresponding metathesis product 2,5-dihydrofuran 
P1 after 1 h (Table 7). After extended reaction time, the isomer 2,3-dihydrofuran 
P2 was observed. The authors suggested that this was due to prolonged reaction 
time and also to the decomposition caused by the catalyst. A number of additives 
were examined such as acetic acid, 1,4-benzoquinone, 3,5-di-tert-butyl-4-
hydroxytoluene (BHT), (2,2,6,6-tetramethylpiperidin-1-yl)oxyl (TEMPO), phenol, 
and 4-methoxyphenol. Only acetic acid and 1,4-benzoquinone were effective.   
 
 
Table 7: Role of additives in the prevention of undesirable isomerisation 
during the ring-closing metathesis reaction.120 
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Although acetic acid prevented the isomerisation of the diallyl ether metathesis 
products, it did not exhibit any efficiency when self-metathesis reaction of (Z)-1,4-
bis(tert-butyldimethylsiloxy)-2-butene was applied (Table 8). Whereas, the 1,4-
benzoquinone additive showed the same efficiency. 
 
Table 8: 1,4-Benzoquinone as the most effective additive in the prevention of 
undesirable isomerisation during olefin metathesis.120 
 
The Hoveyda research group reported a number of Ru-based catalysts that were 
recyclable as olefin metathesis initiators. These active catalysts such as the 
Hoveyda first- and second-generation catalysts 71 and 72 were easily obtained 
from the Grubbs first- and second-generation catalysts 69 and 70, 
respectively.90,91 For example, the Hoveyda first-generation catalyst 71 which 
exhibited high activity for the ring-closing metathesis reaction was recovered after 
silica gel chromatography as a homogeneous solid residue in up to 95% yield 
(Table 9).90 The catalyst 71 (5 mol%) converted acyclic alkenes in 
dichloromethane at 22 °C to the corresponding metathesis products in high yields. 
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Table 9: The RCM reaction of acyclic dienes using the Ru-catalyst 71.90 
The 1H NMR and 13C NMR spectra and elemental analysis of the recovered 
catalyst and recrystallised form of 71 were identical. Thereafter, the recovered 
catalyst 71 was reused directly in the subsequent ring-closing metathesis 
reactions and exhibited the same efficiency (Table 10). The recycled catalyst 71 
was transferred to a new reaction vessel and charged with the substrate and 
solvent. Then, the RCM reaction of the same substrates (in Table 9) was repeated 
three times at 22 °C using the recycled catalyst 71 (5 mol%) in dichloromethane. 
Yields of the products and the recovered catalyst were consistent with yields of the 
first use of the same catalyst.  
 
Table 10: The RCM reaction using the recycled ruthenium-catalyst 71.90 
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1.4.5 Applications of the Ring-Closing Metathesis Reaction 
Over two decades, the ring-closing metathesis reaction has played an important 
role as an attractive and powerful transformation in olefin cyclisation chemistry. 
However, development of the well-defined RCM catalysts led to impressive 
synthetic applications.63,64 The Fürstner research group used development of the 
ring-closing metathesis reaction for synthesis of natural products. For example, 
they utilised Mo- and Ru-based catalysts in the total syntheses of marine natural 
products. In 1996, they reported a concise total synthesis of dactylol 87 and its 
epimer 88 via the ring-closing metathesis reaction and using Schrock catalyst 66. 
Consequently, this novel and short method efficiently afforded this natural product 
and its epimer in six steps (Scheme 31).126 First, cyclopentenone 80 was 
subjected to two reaction steps to give enone 81. Afterwards, chemo- and 
diastereoselective hydrogenation of 81 with tri-n-butyltin hydride in the presence of 
zinc chloride and a catalytic amount of Pd(PPh3)4 gave 82 in 83% yield. Next, 
treatment of the resulting trans-isomer 82 with mixture of Grignard reagent of 3-
bromo-2-methyl-1-propene and suspension of anhydrous cerium(III) chloride in 
THF gave 83 and 84 in a 1:1.2 ratio. Thereafter, column chromatographic 
separation of the diastereomers followed by O-silylation using in situ formed N,O-
bis(trimethylsilyl)acetamide from (Me3Si)2NH, acetyl chloride, and 
dimethylaminopyridine (DMAP) gave stable silyl ethers 85 and 86 in 93% and 95% 
yield, respectively. Finally, cyclisation of 85 and 86 using a relatively low loading of 
Schrock catalyst 66 afforded the corresponding alkenes which were subjected to 
desilylation using tetra-n-butylammonium fluoride (TBAF) to give doctylol 87 and 
3a-epi-dactylol 88 in 92% and 85% yield, respectively. Therefore, this approach 
demonstrated a successful application of the RCM process for synthesis of 
challenging 8-membered rings and for synthesis of the natural product 87 and its 
epimer 88. 
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Scheme 31: Total synthesis of dactylol 87 and its epimer 88. 
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In addition, Fürstner and co-workers reported total syntheses of amphidinolide T1, 
T3, T4, and T5.127 These cytotoxic macrocycles of marine origin were synthesised 
utilising the ring-closing metathesis process as a key step. Amphidinolide T1 and 
T4, for example, were synthesised from commercially available hydroxyl ester 89 
which was converted to compound 90 through a series of steps (Scheme 32). 
Hereafter, intermediate 90 underwent macrocyclisation using ruthenium catalyst 
91 to generate intermediate 92 in 86% yield (E/Z, 6:1). Next, hydrogenation of the 
macrocycle followed by methylenation using Nysted’s reagent 93 gave 19-
membered macrocyclic ring 94 in good yield. 
 
Scheme 32: Synthesis of macrocycle 94. 
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In the last stage, the macrocycle precursor 94 was used to synthesise 
amphidinolide T1 (96) and T4 (98) (Scheme 33). In one route, selective 
deprotection of the TBDPS group using [(Me2N)3S][Me3SiF2] gave 95 in 84% yield. 
Then, Dess-Martin oxidation of the resulting alcohol 95 followed by MOM group 
removal under slightly acidic conditions using Dowex AG 50W-X4 resin in MeOH 
gave amphidinolide T1 (96) in 52% yield. Alternatively, removal of the MOM group 
using TMSBr generated in situ, followed by Dess-Martin oxidation and selective 
cleavage of the TBDPS group led to formation of amphidinolide T4 (98) in high 
yields over three steps.  
 
Scheme 33: Total syntheses of amphidinolide T1 (96) and T4 (98). 
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(Z/E)-Setereoselective macrocyclisation was one of the key features of ruthenium-, 
molybdenum- and tungsten-catalysed RCM reactions.63 For example, Grubbs and 
co-workers utilised the ruthenium-catalysed RCM approach for the formation of 
diverse of macrocycles in high Z-selectivity from different dienes with a variety of 
functional groups and ring sizes (Scheme 34).113   
 
 
Scheme 34. Z-Selective macrocyclisation using ruthenium catalyst. 
 
Molybdenum- and ruthenium-based catalytic tandem, domino and multi-olefin 
metathesis transformations have attracted the attention of many research groups 
as a unique approach in total synthesis of natural products. Martin and co-workers 
reported the first total synthesis of novel sesquiterpene lactone (+)-8-epi-xanthatin 
(104) via a domino ring-closing enyne metathesis (RCEYM)/cross metathesis 
(CM) reaction.128 This natural product, which exhibits a range of biological 
activities, was synthesised from commercially available ester 99 in 14 steps and in 
5.5% overall yield (Scheme 35). Firstly, the starting material 99 was tosylated 
using TsCl in the presence of Et3N and DMAP to give 100 in 96% yield. Then, a 
series of sequential transformations were carried out on 100 that led to enol triflate 
101. Afterwards, palladium-catalysed carbonylation of 101 gave the corresponding 
acrylate 102 in 85% yield. Thereafter, treatment of 102 with TBAF to remove the 
silyl protecting groups followed by spontaneous lactonisation of the intermediate 
generated the desired enyne 103 in 78% yield. For the last step, the domino 
RCEYM/CM reaction process of enyne 103 and methyl vinyl ketone in the 
presence of Hoveyda second-generation catalyst 72 afforded lactone (+)-8-epi-
xanthatin (104) in 83% yield. 
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Scheme 35: The first total synthesis of (+)-8-epi-xanthatin (104). 
 
In 2004, Nolan, Mioskowski and co-workers reported a new method for the 
synthesis of a highly substituted dihydrofuran ring utilising a ruthenium 
imidazolylidene catalytic ring-closing metathesis process.129 The strategy was 
applied in synthesis of solamin (111) (Scheme 36). The natural product 111 was 
obtained from commercially available propargylic alcohol in sequential reaction 
steps. First of all, the substrate precursor for the RCM reaction was synthesised 
from a coupling reaction between two fragments 105 and 106, which were both 
obtained from propargylic alcohol.  Epoxide ring-opening reaction of 106 by 105 in 
the presence of Cu(OTf)2 reagent gave the corresponding ether 107 in 35% 
isolated yield and recovery of 105 in 46% yield. Then, the resulting ether was 
converted to the silyl protected diene 108 in 95% yield.  
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Scheme 36: The total synthesis of solamin (111). 
 
While cyclisation of 108 using Mo-based Schrock catalyst 110 failed to give the 
metathesis product, initiation of the RCM reaction using Grubbs first-generation 
catalyst 69 was slow and gave 109 in 35% yield. Alternatively, catalyst 91, 1,3-
dimesitylimidazol-2-ylidene ruthenium benzylidene, (5 mol%) afforded 109 in 80% 
isolated yield. The next six steps transformed the metathesis product 109 to the 
natural product, solamin (111). 
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Synthesis of chiral molybdenum and ruthenium catalysts was a point of interest of 
many research groups. Accordingly, detailed mechanistic studies and 
comprehensive synthetic investigations led to the development and synthesis of a 
number of effective chiral molybdenum and ruthenium catalysts. Some of these 
catalysts exhibit efficient use in total synthesis of natural products and construction 
of chiral molecules.103–114 The Schrock and Hoveyda research groups developed 
enantioselective synthesis of cyclic secondary amines, cyclic amides and amines, 
and cyclic enol ethers through the molybdenum-catalysed asymmetric ring-closing 
metathesis (ARCM) reaction.130–132 For example, the authors reported the 
enantioselective synthesis of cyclic unsaturated secondary amines which was 
carried out by the Mo-catalysed ARCM reaction of an achiral olefin in up to 93% 
ee.130 First, achiral polyene substrate 112 was converted efficiently to secondary 
bicyclic amine 114 after 3 h at 55 °C in 75% isolated yield and 93% ee (Scheme 
37). This enantioselective transformation was initiated by chiral molybdenum 
alkylidene complex 113. The resulting optically enriched benzazepine 114 (93% 
ee) was converted to a polycyclic structure. During this stage, allylation with allyl 
bromide and benzylpotassium (C7H7K) followed by addition of achiral Schrock 
catalyst 66 gave tricyclic amine 115 in 69% yield and 93% ee.  
 
Scheme 37: Enantioselective synthesis of bicyclic amine 114 and its 
conversion to tricyclic amine 115. 
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The first enantioselective synthesis of cyclic amides and amines via the Mo-
catalysed ARCM reaction with up to 98% ee was reported in 2005.131  Key 
substrates were prepared from commercially available materials and underwent 
the ARCM reaction using a number of molybdenum alkylidene catalysts. For 
example, cyclic amide 116 was subjected to triallylborane 117 according to 
Bubnov conditions to afford amine 118 in 65% yield (Scheme 38).133 Thereafter, 
allylation of 118 in the presence of benzylpotassium gave the desired triene 119 in 
92% yield. Then, the catalytic ARCM reaction of 119 led to formation of N-fused 
5,6-bicyclic amide 121 in 91% isolated yield and >98% ee after 48 h using 10 
mol% loading of binaphthol-based molybdenum complex 120 as the most effective 
chiral catalyst among the others screened. 
 
 
Scheme 38: The first enantioselective synthesis of optically enriched N-
fused bicyclic amide 121. 
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Within this context, Martin and co-workers reported the first enantioselective 
synthesis of (+)-isolysergol (130) via asymmetric ring-closing metathesis.134 This 
new method involved microwave-mediated, diastereomeric Mo-catalysed ARCM 
reaction as a key step towards total synthesis of natural product (130) from 
commercially available substrate 122 (Scheme 39). The starting material 122 was 
converted through a series of steps to 123 which was subjected to 
bispentadienylzinc and gave a mixture of 124 and 125 in 91% yield (in 2:1 
regioselectivity) which was easily separated. Subsequently, the separated triene 
124 was microwave-irradiated (50 W, 0.5 h) in the presence of Schrock-Hoveyda II 
catalyst 67 to afford 126 and 127 in 55% and 20% yields, respectively. During this 
process, Grubbs I 69, Grubbs II 70, and Schrock catalyst 66 in addition to several 
other chiral molybdenum-based catalysts were examined but without improved 
levels of diastereoselectivity of 126 or 127. Selective dihydroxylation of 126 
utilising Donohoe conditions gave diol 128 in 74% yield.135 Afterwards, oxidative 
cleavage of diol 128 with periodic acid in the presence of trifluoroacetic acid, 
followed by reduction using sodium cyanoborohydride gave 129 in 83% yield. In 
the last step, quantitative yield of the desired natural product (130) was obtained 
from removal of the tosyl protecting group. 
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Scheme 39: The first enantioselective synthesis of (+)-isolysergol (130). 
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1.4.6 Conclusions  
The ring-closing metathesis (RCM) reaction has emerged as an effective, common 
and powerful transformation that has been universally used as a key step in 
synthetic organic chemistry for the total syntheses of natural products. This 
method can be initiated using transition metals such as tungsten, rhenium, 
molybdenum, and ruthenium.  
Well-defined molybdenum and ruthenium alkylidene catalyst complexes exhibited 
the most effective catalysis of the RCM reaction. Developments of these catalytic 
systems led efficiently to construction of a range of cyclic systems, with the 
catalyst becoming commercially available.  
Further developments led to the synthesis of chiral Mo- and Ru-based catalyst 
systems which were utilised efficiently for the construction of chiral cyclic 
compounds. The asymmetric ring-closing metathesis (ARCM) catalysts have 
contributed widely to the total synthesis of natural products. (Z/E)-Setereoselective 
macrocyclisation using specially designed catalysts was also utilised for the 
synthesis of natural products.  
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1.5 One-Pot Multi-Reaction Processes 
1.5.1 General Concepts 
“Green chemistry efficiently utilises (preferably renewable) raw materials, 
eliminates waste and avoids the use of toxic and/or hazardous reagents and 
solvents in the manufacture and application of chemical products.”136 On the basis 
of these principles, organic chemists turned their attention towards decreasing the 
environmental footprint of chemistry. Their efforts focused on development, design 
or discovery of efficient methods for synthesis of environmentally benign or safe 
organic products. Design of such processes can be guided by the twelve principles 
reported by Anastas and co-workers.137,138 
Awareness of environmental impact during the design of organic processes made 
discovery of new approaches and methods a challenge. The best synthetic 
processes involve reactions that proceed simply, selectively (chemo-, regio-, 
diastereo-, and enantioselectivity) and in environmentally friendly fashion (atom 
economy) to generate products.139 Combination of efficiency (step economy), 
environmental impact (atom economy), and pot economy concepts in synthetic 
chemistry leads to considerable enhancement of greener methodologies.140 While 
the step economy term means the reduction in the number of synthetic steps for 
more efficient methods, the pot economy term refers to conducting many 
sequential reactions in the same vessel without the need for work-up or 
purification between synthetic steps.140 Ultimately, development and discovery of 
organic syntheses that meet our needs and environmental requirements led to 
accepting the concept of one-pot processes as an efficient and promising 
approach in organic synthesis.141  
 
1.5.2 Types of One-Pot Processes 
Conduction of sequential and/or multi-step reactions in one vessel (one-pot 
synthesis) was described by using several terminologies, such as domino 
reactions, cascade reactions, tandem reactions, or multi-step multi-reaction 
processes.122,141–146 
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1.5.2.1 Domino Reactions 
Tietze and Beifuss termed “one-pot reactions” as “sequential transformations” and 
classified them into two main categories; domino reactions and consecutive 
reactions.142 According to the Tietze definition, the domino reaction is “a process in 
which more than one bond-forming transformation (usually C-C bonds) takes place 
in one vessel and under the same conditions without an addition of any reagent or 
catalyst” (Scheme 40).143 In consecutive reactions, the addition of another reagent, 
or catalyst was allowed after the first transformation without isolation of the formed 
product.142  
 
Scheme 40: Domino Knoevenagel hetero-Diels-Alder reaction.143 
 
1.5.2.2 Cascade Reactions 
In case of cascade reactions,146 Tietze suggested that “cascade” terminology is 
close to the meaning of the “domino” term and it is commonly used in literature to 
describe sequential reactions, but it does not describe the real meaning (Scheme 
41).143 Furthermore, Sutherland and co-workers classified the one-pot processes 
into two categories: domino or cascade reactions, and multi-step multi-reaction 
processes.122 Whereas Fogg and dos Santos described the cascade reactions as 
a “multiple domino sequence.”144  
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Scheme 41: Cascade reactions.146 
 
1.5.2.3 Tandem Reactions 
Fogg and dos Santos defined the tandem reaction as sequential reactions of 
substrate that are initiated by one or more catalysts via two or more 
mechanistically distinct processes which proceed through cooperative 
mechanisms or one after the other.144 The authors also classified the tandem 
sequences to orthogonal, assisted, and auto-tandem catalysis (Figure 5). In the 
case of the orthogonal tandem catalysis, all catalysts which initiate two or more 
distinct mechanisms are non-interfering and present from the outset of reaction. 
The auto-tandem processes involve “two or more mechanistically distinct 
catalyses promoted by a single catalyst precursor: both cycles occur 
spontaneously by cooperative interaction of the various species (catalyst, 
substrate, additional reagents if required) present at the outset of reaction. No 
reagents beyond those originally present need be added to trigger the change in 
mechanism.” In the assisted tandem processes, an addition of a further reagent is 
necessary to trigger a change in mechanism by changing a single catalyst 
species, found from the outset of reaction, to another species that causes another 
transformation.144  
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Figure 5: Types of tandem reactions.144 
 
1.5.2.4 One-Pot Multi-Reaction Processes  
Definition of one-pot multi-reaction processes is more comprehensive than other 
terms of the sequential transformations (domino, cascade, and tandem reactions) 
and simply combines all of those terminologies. They can be defined as multi-step 
reactions that are carried out in one vessel without the need for workup or isolation 
procedures between each step until the formation of final products. In addition, 
changing of reaction conditions and/or addition of any reagent or catalyst at any 
stage is allowed.122,141,142  
From the previous definitions of all types of the one-pot syntheses and according 
to taxonomy reported by Fogg and dos Santos, these processes can be simplified 
and illustrated (Figure 6).144  
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Figure 6: Types of the one-pot processes. 
 
One-pot syntheses were considered effective, efficient and greener approaches 
for construction of complex molecules such as biologically active molecules, 
pharmaceutical and medicinal compounds, natural products and other targets. 
Indeed, they reduced the number of reaction steps which lead to decrease of 
reaction times, costs, efforts, and environmental impact. From the perspective of 
the pot economy, these approaches avoided the need of several workup 
procedures, isolations, and purification of intermediates.122,141 Consequently, the 
need and necessity to develop or discover ideal and typical chemical reactions to 
increase selectivity and efficiency with minimal waste were always demanded as a 
high priority and a main goal for organic chemists in both academia and industry. 
Synthesis of tropinone (131) reported by Robinson, an entire century ago,145 was 
considered as an early, elegant example of one-pot synthesis (first domino 
reaction) (Scheme 42). Later, efforts by organic chemists working on this type of 
chemistry were centred around two issues; efficiency and environmental 
sustainability.141,143 
 
Scheme 42: One-pot synthesis of tropinone (131).145 
 
Tandem reactions 
Domino or cascade reactions 
One-pot multi-reaction processes 
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1.5.3. Application of the One-Pot Multi-Reaction Process  
One-pot multi-reaction syntheses, whether they are tandem, domino, cascade or 
sequential catalytic transformations attracted attention of organic chemists as 
unique, potential strategies for widespread application in organic syntheses, such 
as total synthesis of natural products and construction of biologically active 
compounds. Development of this methodology also played a major role in the 
generation of environmentally benign products taking account of economic and 
environmental concerns.122,141,143,146 As discussed in the ring-closing metathesis 
section, organic chemists have used tandem and domino strategies utilising RCM 
catalysts for construction of a wide range of cyclic structures and total synthesis of 
natural products.78,93–97,128 For example, Grubbs and co-workers reported the total 
synthesis of (R)-(−)-muscone (135) via auto-tandem three-step ruthenium-
catalysed reactions (Scheme 43). The RCM reaction of readily available diene 132 
using Grubbs II catalyst 70 (7 mol%) followed by ruthenium-catalysed transfer 
dehydrogenation of intermediate 133 in the presence of 3-pentanone and sodium 
hydroxide gave macrocycle 134.96 The resulting ketone 134 was hydrogenated, 
again using Grubbs II catalyst 70 to afford the natural product (R)-(−)-muscone 
(135) in 56% yield over three steps.  
  
Scheme 43: Auto-tandem three-step Ru-catalysed synthesis of natural 
product (R)-(−)-muscone (135).96 
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The concept of the pot economy strategy was efficiently embodied by the Hayashi 
research group. Recently, three-pot nine-step, three-pot eight-step, and one-pot 
six-step reaction processes were used for the total synthesis of biologically active 
and pharmaceutical compounds.147–149 For example, a high-yielding 
enantioselective total synthesis of the DPP4-selective inhibitor ABT-341 (147) via 
a one-pot six-step reaction process was effectively achieved (Scheme 44).149 
During this process, the inhibitor ABT-341 (147) was synthesised from four 
components: nitroalkene 136, acetaldehyde 138, vinyl phosphonate 140, and 
amine 145. In step one, an enantioselective Michael reaction of nitroalkene 136 
and acetaldehyde 138 was initiated by diphenylprolinol silyl ether organocatalyst 
137 (10 mol%) and the excess of 138 was removed under reduced pressure to 
afford intermediate 139. Next, the intermediate 139 was charged with vinyl 
phosphonate 140 and cesium carbonate (Cs2CO3) in dichloromethane at 0 °C 
which promoted a Michael reaction and was followed by a Horner-Wadsworth-
Emmons (HWE) reaction that afforded 141 and 142. Then, addition of ethanol to 
the reaction mixture in the presence of TMSCl drove conversion of the ester 141 to 
the cis-substituted cyclohexene 142 at room temperature. In step three, 
isomerisation of the cis-substituted cyclohexene 142 to trans-substituted isomer 
143 was achieved by addition of Hünig’s base (EtN(i-Pr)2) at room temperature. 
Then, treatment of the crude mixture of 143 with trifluoroacetic acid (TFA) in 
dichloromethane afforded the corresponding acid 144. Afterwards, a coupling 
reaction of the carboxylic acid 144 with heterocyclic amine 145 in the presence of 
O-(benzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium tetrafluoroborate (TBTU) and 
Et3N in N,N-dimethylformamide (DMF) generated the corresponding amide 146. In 
the last step, the nitro group was reduced utilising a mixture of zinc and acetic acid 
in ethyl acetate to provide the inhibitor ABT-341 (147) in 63% yield over six steps.   
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Scheme 44: One-pot six-step total synthesis of DPP4-selective inhibitor 
ABT-341 (147). 
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Interestingly, Overman rearrangement products showed remarkable tolerance 
towards different reaction conditions when they were charged with further catalysts 
to promote subsequent transformations in the same vessel. As a result, this 
property has been efficiently exploited by the Sutherland group. Over the past 
decade, they have developed a combination of the thermal and metal-catalysed 
Overman rearrangements with the ring-closing metathesis (RCM) reactions in the 
one-pot multi-step multi-reaction syntheses for construction of nitrogen-containing 
compounds and synthesis of natural products and biologically active 
molecules.122,150–160 For example, Sutherland and co-workers, reported the 
stereoselective synthesis of alkaloid, (+)-physoperuvine (155), using a one-pot 
strategy of the Overman rearrangement and the ring-closing metathesis reaction 
as a key step (Scheme 45).151 The first step of this synthesis was conversion of 
commercially available ethyl 6-heptenoate 148 into allylic alcohol 151 in four steps. 
First, a DIBAL-H reduction of 148 gave primary alcohol 149 in 94% yield. Next, a 
one-pot Swern oxidation and Horner-Wadsworth-Emmons (HWE) reaction 
afforded the corresponding (E)-α,β-unsaturated ester 150 in 85% yield over two 
steps. Then, a DIBAL-H reduction of the ester 150 led to a quantitative formation 
of the key substrate, allylic alcohol 151. In the second stage, (S)-N-
(cycloheptenyl)trichloroacetamide 154 was synthesised from allylic alcohol 151 
using a one-pot process. The allylic alcohol 151 was converted to allylic 
trichloroacetimidate 152 using a catalytic amount of DBU followed by the one-pot, 
two-step reaction process of the asymmetric palladium(II)-catalysed Overman 
rearrangement, using (S)-COP-Cl 24 (10 mol%), and the RCM reaction with 
Grubbs first-generation catalyst 69 (10 mol%) to give the amino-substituted 
cycloheptene 154 in 82% yield over three steps. Finally, subsequent 
transformations led to the total synthesis of (+)-physoperuvine (155). 
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Scheme 45: Stereoselective synthesis of (+)-physoperuvine (155) using the 
one-pot multi-step multi-reaction process. 
 
1.5.4 Conclusion  
One-pot reaction processes have attracted attention of organic chemists as an 
important strategy to access advanced synthetic intermediates, rapidly and 
efficiently, and to significantly minimise environmental impact. These methods 
have been utilised efficiently as key stages in the construction of a wide range of 
organic compounds and natural products. According to how substrates, catalysts, 
and reagents are added, one-pot reaction syntheses have been classified into 
domino, cascade and tandem reactions, in addition to one-pot multi-step multi-
reaction processes. The one-pot multi-step multi-reaction processes have wider 
definition than others and are more flexible in applications for synthesis of organic 
compounds over the other approaches. 
70 
 
2.0  Results and Discussion 
2.1 Synthesis of 5-Amino-Substituted 2,5-Dihydro-1-benzoxepines 
2.1.1 Previous Work within the Sutherland Group 
Previously, the Sutherland group has developed access to cyclic allylic amide 
systems via one-pot reaction processes. This strategy was utilised for the total 
synthesis of natural products and the construction of complex molecules that have 
biological activity (Scheme 46).150–152,155,160  
 
Scheme 46:  One-pot Overman rearrangement and RCM reaction process. 
The first synthesis of the cyclic allylic amide systems utilising this methodology 
began by preparation of allylic alcohols as the key substrates. Commercially 
available alken-1-ols 156a–d were converted to the corresponding allylic alcohols 
158a–d in three steps (Scheme 47).150 First, a one-pot Swern oxidation and 
Horner-Wadsworth-Emmons (HWE) reaction process using Masamune-Roush 
conditions led to the formation of the corresponding (E)-α,β-unsaturated esters 
157a–d in 69–90% yield.161,162 Next, DIBAL-H reduction of the resulting esters 
157a–d afforded allylic alcohols 158a–d in high to quantitative yield. The precursor 
allylic alcohols were reacted with trichloroacetonitrile and a catalytic amount of 
DBU to form allylic trichloroacetimidates 159a–d. These intermediates 159a–d 
were then subjected to a one-pot palladium(II)-catalysed Overman rearrangement 
and ruthenium(II)-catalysed ring-closing metathesis reaction process to give the 
cyclic allylic trichloroacetamides 160a–d in high yields over three steps.   
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Scheme 47:  Development of the one-pot Overman rearrangement and RCM 
reaction process. 
Further work showed that this process could be extended for the synthesis of 
heterocyclic ring systems. These type of structural variations were utilised 
efficiently for the synthesis of different heterocyclic systems such as bicyclic -
lactams (Scheme 48).153,154,157  
 
Scheme 48: Synthesis of heterocyclic bicyclic -lactams via the one-pot 
process. 
For example, synthesis of 3-amidoazepine using a one-pot multi-bond forming 
three-step process represented a typical target for this new methodology.157 
Initially, commercially available 2-aminoethanol 161 was converted quantitatively 
to 162 via a coupling reaction with 4-bromo-1-butene in the presence of sodium 
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iodide (Scheme 49). The resulting alcohol 162 was protected with TBDPSCl which 
then allowed Boc protection of the secondary amine to give 163. Then, silyl 
deprotection using TBAF at 0 °C afforded alcohol 164. Next, Swern oxidation of 
alcohol 164 followed by a Witting reaction using 
(triphenylphosphoranylidene)acetaldehyde afforded 165. Afterwards, sodium 
borohydride reduction of the resulting aldehyde 165 generated (E)-allylic alcohol 
166 in 88% isolated yield.  
 
Scheme 49: Synthesis of allylic alcohol 166 for the one-pot process. 
 
With the key substrate 166 in hand, this was then subjected to the one-pot 
Overman rearrangement and ring-closing metathesis reaction process (Scheme 
50). Allylic alcohol 166 was converted to 167 using trichloroacetonitrile and a 
catalytic amount of DBU at room temperature. Next, the crude mixture of this 
reaction was charged with bis(acetonitrile)palladium(II) chloride (10 mol%) to 
generate the Overman rearrangement intermediate 168 which was then cyclised 
utilising Grubbs second-generation catalyst 70 (10 mol%) to give 2,3,6,7-
tetrahydro-3-amidoazepine 169 in 79% yield over three steps.  
 
73 
 
 
Scheme 50: Synthesis of 3-amidoazepine 169 via the one-pot process.  
 
Further developments within the Sutherland group demonstrated that cyclic allylic 
amides as synthetic intermediates could be functionalised by directed oxidation 
reactions for the diastereoselective synthesis of hydroxylated aminocarbocyclic 
and aminoheterocylic scaffolds.155,157 The study showed that directed epoxidation 
followed by epoxide ring opening or directed dihydroxylation could be efficiently 
achieved under standard conditions to form highly functionalised cyclic allylic 
amides.157 For example, stereoselective oxidation of the 3-amidoazepine ring 169 
was performed via two different routes to give 3-aminoazepan-4-ol 172  and 3-
aminoazepan-4,5-diol 173 (Scheme 51). Initially, 3-amidoazepine 169 was 
subjected to directed epoxidation using m-CPBA to give epoxide 170 in 58% 
yield.163,164 Lithium aluminium hydride was then used to conduct a regioselective 
reductive epoxide opening followed by Boc group deprotection and hydrolysis of 
the unpurified oxazolidinone intermediate 171 to give the cis-diastereomer, 
(3S*,4R*)-3-aminoazepin-4-ol (172) in 61% yield over two steps. In addition, 
directed selective dihydroxylation of 3-amidoazepine ring 169 under Donohoe 
conditions using osmium tetroxide (OsO4) and N,N,N’,N’-
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tetramethylethylenediamine (TMEDA) gave syn-diol 173 as a single diastereomer 
in 81% yield.165,166 Then, removal of the trichloroacetamide protecting group under 
basic conditions followed by removal of the Boc-protecting group under acidic 
conditions afforded (3S*,4S*,5R*)-3-aminoazepane-4,5-diol (174) in 78% yield. 
 
Scheme 51: Functionalisation of 3-amidoazepine 169 via directed oxidation.  
2.1.2 Aims  
The aim of this project was to expand the scope of the previously developed one-
pot reaction processes for the preparation of 5-amino-substituted 2,5-dihydro-1-
benzoxepines. 1-Benzoxepines are interesting seven-membered heterocyclic 
substances. They are found in many natural products and make up a wide 
spectrum of synthetic scaffolds that have biological activities and medicinal 
applications (Figure 7).167–170 For example, the guanidine derivative of 1-
benzoxepine 175 has hypotensive effects,167 while 2,3,4,5-tetrahydro-1-
benzoxepine 176 is a potent acyl-CoA, cholesterol O-acyl transferase (ACAT) 
inhibitor.168  A number of 1-benzoxepino[3,4-b]pyridines 177 which display 
antiulcer activity have also been synthesised.169 The 2,5-dihydro-1-benzoxepine 
pterulone (178) was isolated from a Pterula fungal species and showed 
antibacterial properties.171  
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Figure 7. Structures of some biologically active 1-benzoxepines. 
It was proposed that substituted salicylaldehydes could be efficiently converted 
into the required allylic alcohols (Scheme 52). The one-pot process of a thermal 
Overman rearrangement followed by a ruthenium-catalysed ring-closing 
metathesis reaction would give the target compounds. This approach would allow 
the synthesis of a small library of 5-amino-substituted 2,5-dihydro-1-benzoxepines 
that could then be used for the preparation of biologically active compounds such 
as the hypotensive agent 175 (Figure 7). 
  
Scheme 52: Proposed access to 5-amino-2,5-dihydro-1-benzoxepines from 
salicylaldehydes using the one-pot multi-reaction process.  
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2.1.3 Synthesis of Allylic Alcohols 
As mentioned above, various allylic alcohols which are the key substrates for the 
one-pot reaction process were prepared in three steps. Initially, starting material 
180c was prepared from commercially available 3-chlorophenol (179). Formylation 
of 3-chlorophenol (179) was carried out using paraformaldehyde in the presence 
of magnesium chloride and triethylamine (Scheme 53).172 This gave 4-chloro-2-
hydroxybenzaldehyde (180c) in 39% isolated yield. By-product 6-chloro-2-
hydroxybenzaldehyde (181) was also isolated. The low yield of the desired product 
was due to moisture sensitivity of magnesium chloride and the formation of 181.   
 
 
Scheme 53. Synthesis of salicylaldehyde (180c). 
 
Then, 4-chlorosalicylaldehyde (180c) and other commercially available substituted 
salicylaldehydes 180a–g were converted to the corresponding O-allylic 2-
hydroxybenzaldehydes 182a–g via reaction with allyl bromide in the presence of 
potassium carbonate (Figure 8).173,174 The allylation of 2-hydroxybenzaldehydes 
required only a short time to afford almost quantitative yields of the products. A 
range of analogues were required to demonstrate the scope of the methodology. 
In addition to the unsubstituted benzene ring of the starting material 180a, an 
electron donating group such as a methyl group in substrate 180a and an electron 
withdrawing group such as chloro-substituted analogue 180c were also used. 
Polysubstituted analogues were also investigated (180d–g) for the preparation of 
more complex targets.175  
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Figure 8: Allylation of 2-hydroxybenzaldehydes 180a–g. 
Next, Horner-Wadsworth-Emmons (HWE) reaction under mild Masamune-Roush 
conditions was carried out to form the corresponding (E)-α,β-unsaturated esters 
183a–g (Table 11).162 In this transformation, 2-allyloxybenzaldehydes 182a–g 
were reacted with triethyl phosphonoacetate (TEPA) and 1,8-
diazabicyclo[5,4,0]undec-7-ene (DBU) in the presence of lithium bromide. Using 
these conditions the products were obtained exclusively as the E-alkene.  
 
Entry 182 183 (%) 
1 R = H, 182a 183a (95) 
2 R = 5-Me, 182b 183b (88) 
3 R = 4-Cl, 182c 183c (94) 
4 R = 3,5-Cl2, 182d 183d (quant.) 
5 R = 4,5-F2, 182e 183e (93) 
6 R = 3-OMe, 5-NO2, 182f 183f (quant.) 
7 2-Hydroxy-1-naphthaldehyde, 182g 183g (92) 
 
Table 11. Synthesis of (E)-α,β-unsaturated esters 183a–g. 
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All the resulting (E)-α,β-unsaturated esters showed a large coupling constant 
greater than 16.0 Hz in the 1H NMR spectra. For example, the coupling constant 
for the 2-H and 3-H hydrogen atoms of 183a showed a value of 16.2 Hz, indicative 
of a disubstituted E-alkene (Figure 9). 
 
 
 
Figure 9: The trans-geometry of the (E)-α,β-unsaturated ester 183a. 
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Treatment of the resulting (E)-α,β-unsaturated esters 183a–g with 
diisobutylaluminium hydride (DIBAL-H) produced the corresponding (E)-allylic 
alcohols 184a–g in excellent yields (Figure 10). Overall, the conditions used for 
the three steps yielded the products in high to quantitative yields for all types of 
substituents.  
 
Figure 10: Synthesis of allylic alcohols 184a–g. 
 
2.1.4 The One-Pot Multi-Reaction Synthesis of 1-Benzoxepines 
This reaction was developed by a previous group member (Ewen Calder) who 
showed that the RCM step could be catalysed by Grubbs second-generation 
catalyst (5 mol%) to give a 65% overall yield of 187a (Scheme 54).176,177 Repeat of 
this one-pot process in this project under the same conditions gave 187a in a 
similar yield of 68% over the three steps. 
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Scheme 54. Synthesis of 1-benzoxepine 187a via the one-pot reaction 
process. 
 
1-Benzoxepine analogues 187a–g were synthesised according to the optimal 
conditions of the ring-closing metathesis step developed by Calder and based on 
the standard conditions of the one-pot Overman rearrangement-ring closing 
metathesis reaction process that has been developed within the Sutherland 
group.122,150,160,177 In the first step, allylic alcohols 184a–g were transformed to 
allylic tricholoracetimidate intermediates 185a–g by treatment with 
trichloroacetonitrile in the presence of a catalytic amount of DBU (Figure 11). The 
Overman rearrangement step was then performed under thermal conditions to 
generate the corresponding allylic trichloroacetamides 186a–g. Next, the one-pot 
reaction process was completed by addition of Grubbs second-generation catalyst 
70 (5 mol%) to produce the substituted 5-amino-2,5-dihydro-1-benzoxepines 
187a–g in good yields over three steps. It was found that substrates bearing 
electron-withdrawing groups required more time during the Overman 
rearrangement step to proceed to completion. Accordingly, analogues 187c and 
187e required 24 hours, while 187f required 48 hours for the Overman 
rearrangement step. Slightly lower yields were observed for ortho-substituted 
compounds which may be due to steric hindrance during the RCM step. 
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Figure 11. Synthesis of 5-amino-substituted 2,5-dihydro-1-benzoxepines 
187a–g. 
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2.1.5 Synthesis of 8-Chloro-5-guanidino-2,3,4,5-tetrahydro-1-benzoxepine 
As this approach allowed efficient access to 2,5-dihydro-1-benzoxepines, it was 
decided to use this strategy for the preparation of a pharmaceutically important 
compound. Hypotensive agent 175 was synthesised from the previously prepared 
chlorine-derived 1-benzoxepine analogue 187c. Initially, optimal conditions of each 
step were investigated. Previous attempts within the Sutherland groups showed 
that hydrogenation using palladium on charcoal was an efficient method to reduce 
trichloroacetamide-containing alkenes.178 Hydrogenation of 187c under these 
conditions was used to reduce the alkene moiety of 187c (Scheme 55). This also 
led to reduction of the trichloromethyl moiety and gave 188 in 94%. 
 
 
Scheme 55. Hydrogenation of 1-benzoxepine 187c. 
 
Removal of the dichloroacetyl group required harsher conditions than a typical 
trichloroacetyl group. According to previous work in the Sutherland group, it was 
found that removal of a dichloroacetyl group required acidic conditions (6 M aq. 
HCl, MeOH, 60 °C and 24 h) (Table 12).178 Using these conditions gave low 
conversions (11%) of the desired intermediate 189 (entry 1). Further investigation 
for the reaction temperature and time were performed to access optimal 
conditions. Removal of the dichloroacetyl protecting group of 188 required a 
temperature of 100 °C and a reaction time of 144 hours (entry 4).  
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Entry Temp. (°C) Time (h) Yield (%) 
1 60 24 11 
2 80 72 21 
3 100 48 32 
4 100 144 78 
 
Table 12. Removal of the dichloroacetyl protecting group of 186. 
 
Coupling of 5-amino-8-chloro-2,3,4,5-tetrahydro-1-benzoxepine (189) with N,N’-
bis(tert-butoxycarbonyl)-1H-pyrazole-1-carboxamidine (190) was then investigated 
(Scheme 56). Bernatowicz and co-workers reported the importance of 190 as a 
guanylation agent of amines under mild conditions.179,180 Sutherland and co-
workers reported efficient use of this reagent 190 for the preparation of several 
guanidine-containing bio-active compounds.49,181 The guanylation of the free 
amine moiety of 189  with N,N’-bis(tert-butoxycarbonyl)-1H-pyrazole-1-
carboxamidine (190) in the presence of Hünig’s base gave protected guanidine 
derivative 191 in 80% isolated yield after 48 hours at room temperature.  
 
Scheme 56: Guanylation of 189. 
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To improve the efficiency of deprotection of the dichloroacetyl group and 
guanylation, the two steps were repeated without purification of the intermediate 
amine 189. This gave the protected guanidine derivative 191 in 75% yield over the 
two steps (Scheme 57). 
 
Scheme 57: Synthesis of the protected guanidine derivative 191. 
 
Finally, removal of the Boc-protecting groups of the guanidine derivative 191 to 
form the hypotensive agent 175 was investigated (Table 13).49 Initially, 
deprotection using trifluoroacetic acid was attempted at room temperature to show 
only the starting material 191 after 6 h (entry 1). Increasing the reaction time to 32 
hours gave a low conversion (11%) of the desired product 175 (entry 2). Further 
investigation of the reaction time and temperature led to 100% conversion at 45 °C 
after 48 h (entry 5). Using the optimal conditions gave 8-chloro-5-guanidino-
2,3,4,5-tetrahydro-1-benzoxepine (175) in quantitative yield. The high efficiency of 
the one-pot process and the latter steps of this route allowed the synthesis of 8-
chloro-5-guanidino-2,3,4,5-tetrahydro-1-benzoxepine (175) in 40% overall yield 
form 4-chloro-2-hydroxybenzaldehyde (180c) 
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Entry Temp. (°C) Time (h) Conversion (%) 
1 rt 6 0 
2 rt 32 11 
3 rt 90 30 
4 45 27 64 
5 45 48 100 
 
Table 13. Deprotection of 191 under acidic conditions. 
 
2.1.6 Dihydroxylation of 5-Amino-Substituted 2,5-Dihydro-1-benzoxepines 
The next stage of this project investigated the stereoselective oxidation of the 2,5-
dihydro-1-benzoxepines. Hydroxylated 5-amino-1-benzoxepines such as 
cathepsin S inhibitor 192 have significant pharmaceutical activity (Figure 12).182,183 
Therefore, dihydroxylation of 5-amino-substituted 2,5-dihydro-1-benzoxepines 
yielding the corresponding syn- and anti-3,4-diols might produce compounds with 
interesting biological activity. 
 
Figure 12. Cathepsin S inhibitor 192, a hydroxylated 5-amino-1-benzoxepine. 
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2.1.6.1 Synthesis of cis-3,4-Diols of 5-Amino-1-benzoxepines 
Direct dihydroxylation of selected 1-benzoxepines under Donohoe conditions was 
investigated.165,166 Osmium tetroxide was used to react with 5-amino-substituted 
2,5-dihydro-1-benzoxepines 187b, 187f, and 187g in the presence of 
tetramethylethylenediamine (TMEDA) to afford the corresponding diastereomeric 
(3R*,4S*,5S*)-diols 193b, 193f and 193g (Figure 13). Overall, the products were 
formed as single cis-diastereomers in high yields. The cis-selectivity of 
dihydroxylation is likely controlled by hydrogen bonding between the N–H group of 
the amide as a hydrogen bond donor and the OsO4/TMEDA complex 194 as a 
hydrogen bond acceptor.165,166 Initially, TMEDA base chelates to OsO4 to form 
OsO4/TMEDA complex 194 which interacts with 1-benzoxepine to form 
intermediate 195 via hydrogen bonding. In complex 194, the electron density of 
the osmium atom and attached oxygen atoms increases due to the electronic 
donation from the nitrogen atoms. This results in the hydrogen bonding associated 
with the directed intermediate during the dihydroxylation. Cleavage of the 
intermediate complex 196 and release of the desired diol is achieved during work 
up. 
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Figure 13. Synthesis of cis-3,4-diols 193b, 193f and 193g. 
The relative stereochemistry of 193b, 193f and 193g was confirmed by NOE 
experiments that showed the cis-relationship of the vicinal amino diol motifs 
(Figure 14).  
Figure 14. NOE analysis of 193b, 193f and 193g. 
88 
 
2.1.6.2 Synthesis of trans-3,4-Diols of 5-Amino-1-benzoxepines 
It was proposed that epoxidation of 1-benzoxepines under O’Brien conditions 
followed by acid mediated hydrolysis would lead to oxirane ring opening and the 
formation of the analogous trans-3,4-diols (Figure 15).164 Initially, epoxidation of 1-
benzoxepines 187b, 187e and 187g was conducted by addition of m-
chloroperbenzoic acid (m-CPBA) to give intermediates 198b, 198e, and 198g as 
two diastereomers. The diastereomeric ratio ranged from 3:1 to 6:1. These results 
were consistent with Henbest’s rule.163 Henbest reported that the cis-epoxidation 
via transition state intermediate 197 was preferable over the trans-epoxidation due 
to the hydrogen bond that formed between N-H group and oxygen atom of the 
perbenzoic acid (m-CPBA). The low diastereoselectivity for 198g may be due to 
the ortho-substitution of the amide directing effect by the naphthalene moiety. 
Next, acid-mediated epoxide ring opening of 198b, 198e, and 198g led to the 
formation of the corresponding diols (dr 3:1 to 6:). The major diastereomeric 
(3S*,4S*,5S*)-diols 199b, 199e, and 199g were isolated in good overall yields.  
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Figure 15. Synthesis of trans-3,4-diols 199b, 199e and 199g. 
 
The relative stereochemistry of the major diastereomers 199b, 199e and 199g 
was also confirmed using NOE experiments (Figure 16).  
 
 
Figure 16. NOE analysis of 199b, 199e and 199g. 
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2.1.7 Conclusions 
In summary, a new one-pot thermal Overman rearrangement and ring-closing 
metathesis process allowed access to a diverse library of 5-amino-2,5-dihydro-1-
benzoxepines from O-allylic cinnamyl alcohols in high yields. These key substrates 
for this process were rapidly prepared from salicylaldehydes in high yields. By this 
outcome, this method minimises the negative impact of chemistry on the 
environment. In addition, the generality of this approach allowed the construction 
of important heterocyclic compounds such as a hypotensive agent. The 
importance of this approach was also demonstrated with functionalisation of the 
products under mild conditions. Stereoselective oxidation of the alkene moiety of 
the 5-amino-substituted 2,5-dihydro-1-benzoxepines gave access to 
pharmaceutically interesting scaffolds.  
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2.2 Synthesis of 5-Amino-Substituted 2,5-Dihydro-1H-benzazepines 
5-Amino-1H-benzazepines have been widely shown to be biologically active, 
finding application as inhibitors for the treatment of a wide range of diseases and 
disorders (Figure 17).184,185 For example, 5-dimethylamino-1-[4-(2-
methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine (200), mozavap-
tan (OPC-31260), is an effective vasopressin V2 receptor antagonist. Its 
enantiomeric metabolites, which showed significant biological activity, have 
recently been synthesised for more investigations with regard to medicinal 
applications.184 A wide spectrum of substituted 2,3,4,5-tetrahydro-1H-benzazepine 
analogues such as 201 were developed for the treatment of dyslipidemia.185 
 
Figure 17. Structure of some medicinally active 1H-benzazepines. 
 
2.2.1 Aims  
Due to the success of the one-pot approach for the synthesis of 5-amino-2,5-
dihydro-1-benzoxepines, it was decided to extend this process to the 
corresponding 1H-benzazepines. It was proposed that this one-pot reaction 
strategy would allow easy, efficient synthesis of a small library of 5-amino-
substituted 2,5-dihydro-1H-benzazepines from commercially available anilines 
(Scheme 58). The suggested strategy consisted of two main stages. First, 
commercially available substituted anilines would be transformed into cinnamyl 
alcohol substrates via five sequential reactions. This would involve iodination of 
the anilines, followed by a Mizoroki-Heck reaction to form the cinnamyl esters. 
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Protection and allylation of the amino groups and finally reduction of the esters 
would give the cinnamyl alcohols. In the second stage, a one-pot synthesis of 1H-
benzazepines would be then performed using the previously prepared cinnamyl 
alcohols. The product of the one-pot process would then be used for the synthesis 
of medicinally important substances such as mozavaptan (200), a drug for 
treatment of hyponatremia (Figure 17). 
 
Scheme 58: Proposed access to 5-amino-2,5-dihydro-1H-benzazepines from 
substituted anilines using a one-pot multi-reaction process.  
 
2.2.2 Synthesis of Allylic Alcohols 
The first aim of this project was the preparation of (E)-(2-allylamino)cinnamyl 
alcohols for the one-pot reaction process. These key substances were formed 
from selected commercially available substituted anilines 202b,d–f and 
commercially available 2-iodoaniline (203a). Selected commercially available 
substituted anilines 202b,d–f were subjected to standard iodination to afford the 
corresponding substituted 2-iodoanilines 203b,d–f (Table 14).186,187 As shown, the 
aniline with the electron-donating substituent (Me) afforded the highest isolated 
yield (93%, entry 1). In contrast, analogues with electron-withdrawing groups 
required a higher temperature and prolonged reaction times to afford the desired 
products in lower isolated yields. As expected, analogue 203e was isolated in low 
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yield of 15% (entry 3) due to the formation of by-products such as 5-fluoro-2,4-
diiodoaniline (204). 
 
Entry 202 Temp. (°C) Time (h) 203 (%) 
1 R = 4-Me 50 24 203b (93) 
2 R = 4-F 70 60 203d (81) 
3 R = 5-F 70 50 203e (15) 
4 R = 4-Cl 70 90 203f (59) 
 
Table 14: Standard aromatic iodination of anilines (203b,d–f). 
 
For the other analogues, 2-iodoaniline (203a) was used from commercial sources, 
while 2-iodo-4-methoxyaniline (203c) was prepared from 3-iodoanisole (205) in an 
alternative route. A one-pot electrophilic aromatic nitration of 3-iodoanisole (205) 
and reduction process using iron metal in the presence of ammonium chloride 
gave 2-iodo-4-methoxyaniline (203c) in 30% yield over the two steps (Scheme 
59).188 This route was chosen due to the fact that the methoxy substituent is a very 
powerful electron-donating group. Attempted electrophilic aromatic iodination of 4-
methoxyaniline led to poly-iodinated by-products. 
 
Scheme 59: Alternative route to synthesis of 2-iodo-4-methoxyaniline (203c).  
94 
 
On preparation of the 2-iodoanilines, a number of transformations were performed 
to form the allylic alcohols, key substrates for the one-pot reaction process. For 
achieving this plan, optimal conditions for the transformation of substituted 2-
iodoanilines into the precursor allylic alcohols were investigated. First, Mizoroki-
Heck reaction using 2-iodoaniline (203a) was investigated (Table 15). 2-
Iodoaniline (203a) was subjected to the Mizoroki-Heck reaction using methyl 
acrylate (2 equiv) and catalysed by palladium(II) acetate (1 mol%) to give (E)-α,β-
unsaturated methyl ester 206a in 50% isolated yield (entry 1).187 This gave only 
the E-alkene. Further investigation showed that a higher catalyst loading (5 mol%) 
allowed efficient preparation of 206a in quantitative isolated yield after a 
significantly shorter reaction time (entry 4). 
 
Entry 
Pd(II) 
(mol%) 
PPh3 
(mol%) 
K2CO3 
(equiv) 
TBAB 
(mol%) 
Mixture 
conc. 
(M) 
Time 
(h) 
Yield 
(%) 
1 1 2 2 5 0.5 25 50 
2 2 2 2 5 0.2 16 79 
3 5 10 10 25 0.1 1 94 
4 5 10 1 25 0.1 2 99 
 
Table 15. Optimisation of the Mizoroki-Heck reaction of 203a.  
The free amine group was then protected with tosyl chloride in the presence of 
pyridine to give 207a in 93% yield (Scheme 60). Allylation of the corresponding 
amine 207a using allyl bromide under standard conditions formed the allylated 
amine 208a in quantitative yield.189  
 
Scheme 60. Tosylation and allylation of 206a. 
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Finally, conversion of the resulting ester 208a to allylic alcohol 209a was also 
investigated (Table 16). DIBAL-H reduction under standard conditions allowed 
access to the desired allylic alcohol in 77% isolated yield after 2 h (entry 1). 
Increasing the reaction mixture concentration (0.1 M) and extending the reaction 
time to 18 h afforded cinnamyl alcohol 209a in very high yield (entry 3).190 
 
Entry Conc. (M) Time (h) Yield (%) 
1 0.04 2 77 
2 0.10 2 87 
3 0.10 18 96 
 
Table 16. Synthesis of allylic alcohol 209a. 
 
Having established the optimal conditions for the synthesis of allylic alcohol 209a 
from commercially available 2-iodoaniline (203a), these conditions were used for 
the other substituted anilines 203b–f. Initially, 2-iodoanilines 203b–f were 
subjected to the Mizoroki-Heck reaction using methyl acrylate and catalysed by 
palladium(II) acetate (5 mol%) to give (E)-α,β-unsaturated methyl esters 206b–f in 
high to quantitative yields (Table 17). The free amine group was then protected 
with tosyl chloride in the presence of pyridine to give 207b–f in very high yields. 
Allylation of the corresponding amines 207b–f using allyl bromide under standard 
conditions formed the allylated amines 208b–f in high to quantitative yields. 
Finally, DIBAL-H reduction of the resulting esters 209b–f allowed access to the 
desired allylic alcohols in high isolated yields.190 As illustrated in Table 17, all the 
used conditions for each step allowed rapid, easy and efficient access to the 
desired products in high to quantitative yield.   
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Entry 203 206 (%) 207 (%) 208 (%) 209 (%) 
1 R = 4-Me, 203b 206b (quant.) 207b (99) 208b (91) 209b (98) 
2 R = 4-OMe, 203c 206c (quant.) 207c (93) 208c (92) 209c (80) 
3 R = 4-F, 203d 206d (81) 207d (88) 208d (84) 209d (98) 
4 R = 5-F, 203e 206e (84) 207e (97) 208e (79) 209e (99) 
5 R = 4-Cl, 203f 206f (76) 207f (91) 208f (quant.) 209f (92) 
 
Table 17. Synthesis of allylic alcohols 209b–f. 
 
To fully explore the scope of this approach, a substrate with a powerful electron-
withdrawing moiety such as nitro group was required. Utilising the same synthetic 
route as described above for the 4-nitro analogue failed. First, iodination of 4-
nitroaniline under standard conditions and elevated temperature and extended 
reaction times did not afford any evidence for the formation of 2-iodo-4-nitroaniline 
(203g). Instead, iodination of commercially available 4-nitroaniline (202g) utilising 
the newly developed methodology reported by the Sutherland research group 
gave 2-iodo-4-nitroaniline (203g) in quantitative yield (entry 1, Table 18).188 The 
reaction involves the use of catalytic amounts of silver(I) triflimide to activate N-
iodosuccinimide (NIS) for the electrophilic aromatic iodination of 4-nitroaniline 
(202g) via 210. Optimisation of this reaction showed that more concentrated 
reaction mixtures gave high yields and allowed lower catalyst loading (entries 2 
and 3). The optimal conditions (0.2 M) with low catalyst loading (2.0 mol%) 
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afforded the desired product in a similar yield (99%), but the reaction required a 
longer time to reach 100% completion (entry 4). Scale-up of this transformation 
was also demonstrated with gram-scale synthesis of 203g (entry 3).  
 
Entry Conc. (M)  AgNTf2 (mol%) NIS (equiv.) Time (h) 203g (%) 
1 0.1 7.5 1 1.5 99 
2 0.2 2 1 1.5 77 
3 0.2 2 1.1 4 90 
4 0.2 2 1 24 99 
 
Table 18: Silver(I) triflimide catalysed iodination of 4-nitroaniline (202g).  
Having efficient access to 2-iodo-4-nitroaniline (203g), it was then subjected to the 
same conditions of the Mizoroki-Heck reaction. This reaction led to the formation 
of undesired product 211 (Figure 18). Analysis of the 1H NMR spectrum showed 
that the product 211 was formed as the sole compound. It was proposed that this 
occurred by conjugate addition of the amine followed by the Mizoroki-Heck 
reaction.   
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Figure 18. Formation of 211 as a result of an attempted Mizoroki-Heck 
reaction of nitro analogue 203g. 
To confirm the order of events, a second attempt under the same conditions was 
carried out with the reaction being stopped after 1 hour (Figure 19). According to 
the 1H NMR spectrum of the crude reaction mixture, it was found that 44% of 
starting material was converted to the conjugate addition intermediate 212 after 1 
hour. This showed that conjugate addition was definitely taking place before the 
Mizoroki-Heck reaction. 
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Figure 19. 1H NMR spectrum of an attempted Mizoroki-Heck reaction of the 4-
nitro analogue 203g after 1 hour indicating a mixture of the starting material 
203g and the undesired coupling product 212.  
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As a result of this unexpected outcome, another route for access to the 4-nitro-
derived allylic alcohol was investigated. It was proposed that interchanging the 
order of steps between the Mizoroki-Heck reaction and the tosylation of 203g 
might prevent the amino group being involved in the coupling reaction with methyl 
acrylate. Tosylation of 2-iodo-4-nitroaniline (203g) using tosyl chloride was carried 
out at room temperature to give conversion of 1% of 203g (Table 19, entry 1). 
Raising the reaction temperature and increasing the amount of tosyl chloride (1.5 
equivalents) led to conversion to the tosylated amine 213 and by-product 214 in 
47% and 16%, respectively (entry 2). By elevating the reaction temperature (100 
°C), the conversion to the product 213 decreased (entry 3). Due to these modest 
results, an alternative method was investigated.  
 
Entry 
TsCl 
(equiv)  
Temp. 
(°C) 
Time 
(h) 
Conversion 
of 203g (%) 
Conversion 
to 213 (%)  
Conversion 
to 214 (%) 
1 1.2 rt 15 1 - - 
2 1.5 50 192 - 47 16 
3 1.0 100 54 - 18 0 
4a 1.0 130 23 33 - 0 
 
Table 19: Tosylation of the nitro analogue 203g. aPyridine (4.0 equiv.) was 
added and p-xylene was used as a solvent. 
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Due to the powerful electron-withdrawing effect of the nitro moiety, using a 
stronger base to activate the amino group was investigated. Kelly and McNeil 
reported easy access to protected aryl amines with the Boc-protecting group using 
lithium hexamethyldisilazide (LiHMDS) under mild conditions.192 A previous 
Sutherland group member used Kelly conditions to protect 4-iodo-2-nitroaniline in 
60% isolated yield.193 Tosylation of 2-iodo-4-nitroaniline 203g using tosyl chloride 
under Kelly conditions was investigated (Table 20). Treatment of 203g with tosyl 
chloride (1 equiv) in the presence of LiHMDS (2 equiv) at room temperature led to 
just 2% conversion of aryl amine 203g to the protected aryl amine 213 after 16 h 
(entry 1). By doubling the amounts of reagents and increasing the reaction time to 
42 h led to a slight increase of conversion to the desired product (entry 2). Further 
increase of the amount of tosyl chloride (4 equiv) along with raising the reaction 
temperature to 50 °C led to the tosylated aniline 213 in moderate conversion (entry 
3). Further addition of tosyl chloride did not show any improvement in the 
formation of 213 (entry 4). This method led to the formation of 213 without 
appearance of the by-product 214. 
 
 
Entry 
TsCl 
(equiv)  
LiHMDS 
(equiv) 
Conc. 
(M) 
Temp. 
(°C) 
Time 
(h) 
Conv. of 
203g (%) 
Conv. to 
213 (%) 
Conv. to 
214 (%) 
1 1 2 0.10 0°C–rt 16 2 - - 
2 2 4 0.10 rt 42 4 - - 
3 4 4 0.10 50 20 - 51 0 
4 6 4 0.06 50 74 - 45 0 
 
Table 20: Tosylation of the nitro analogue 203g using LiHMDS. 
 
Having access to the tosylated aniline 213, the Mizoroki-Heck reaction was then 
investigated (Table 21).  Coupling of iodoaniline 213 with methyl acrylate using 
palladium(II) acetate under the optimised conditions led to formation of (E)-α,β-
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unsaturated methyl ester 207g in relatively low conversion. A higher catalyst 
loading (10 mol%) with prolonged reaction time was unsuccessful.  
 
Entry 
Pd(II) 
(mol%) 
PPh3 
(mol%) 
K2CO3 
(equiv) 
TBAB 
(mol%) 
Time 
(h) 
Conversion 
to 207g (%) 
1 5 10 2 25 1 19 
2 10 20 4 50 48 10 
 
Table 21. Optimisation of the Mizoroki-Heck reaction of 213. 
 
Due to the unsatisfactory yields and the formation of by-products that are 
associated with the nitro analogue transformations, it was decided that using a 
different strategy should be investigated. Consequently, a different method was 
developed for the nitro analogue (Table 22). Initially, a nucleophilic aromatic 
substitution reaction with p-toluenesulfonamide (1 equiv) in the presence of 
potassium carbonate was carried out with commercially available 2-chloro-5-
nitrobenzaldehyde (215) and afforded substituted aminobenzaldehyde 216 in 70% 
yield after 18 h (entry 1).194 Increasing the amount of p-toluenesulfonamide (2 
equiv) decreased the reaction time to 2 h and gave 216 in 86% isolated yield 
(entry 2).  
 
Entry 
TsNH2 
(equiv) 
K2CO3 
(equiv) 
Time 
(h) 
216 
(%) 
1 1 2 18 70 
2 2 2 2 86 
 
Table 22. Nucleophilic aromatic substitution reaction of 215.  
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In the next stage, a Horner−Wadsworth−Emmons (HWE) reaction with triethyl 
phosphonoacetate (TEPA) under Masamune−Roush conditions was carried out to 
transform the resulting aldehyde 216 into the corresponding (E)-α,β-unsaturated 
ester 217 in 99% yield (Scheme 61). This gave only the E-alkene. Utilising the 
same conditions for allylation as before afforded 218 in 55% yield. This moderate 
isolated yield was due to the decreased nucleophilicity of this compound 
compared to other analogues in this series. Finally, DIBAL-H reduction of 208 
under standard conditions led to synthesis of nitro analogue 209g in high isolated 
yield.  
 
Scheme 61. Synthesis of allylic alcohol 209g. 
 
2.2.3 Optimisation of One-Pot Multi-Reaction Process for 1H-Benzazepines 
Having performed the first part of this study, the synthesis of cinnamyl alcohols, it 
was proposed that the use of the previously optimised conditions for the 1-
benzoxepines might allow access to 5-amino-substituted 2,3-dihydro-1H-
benzazepines. Initially, the most simple cinnamyl alcohol 203a was investigated 
for the one-pot reaction process (Table 23). The thermal Overman rearrangement 
required 140 °C and 48 h for reaction completion. With regard to the RCM step, it 
required Grubbs second-generation catalyst 70 (10 mol%), 50 °C and 48 h to 
complete conversion of 220a to 221a. These conditions gave the metathesis 
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product 221a in 69% isolated yield over three steps (entry 1). Increasing the 
temperature of the Overman rearrangement step to 160 °C reduced the reaction 
time to 24 h and afforded the product 221a in 70% from allylic alcohol 209a (entry 
2). Consequently, it was proposed that further investigation of the RCM reaction 
might lead to increased isolated yield. As discussed before, change of the reaction 
concentration and decreasing the catalyst amount were investigated. Doubling the 
concentration of the RCM step from 0.008 M to 0.016 M and using Grubbs 
second-generation catalyst 70 (2.5 mol%) at a higher temperature (60 °C) afforded 
the product 211a in a lower yield of 58% (entry 3). Attempting the one-pot process 
by increasing the Grubbs second-generation catalyst loading (5 mol%) reduced 
the RCM step time to 18 h and afforded 221a in 81% isolated yield from allylic 
alcohol 209a (entry 4). 
 
Entry Overman 
rearrangement 
Conc. 
(M) 
RCM  
reaction 
Yield 
(%) 
1 140 °C , 48 h 0.008 Grubbs II (10 mol%), 50 °C, 48 h 69 
2 160 °C, 24 h 0.008 Grubbs II (10 mol%), 50 °C, 48 h 70 
3 160 °C, 24 h 0.016 Grubbs II (2.5 mol%), 60 °C, 48 h 58 
4 160 °C, 24 h 0.016 Grubbs II (5 mol%), 60 °C, 18 h 81 
 
Table 23. Optimisation of the one-pot synthesis of 1H-benzazepine 221a. 
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2.2.4 Synthesis of 5-Amino-Substituted 2,5-Dihydro-1H-benzazepines  
Having established the optimal conditions for the one-pot synthesis of 1H-
benzazepines, the scope of this process was explored. The optimal conditions 
were used for the prepared (E)-(2-allylamino)cinnamyl alcohols 209b–g (Figure 
20). The one-pot reaction process for all substituents of allylic alcohols afforded 
the 5-amino-2,5-dihydro-1H-benzazepines 221b–g in high yields over three step. 
Only analogue 209g with a powerful electron-withdrawing group required 
prolonged reaction times for the Overman rearrangement (43 h) and the RCM 
reaction (31 h) steps. Under these conditions the corresponding 1H-benzazepine 
221g was obtained in 49% isolated yield.   
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Figure 20. Synthesis of 5-amino-2,5-dihydro-1H-benzazepines 221b–g. 
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2.2.5 Formal Synthesis of Mozavaptan  
The importance and generality of this developed methodology was demonstrated 
with easy access to 5-amino-2,3,4,5-tetrahydro-1H-benzoazepine 228 (Scheme 
59), an advanced intermediate of the pharmaceutical active substance, 
mozavaptan (200) (Figure 17).184 For the synthesis of this intermediate 228, a 
number of transformations were studied. Initially, hydrogenation of 221a under 
standard conditions was investigated (Table 24). Hydrogenation of 221a using 
palladium on charcoal (20%) under an atmosphere of hydrogen at room 
temperature led to low conversion (10%) to 223 (entry 1). Attempted 
hydrogenation with higher catalyst loading (40%) and prolonged reaction times 
showed high conversion to the sole product 223 (entries 2 and 3). Further 
investigation using 50% of the catalyst loading at 55 °C led to conversion to 223 
and 224 in 36% and 28%, respectively, after 72 h.  
 
Entry 
Pd/C 
(%) 
Temp. 
(°C) 
Time 
(h) 
Conversion 
222 
(%) 
223 
(%) 
224 
(%) 
1 20 rt 21 0 10 0 
2 40 50 43 0 67 0 
3 40 50 70 0 75 0 
4 50 55 72 0 36 28 
 
Table 24. Hydrogenation of 221a using standard conditions. 
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On the other hand, reduction of 221a using p-toluenesulfonyl hydrazide 
(TsNHNH2) in the presence of potassium acetate was investigated (Table 25).
175 
As with the previous method, these conditions led to hydrogenation of the alkene 
in addition to reduction of the trichloroacetyl moiety to form two compounds 222 
and 223 (entry 1). Reduction of 221a using TsNHNH2 at 70 °C led to a 49% 
conversion to 222 (entry 2). In contrast to the previous method, formation of the 
by-product 224 was not observed. 
 
Entry Temp. (°C) 
Conversion 
222 (%) 223 (%) 224 (%) 
1 50 15 3 0 
2 70 49 2 0 
 
Table 25. Hydrogenation of 211a using TsNHNH2. 
 
Due to the formation of dichloro- and monochloroacetamide by-products during 
attempted hydrogenation of 221a under standard conditions and using p-
toluenesulfonyl hydrazide, it was proposed that exchanging the protecting group 
was required. This was necessary to avoid the formation of side products during 
the hydrogenation step which would affect the isolated yield. Consequently, the 
trichloroacetamide was replaced with the Boc-protecting group using standard 
conditions developed by previous Sutherland group members via a one-pot 
approach.48,159 Initially, removal of the trichloroacetyl protecting groups under 
basic conditions was investigated (Table 26). Treatment of 221a with sodium 
hydroxide (2M) at room temperature for 6 h did not lead to the removal of the 
trichloroacetyl protecting group (entry 1). Addition of methanol to the reaction 
mixture and raising the reaction temperature to 60 °C led to removal of the 
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protecting group. Then, addition of di-tert-butyl dicarbonate (Boc2O) to the reaction 
mixture at room temperature gave 226 in 51% isolated yield after 24 h (entry 2). 
Further attempts at the conversion of 221a to the Boc-protected analogue 226  via 
the one-pot approach using a mixture of sodium hydroxide and methanol (5:3) at 
60 °C for 18 h followed by reprotection by the addition of di-tert-butyl dicarbonate 
(Boc2O) at room temperature gave 226 in 73% isolated yield after 24 h (entry 4). 
 
Entry NaOH:MeOH 
Temp. 
(°C) 
Time 
(h) 
225 
Conversion  
(%) 
226 
Yield  
(%) 
1 1:0 rt 6 0 - 
2 5:1 60 24 100 51 
3 1:1 60 18 100 38 
4 5:3 60 18 100 73 
 
Table 26. One-pot approach for the conversion of 221a to 226. 
 
With success of exchanging the protecting group, hydrogenation of 226 using 
standard conditions under an atmosphere of hydrogen was investigated (Table 
27). Based on the observations of the hydrogenation of 1-benzoxepine 185c and 
1H-benzazepine 221a, hydrogenation of 1H-benzazepine 226 using palladium on 
charcoal (20%) for the formation of 227 at room temperature failed (entry 1). 
Changing the conditions to a higher catalyst loading (50%) and raising the reaction 
temperature to 50 °C led to completion of the reaction after 24 h (entry 2). 
Increasing the reaction temperature to 60 °C with a 30% catalyst loading also led 
to complete conversion of 226 (entry 3). Changing form ethyl acetate to methanol 
was less efficient (entries 4 and 5) 
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Entry 
Pd/C 
(%) 
Solvent 
(0.02 M) 
Temp. 
(°C) 
Time 
(h) 
Conversion  
(%) 
1 20 EtOAc rt  1 0 
2 50 EtOAc 50 24 100 
3 30 EtOAc 60 17 100 
4 10 MeOH 50 48 0 
5 20 MeOH 50 72 50 
 
Table 27. Hydrogenation of the Boc-protected 1H-benzazepine 226. 
 
Removal of the tosyl protecting group of 227 was also investigated (Scheme 
62).184 Treatment of 227 with magnesium under reflux gave the corresponding 1H-
benzazepine 228 in 78% isolated yield after 4 h.  
 
Scheme 62. Removal of the tosyl protecting group of 227. 
Having access to the optimal conditions for the hydrogenation and the 
deprotection of the tosyl protecting group, further attempts at both reactions were 
performed (Scheme 63). Hydrogenation of 226 using standard conditions under an 
atmosphere of hydrogen followed by removal of the tosylate group with 
magnesium under reflux without purification of the intermediate led to isolation of 
228 in 88% over two steps. This approach allows access to the hyponatremia late-
stage intermediate 228 efficiently in 46% overall yield over eleven steps, 
compared to the conventional methods which require intermediate separation in 
each step. 
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Scheme 63. Formation of the advanced intermediate 228. 
The Matsubara research group reported the synthesis of mozavaptan (200) from 
the intermediate 228 via three steps (Scheme 64).184 Benzoylation of the Boc-
protected 1H-benzazepine 228 with 4-(2-methylbenzoylamino)benzoyl chloride 
(229) followed by removal of the Boc-protecting group and reductive amination of 
the resulting free amine with formaldehyde. 
 
Scheme 64. Formal synthesis of mozavaptan (200).184 
 
2.2.6 Conclusions 
In conclusion, a new one-pot thermal Overman rearrangement and ring-closing 
metathesis process was utilised for the synthesis of a library of 5-amino-2,5-
dihydro-1H-benzazepines from allylic trichloroacetimidates. The allylic alcohols 
were rapidly and efficiently prepared from anilines in five subsequent reactions. A 
strong electron-withdrawing group analogue was efficiently prepared under mild 
conditions. The generality of this approach was utilised for the late-stage synthesis 
of mozavaptan.  
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2.3 Synthesis of 2H-Chromenes  
2.3.1 Introduction  
2H-Chromenes which are also known as 2H-benzopyrans are common 
heterocycles found as natural products and synthetic compounds. They display a 
variety of pharmaceutical and biological activities.195 The natural product, α-
monomethyl 2H-chromene 230, was isolated from the leaf essential oil of 
Calyptranthes tricona (Figure 21).196 The natural product, cannabichromene (231) 
which has analgesic, anti-inflammatory, and antiviral properties is another example 
of a natural product of 2H-chromenes.197 Synthetic 2H-chromenes also play an 
important role in medicinal and pharmaceutical applications such as iclaprim (232), 
an antibiotic used for skin infections.198 Daurichromenic acid (233) which is a 
highly potent anti-HIV agent represents a synthetic 2H-chromene.199 
 
Figure 21. Structures of 2H-chromene natural products 230 and 231 and 
synthetic compounds 232 and 233. 
Due to the biological and medicinal significance of 2H-chromenes, a range of 
methods were developed for the construction of these heterocycles.  The most 
common methods for the synthesis of 2H-chromenes are thermal or metal-
catalysed cyclisation or ring-closing metathesis reactions.200,201 Thermal 
intramolecular electrophilic hydroarylation via a Claisen rearrangement has been 
used for the synthesis of 2H-chromenes.200 This 6-endo-dig cycloisomerisation 
approach can also be catalysed using transitional metals such as gold(I), gold(III), 
platinum(IV), indium(III), mercury(II), and palladium(II).202–208  In addition, the 
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construction of 3,4-disubstituted 2H-chromenes under metal-free conditions, using 
reagents such as I2, ICl and PhSeBr, can be performed via electrophilic cyclisation 
of substituted propargylic aryl ethers.209,210   
 
2.3.2 Cycloisomerisation 
Cycloisomerisation or electrophilic hydroarylation, is a rearrangement of aryl-
tethered alkynes to afford a 6-endo-dig compound.202,203,211 In particular, the gold-
catalysed cycloisomerisation of substituted aryl propargyl ethers will give 
substituted 2H-chromenes. The proposed mechanism of the hydroarylation 
reaction is initiated by addition of a gold(I) catalyst (Scheme 65). As a result of the 
high aurophilicity of the alkyne moiety of 234, the aryl propargyl ether is activated 
by gold(I) metal to form the auropropargyl complex 235. The high electrophilicity of 
Au(I) species to the electronic cloud of the π-system of the alkyne supports the 
endo-selective hydroarylation to form the Wheland-type intermediate,  arenium 
ion, 236.202,203,211 Release of the gold(I) catalyst affords 2H-chromene 237. 
 
 
Scheme 65. Mechanism of gold(I)-catalysed cycloisomerisation reaction. 
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2.3.3 Aims  
Due to the importance of 2H-chromenes, the aim of this project was to develop a 
novel one-pot Overman rearrangement and gold(I)-catalysed hydroarylation 
reaction process. This project was based on the previously developed one-pot 
multi-step multi-reaction processes in the Sutherland group.122,150–160 This 
methodology would allow the synthesis of a number of allylic amine derived 2H-
chromenes (Scheme 66). This proposed approach would begin with the 
preparation of allylic alcohols from commercially available salicylaldehydes. In the 
next stage, allylic alcohols would be subjected to a one-pot Overman 
rearrangement and hydroarylation reaction processes to form the 2H-chromenes. 
Once this chemistry was developed, it was proposed that this strategy would be 
then used to access the corresponding coumarin analogues via chemoselective 
allylic oxidation. 
 
Scheme 66: Proposed synthesis of 2H-chromenes and coumarins.  
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2.3.4 Synthesis of Allylic Alcohols 
As discussed before for the synthesis of 1-benzoxepines (Section 2.1), the same 
standard conditions for the synthesis of allylic alcohols were used.173,174 Alkylation 
of commercially available salicylaldehydes 180a,h–k using propargyl bromide in 
the presence of potassium carbonate gave O-propargyl benzaldehydes 238a–e in 
essentially quantitative yields (Figure 22).212  
 
Figure 22: Allylation of 2-hydroxybenzaldehydes 238a–e.  
Next, Horner-Wadsworth-Emmons (HWE) reaction with triethyl phosphonoacetate 
(TEPA) under mild Masamune-Roush conditions was carried out to form the 
corresponding (E)-α,β-unsaturated esters 239a–e in quantitative yields (Table 
28).162 As observed from the 1H NMR spectra of the products, this method gave 
only the E-alkene. DIBAL-H reduction of the resulting esters under standard 
conditions gave cinnamyl alcohols 240a–e in high isolated yields. Overall, 
conversion of commercially available starting materials to the key substrates 
(allylic alcohols) was easily and rapidly performed under mild conditions. 
Consequently, all investigated analogues containing either electron-donating and 
electron-withdrawing groups were efficiently prepared using this synthetic 
approach.  
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Entry 238 239 (%) 240 (%) 
1 R = H, 238a 239a (quant.) 240a (93) 
2 R = 5-OMe, 238b 239b (99) 240b (89) 
3 R = 4-OMe, 238c 239c (quant.) 240c (92) 
4 R = 5-Cl, 238d 239d (quant.) 240d (93) 
5 R = 5-NO2, 238e 239e (98) 240e (96) 
 
Table 28: Synthesis of O-propargyl cinnamyl alcohols 240a–e.   
 
2.3.5 Investigation of the Key Steps of the One-Pot Process 
Synthesis of 2H-chromenes required optimisation of the Overman rearrangement 
and hydroarylation steps, separately. First, thermal or metal-catalysed Overman 
rearrangements would be investigated to establish the optimal conditions. It was 
proposed that investigation of thermal or metal-mediated hydroarylation would give 
a clear insight for the best conditions for the one-pot approach. Finally, 
combination of the developed optimal conditions of both steps would allow the 
one-pot process to be developed and access to the 2H-chromenes.  
 
2.3.5.1 Optimisation of the Overman Rearrangement 
With the key substrates for the one-pot process in hand, optimal conditions of the 
Overman rearrangement were investigated (Scheme 67). Initially, cinnamyl alcohol 
240a was treated with trichloroacetonitrile and a catalytic amount of DBU to form 
the allylic trichloroacetimidate intermediate. The thermal Overman rearrangement 
of the resulting intermediate under standard conditions (140 °C, 24 h) afforded the 
corresponding allylic trichloroacetamide 241a in 68% isolated yield over the two 
steps. Decreasing the Overman rearrangement step time to 18 h afforded the 
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Overman product 241a in 97% yield. This shorter reaction time minimises any 
decomposition leading to a higher yield.  
 
Scheme 67: Overman rearrangement for the synthesis of 241a.  
 
Having successfully accessed the optimal conditions of the Overman 
rearrangement, the scope of this transformation was explored (Figure 23). Thus, 
cinnamyl alcohols 240b–e were treated with trichloroacetonitrile and a catalytic 
amount of DBU to form the allylic trichloroacetimidate. The thermal Overman 
rearrangement of the resulting intermediates under the optimised conditions 
afforded the corresponding allylic trichloroacetamides 241b–e in high yields over 
the two steps. While analogues 240b and 240c required 18 h to proceed to 
completion for the Overman rearrangement step, the reaction times for electron-
deficient analogues 240d and 240e required 48 h and 72 h, respectively.  
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Figure 23: Synthesis of allylic trichloroacetamides 241b–e. 
 
2.3.5.2 Optimisation of the Hydroarylation Reaction 
During the investigation of the thermal Overman rearrangement step, analysis of 
the 1H NMR spectra of the crude reaction mixtures indicated that low amounts 
(<10%) of the 2H-chromenes were formed. Consequently, optimal conditions using 
a thermal hydroarylation reaction were first investigated for the synthesis of 2H-
chromenes (Table 29). Initially, a thermal 6-endo-dig cycloisomerisation of 
analogue 241a was investigated at a higher temperature of 160 °C. Analysis of the 
1H NMR spectra of the crude reaction mixture indicated that 35% of the precursor 
241a converted to product 242a after four days (entry 1). Increasing the reaction 
temperature up to 180 °C with an extended reaction time of five days led to a slight 
increase in the conversion to 50% (entry 2). Alternatively, microwave heating of 
the reaction mixture at 180 °C with significantly shorter reaction time (3 h) showed 
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higher conversion (66%) (entry 3). As a result of this, further microwave heating of 
analogue 241a at 200 °C for 2 h gave a high conversion of 91%, but only a 34% 
isolated yield of 242a (entry 4). This low isolated yield is likely due to 
decomposition caused by the high temperature. It was thought that changing to 
milder conditions such as metal-catalysed cycloisomerisation would give higher 
yields. Thus, gold(I)-catalysed hydroarylation reaction of 241a was next 
investigated. Chloro(triphenylphosphine)gold(I) (Ph3PAuCl) (243) (2.5 mol%) 
which was activated by silver(I) hexafluoroantimonate (AgSbF6) (244) (2.5 mol%) 
at 80 °C was used for the cyclisation of 241a to 242a. This gave 242a with a 
conversion of 85% after 4 h (entry 5). The more active catalyst, (triphenyl-
phosphine)gold(I) triflimide (Ph3PAuNTf2) catalyst (245) was then investigated. 
Reaction of 241a with the active gold(I) catalyst 245 (2.5 mol%) pushed the 
reaction to completion in four hours under the same conditions to afford 100% 
conversion of the product (entry 6). Additionally, analysis of the 1H NMR spectrum 
of the crude reaction mixture showed that the gold(I)-catalysed cycloisomerisation 
was a clean transformation and gave exclusive formation of  the 6-endo-dig 
product 242a. 
 
Entry reaction conditions time (h) conversion (%)
a 
1 160 °C 96 35 
2 180 °C 120 50 
3 180 °C (MW) 3 66 
4 200 °C (MW) 2 91 
5 Ph3PAuCl 243 (2.5 mol%), and 
AgSbF6 244 (2.5 mol%), 80 °C 
4 85 
6 Ph3PAuNTf2 245 (2.5 mol%), 80 °C 4 100 
 
Table 29. Optimisation of the hydroarylation reaction of 241a to 242a. 
aConversions were measured using 1H NMR spectroscopy.  
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2.3.6 Stepwise Gold(I)-Catalysed Synthesis of 2H-Chromenes 
Having the optimal conditions of the cycloisomerisation reaction developed, the 
scope of this method was explored (Figure 24). The allylic trichloroacetamides 
241a–e were treated with the active gold(I) catalyst 245 (2.5 mol%) at 80 °C to 
give after 4 h, the corresponding 2H-chromenes 242a–d in essentially quantitative 
yields. Attempted hydroarylation using gram-scale quantities (2–3 g) of analogue 
241a under the same reaction time and temperature, allowed a lower catalyst 
loading (1 mol%) and gave 2H-chromene 242a in quantitative yield.  
 
Figure 24. Stepwise gold(I)-catalysed synthesis of 2H-chromenes 242a–e. 
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Nitro-analogue 241e, afforded the corresponding 2H-chromene 242e in 66% 
isolated yield under the same conditions. Interestingly, analysis of the 1H NMR 
spectrum of the crude reaction mixture showed the presence of a number of side 
products including 2-methylbenzofuran 242f (<10%). This minor by-product was 
likely formed via a 5-exo-trig cycloisomerisation reaction through an ortho-allenyl 
phenolate intermediate 249 (Scheme 68). According to previous reports, the 
propargyl moiety of an aryl substance with a strongly electron-withdrawing group 
can undergo this alternative reaction route through the Au(I)-catalysed 
hydroarylation reaction to form 2-methylfurans.202,203,211  
 
Scheme 68. Cycloisomerisation mechanism of 241e to form 242f. 
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2.3.7 Optimisation of One-Pot Synthesis of 2H-Chromenes 
As a consequence of the positive results, a combination of the thermal Overman 
rearrangement and gold(I)-catalysed hydroarylation reaction for the preparation of 
2H-chromenes 242a–e in a one-pot reaction process was next investigated 
(Scheme 69). The one-pot process of analogues 240a–e under the optimised 
conditions gave none of the corresponding 2H-chromenes 242a–e. While the 
Overman rearrangements were successful, the gold(I)-catalysed hydroarylations 
gave none of the 2H-chromenes. It was proposed that this was because the 
Ph3PAuNTf2 catalyst 245 was not compatible with the conditions of the Overman 
rearrangement. To support this view, a combination of Ph3PAuCl 243 and silver(I) 
triflimide (AgNTf2) catalyst 250,  which forms Ph3PAuNTf2 245 in situ, was used for 
the cycloisomerisation step of the one-pot synthesis of 2H-chromene 242a. This 
also did not show any formation of 2H-chromene 242a. Alternatively, it was 
decided that a less active gold(I) complex might be more compatible with the 
Overman step. Therefore, the combination of Ph3PAuCl 243 with AgSbF6 244 for 
the hydroarylation step within the one-pot process was investigated. Using this 
catalytic system for the second step of the one-pot process gave 2H-chromene 
242a in 80% overall yield.   
 
Scheme 69. One-pot synthesis of 2H-chromene 242a. 
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2.3.8 One-Pot Gold(I)-Catalysed Synthesis of 2H-Chromenes 
The one-pot process was subjected to further optimisation for the other substrates. 
It was found that the optimal conditions for the hydroarylation step required higher 
catalyst loading (7.5 mol% for each) and an extended reaction time of 48 h (Figure 
25). The one-pot reaction process under the optimal conditions gave high yields of 
2H-chromenes 242b–e over three steps. For nitro-analogue 240e, the Overman 
rearrangement was complete after 72 h and the hydroarylation step required 65 h 
and a catalyst loading of 10 mol% of both Ph3PAuCl 243 and AgSbF6 244 to 
generate 2H-chromene 242e in 54% yield over three steps. As with the 
Ph3PAuNTf2 catalysed hydroarylation, a number of minor by-products were also 
observed from the one-pot process. 
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Figure 25. One-pot synthesis of 2H-chromenes 242a–e. 
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2.3.9 Optimisation of the Pd(II)-Catalysed Overman Rearrangement  
The next aim of this project was to develop a one-pot palladium(II)-catalysed 
Overman rearrangement and gold(I)-catalysed cycloisomerisation process for the 
synthesis of 2H-chromenes. Thus, optimal conditions for the Pd(II)-catalysed 
Overman rearrangement step were investigated (Table 30). Treatment of allylic 
trichloroacetimidate intermediate with bis(acetonitrile)palladium(II) chloride catalyst 
(10 mol%) at room temperature gave a conversion of 50% to allylic 
trichloroacetamide 241a (entry 1). Raising the reaction temperature to 40 °C led to 
an increase in the formation of the desired product (entry 2). Use of 
bis(acetonitrile)palladium(II) chloride catalyst at 60 °C or lower catalyst loading (5 
mol%) but higher temperature (80 °C) afforded a quantitative conversion to allylic 
trichloroacetamide 241a (entries 3 and 4). Analysis of the 1H NMR spectrum of the 
crude reaction mixture of the Overman rearrangement (at 80 °C) in the absence of 
palladium(II) catalyst showed no formation of the product 241a (entry 5). Thus, the 
catalyst is responsible for the transformation at 80 °C. 
 
Entry Temp. (°C) Time (h) Pd(II) (mol%) Conversion (%) 
1 rt 22 10 50 
2 40 26 10 88 
3 60 24 10 100 
4 80 24 5 100 
5 80 17 0 0 
 
Table 30: Optimisation of Pd(II)-catalysed Overman rearrangement of 240a. 
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2.3.10 Optimisation of the One-Pot Pd(II)-Catalysed Overman Rearrangement  
and Gold(I)-Catalysed Hydroarylation Process 
 
The next stage of investigation was the development of the one-pot, two catalyst 
process for the synthesis of 2H-chromenes. Initially, the Pd(MeCN)2Cl2 catalyst 
was used for the investigation of the Overman rearrangement within the one-pot 
process (Table 31). It was found that this step required 66 h to go to completion in 
dichloromethane at 40 °C and gave, after the hydroarylation step, 33% isolated 
yield (entry 1). Changing the solvent to toluene and using the optimised 
temperature (80 °C), the Overman rearrangement step was complete in 16 h and 
the 2H-chromene 242a was isolated after the hydroarylation step in 56% yield 
(entry 2). As a palladium(II)-catalysed Overman rearrangement as part of a one-
pot process for the synthesis of 2H-chromene 242a was not as efficient as the 
one-pot process using a thermal rearrangement, optimisation using Pd(II)-
catalysed was not investigated further.   
 
 
Entry Solvent Temp. (°C) Time (h) Yield (%) 
1 CH2Cl2 40 66 33 
2 toluene 80 16 56 
 
Table 31. Optimisation of one-pot process using Pd(II)-catalysed Overman 
rearrangement. 
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2.3.11 Chemoselective Oxidation of 2H-Chromenes to Coumarins  
Coumarins are found in a variety of natural products. The importance of these 
compounds has led to the development of various strategies for their 
construction.213–217 However, there are not many reported methods for the 
synthesis of coumarins from 2H-chromenes.218–221 Therefore, the next aim of this 
project was to develop an effective method to access coumarins from the 2H-
chromenes using a chemoselective allylic oxidation (Table 32). First, the 
chemoselective allylic oxidation of 2H-chromene 242a using tert-butyl 
hydroperoxide (tBuOOH) afforded the corresponding coumarin 251a in 34% yield 
(entry 1). Next, the use of pyridinium dichromate (PDC) to promote the 
chemoselective allylic oxidation of 2H-chromene 242a at room temperature was 
investigated. These conditions led to the formation of coumarin 251a in 58% 
isolated yield (entry 2). The optimal conditions were found using a reaction time of 
6 days which afforded coumarin 251a in 65% isolated yield (entry 3). Increasing 
the reaction temperature was also investigated to reduce the reaction time; 
however, this led to a decrease in yield (entry 4). 
 
 
Entry Catalyst Solvent Temp. (°C) Time (h) Yield (%) 
1 
tBuOOH benzene 40 24 34 
2 PDC CH2Cl2 rt 13 58 
3 PDC CH2Cl2 rt 144 65 
4 PDC CH2Cl2 50 100 44 
 
Table 32. Optimisation for the chemoselective allylic oxidation of 242a. 
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In work performed by Alex Harkiss in the group, some of the other 2H-chromenes 
242b, 242d, and 242e were also converted to the corresponding coumarins under 
similar conditions and in good yields (Figure 26).  
 
Figure 26. Formation of 2H-chromenes 251b–d via PDC oxidation. 
 
2.3.12 Conclusions  
In summary, a novel one-pot Overman rearrangement and gold(I)-catalysed 
hydroarylation reaction process was used for the synthesis of a number of allylic 
amine derived 2H-chromenes from allylic trichloroacetimidates in very high yields. 
The precursor allylic alcohols were obtained rapidly and in three highly efficient 
transformations from salicylaldehydes. Mild chemoselective allylic oxidation of the 
2H-chromenes allowed the preparation of novel coumarins. 
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2.3.13 Synthesis of 6-Amino-Substituted 6,11-Dihydrodibenz[b,e]oxepines 
2.3.13.1 Previous Work within the Sutherland Group 
Having shown that 2-propargyloxy cinnamyl alcohols could be used in one-pot 
multi-bond forming reactions, it was proposed that these compounds could be 
used in other one-pot processes. Previous work in the Sutherland group had 
discovered a one-pot multi-bond forming, four-step process for the construction of 
drug-like polycyclic scaffolds.158 This one-pot process utilised alkyne derived allylic 
alcohols with an Overman rearrangement, ring-closing enyne metathesis and a 
hydrogen bonding directed Diels-Alder reaction (Scheme 70).  
 
Scheme 70. A one-pot multi-bond forming, four-step process. 
 
Further application of this methodology led to the synthesis of heteroaromatic 
structures such as amino-substituted indanes and tetralines via consecutive two-
pot multi-bond forming processes (Figure 27).222 First, a one-pot process involving 
a thermal Overman rearrangement and ruthenium(II)-catalysed ring-closing enyne 
metathesis led to the formation of a number of cyclic dienes from various allylic 
alcohols. In the second one-pot reaction process, a highly regioselective Diels-
Alder reaction with alkynes, quinones or nitriles followed by an oxidation reaction 
gave a diverse library of the amino-substituted indanes and tetralines. 
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Figure 27. Consecutive multi-bond forming processes. 
 
2.3.13.2 Aims 
The aim of this project was to develop a new one-pot, four-step reaction process 
for the preparation of 6-amino-substituted 6,11-dihydrodibenz[b,e]oxepines. 
Dibenz[b,e]oxepines are pharmacologically interesting polycyclic compounds. For 
example, Melloni and co-workers reported the synthesis of a number of tricyclic 
benzoxepines. 223 These compounds displayed anti-depressant activity. The study 
showed that tricyclic derivatives which were attached to an azetidine moiety were 
the most effective structure of these synthesised polycyclic systems and in 
particular, that bearing a basic group in position three of the azetidine ring (Figure 
28).  
 
131 
 
 
Figure 28. Structure of anti-depressant agent 252. 
 
It was proposed that the previously prepared allylic alcohols 240a–e (Section 
2.3.4) could be used for the synthesis of tricyclic benzoxepines (Scheme 71). The 
one-pot multi-reaction process of a thermal Overman rearrangement followed by a 
ruthenium(II)-catalysed ring-closing enyne metathesis and Diels-Alder reaction 
would be investigated. This approach would allow the formation of a small library 
of 6-amino-substituted 6,11-dihydrodibenz[b,e]oxepines that could then be utilised 
for the preparation of pharmacologically active compounds such as anti-
depressant agent 252 (Figure 28). 
 
Scheme 71. Proposed synthesis of tricyclic systems 254a–e. 
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2.3.13.3 Investigation of the One-Pot Multi-Reaction Process 
2.3.13.3.1 Optimisation of Ring-Closing Enyne Metathesis (RCEYM) Step 
The allylic alcohols 240a–e that were required for the one-pot reaction process 
were previously prepared and transformed to the enyne products 241b–e via the 
formation of the allylic trichloroacetimidate in high yields (Figure 23). The optimal 
conditions of the ring-closing enyne metathesis reaction were established by a 
previous group member (Ewen Calder) who showed that the RCEYM reaction 
could be catalysed by Grubbs first-generation catalyst (10 mol%) at 50 °C. Using 
these preliminary results, the ring-closing enyne metathesis (RCEYM) for the 
conversion of enyne 241c to diene 253 was then investigated (Table 33). Initially, 
enyne product 241c was catalysed by Grubbs first-generation catalyst (10 mol%) 
at 50 °C and led to 40% conversion to the corresponding diene 253 after 9 h (entry 
1). Further investigation showed that a higher catalyst loading (15 mol%) allowed 
preparation of 253 in 17% isolated yield after a reaction time of 30 h (entry 2). 
Using the optimal catalyst loading (10 mol%) with a longer reaction time gave a 
similar isolated yield (entry 3). Due to time limitations, optimisation and the full 
scope of this process was not investigated.  
 
Entry 
Grubbs I 
(mol%) 
Time   
(h) 
Conversion 
(%) 
Yield 
(%) 
1 10 9 40 - 
2 15 30 48 17 
3 10 72 - 18 
 
Table 33. Optimisation of the RCEYM reaction of 253.  
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2.3.13.3.2 Optimisation of the Diels-Alder Reaction 
A preliminary study was conducted to investigate whether diene 253 would 
undergo an amide directed Diels-Alder reaction with N-phenylmaleimide to give 
the adduct as a major diastereomer (Scheme 72). Reaction at 50 °C and for 24 
hours gave tricyclic benzoxepine 254 in 63% as a single diastereomer.  
 
Scheme 72: Synthesis of polycyclic compound 254. 
Again due to time restrictions, full analysis of the relative stereochemistry was not 
performed. However, based on previous work,156 it is likely the Diels-Alder reaction 
proceeds via a hydrogen bond directed endo-transition state leading to 
diastereomer 254 which has syn-hydrogen atoms at C-6, C-6a, C-6b and C-9a. 
Future work will fully investigate the enyne metathesis and Diels-Alder reactions 
and hopefully lead to a one-pot synthesis of the tricyclic benzoxepines.  
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3.0 Future Work 
3.1 Synthesis of 11-Amino-Substituted 5,11-Dihydro-1-benzoxepino, 
benzazepino, and benzthiapino[4,3-b]pyridines 
Wolin and co-workers reported the synthesis of tricyclic systems (Figure 29). 
These compounds have displayed inhibition of the enzyme farnesyl-protein 
transferase (FPT).224 These pharmaceutical structures can be used for inhibiting 
the abnormal growth of cells and for inhibiting proliferative diseases.225  
 
Figure 29. Structure of FPT-inhibitors. 
Due to the pharmaceutical importance of these compounds, future work building 
on the research developed in this PhD would optimise the one-pot multi-step 
reactions for their systhesis. The aim of future work would be focused on the 
synthesis of 11-amino-substituted 5,11-dihydro-1-benzoxepino, benzazepino, and 
benzthiapino[4,3-b]pyridines. This proposed approach would begin with the 
preparation of a diverse series of allylic alcohols from commercially available 
anilines, phenols, and thiophenols (Scheme 73). In the next stage, the 
corresponding allylic alcohols would be subjected to one-pot Overman 
rearrangement, ring-closing enyne metathesis and Diels-Alder reaction processes 
to form the tricyclic systems. Once these approaches were developed, it was 
proposed that this strategy would be then used to access a number of Ras-FPT 
inhibitors (Figure 30). 
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Scheme 73. Proposed synthesis of the tricyclic system. 
These tricyclic systems can be then used for the synthesis of Ras-FPT inhibitors 
258. Decarboxylation of 255 under Larrosa conditions followed by removal of the 
trichloroacetyl group of 256 under standard conditions would lead to the formation 
of the free amine derived heterocycles 257 (Scheme 74).226 Treatment of 257 with 
bis(2-chloroethyl)amine hydrochloride under standard condition would give the 
FPT inhibitors 258.227  
 
Scheme 74. Proposed synthesis of the FPT inhibitors 258. 
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3.2 Coumarin Derived α-Amino Acids 
Coumarins (2H-chromen-2-ones) are found in natural product systems and they 
display biological and pharmaceutical activities.216,217 One outstanding aspect of 
coumarins and their derivatives is fluorescence. Recently, this physical property 
has been widely used for the monitoring of biological systems. Some natural and 
synthetic coumarins showed useful optical imaging applications.228,229 Coumarin 
motifs linked to α-amino acids, for example, constitutes one of the coumarin 
classes that have showed potent application as fluorescent probes in various 
bioscience research areas such as medicine, molecular and cellular biology, 
biotechnology, chemical biology and biophysics. These fluorescent compounds 
contributed to the development of medical and biomolecular science and their 
relevant research areas.230 As a consequence of their promising significance, 
coumarin-based α-amino acids have attracted the attention of biomolecular 
science researchers. A number of developed methods for the design and 
synthesis of coumarins and their derivatives such as coumarin α-amino acids have 
been reported.230–232 These have been used in various applications such as 
coumarin-based α-amino acid 259 which was used to mimic phosphotyrosine and 
showed fluorescence activity inside cells (Figure 30).233 
 
Figure 30. Fluorescent coumarin-based α-amino acid 259. 
 
Due to the potential fluorescence activity and application of coumarins α-amino 
acids, future work based from this PhD programme would be to use the allylic 
amine derived coumarins for the synthesis of the corresponding α-amino acids 
(Scheme 75). Regioselective olefin oxidation of the coumarins with ruthenium(III) 
trichloride under Sharpless conditions to form coumarin-based α-amino acids 
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would be investigated. Then, acid mediated removal of the trichloroacetyl group 
would give the desired α-amino acids 260a–e.20,31,46,234 Fluorescence properties of 
these coumarin derived α-amino acids would then be analysed. 
 
Scheme 75. Proposed synthesis of coumarin-based α-amino acids 260a–e. 
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4.0 Experimental    
 
4.1 General Experimental 
 
All reagents and starting materials were obtained from commercial sources and 
used as received. Dry solvents were purified using a PureSolv 500 MD solvent 
purification system. All reactions were performed under an atmosphere of argon 
unless otherwise mentioned. Brine refers to a saturated solution of sodium 
chloride. Flash column chromatography was carried out using Fisher matrix silica 
60. Macherey-Nagel aluminium-backed plates pre-coated with silica gel 60 (UV254) 
were used for thin layer chromatography and were visualised by staining with 
KMnO4. 
1H NMR and 13C NMR spectra were recorded on a Bruker DPX 400 or 
500 spectrometer with chemical shift values in ppm relative to TMS (δH 0.00 and 
δC 0.0), or residual chloroform (δH 7.26 and δC 77.2) as standard. Proton and 
carbon assignments are based on two-dimensional COSY and DEPT experiments, 
respectively. Mass spectra were obtained using a JEOL JMS-700 spectrometer for 
EI and CI or Bruker Microtof-q for ESI. Infrared spectra were obtained neat using a 
Shimadzu IR Prestige-21 spectrometer. Melting points were determined on a 
Reichert platform melting point apparatus. Microwave reactions were conducted 
using a CEM DiscoverTM Synthesis Unit (CEM Corp., Matthews, NC) and 
performed in glass vessels (capacity 10 mL) sealed with a septum. 
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4-Chloro-2-hydroxybenzaldehyde (180c)235 
 
Triethylamine (0.529 mL, 3.80 mmol) was added to a solution of 3-chlorophenol 
(0.128 g, 1.00 mmol) and magnesium chloride (0.143 g, 1.50 mmol) in acetonitrile 
(5 mL). The mixture was stirred for 0.5 h at room temperature. Paraformaldehyde 
(0.201 g, 6.70 mmol) was added. The reaction mixture was heated under reflux for 
24 h. The mixture was cooled to room temperature, acidified with 2M aqueous 
hydrochloric acid (5 mL), extracted with diethyl ether (3 × 50 mL). The combined 
organic layers were washed with brine (50 mL), dried (MgSO4) and concentrated 
in vacuo. Purification by column chromatography (petroleum ether) afforded 4-
chloro-2-hydroxybenzaldehyde (180c) (0.185 g, 39%) as white crystals. 
Spectroscopic data were consistent with the literature.235 Mp 44–46 °C; Rf 0.75 
(50% diethyl ether/petroleum ether); δH (400 MHz, CDCl3) 7.01–7.05 (2H, m, 3-H 
and 5-H), 7.52 (1H, dd, J 8.0, 0.6 Hz, 6-H), 9.90 (1H, d, J 0.3 Hz, OH), 11.20 (1H, 
s, CHO); δC (101 MHz, CDCl3) 118.0 (CH), 119.3 (C), 120.7 (CH), 134.6 (CH), 
143.3 (C), 162.3 (C), 195.5 (CH); m/z (CI) 157 (MH+, 100%), 146 (5), 113 (24), 97 
(13), 81 (22), 73 (76). 
 
2-Allyloxybenzaldehyde (182a)173  
 
Allyl bromide (0.311 mL, 3.60 mmol) was added to a stirred solution of 2-
hydroxybenzaldehyde (180a) (0.366 g, 3.00 mmol) and potassium carbonate 
(0.829 g, 6.00 mmol) in dimethylformamide (15 mL) and warmed to 70 °C for 2 h. 
The reaction mixture was cooled to room temperature, diluted with 5% aqueous 
lithium chloride solution (20 mL) and extracted with diethyl ether (20 mL). The 
organic layer was washed with 5% aqueous lithium chloride solution (3 × 10 mL), 
brine (10 mL), dried (MgSO4), filtered and concentrated in vacuo. Purification by 
column chromatography (diethyl ether/petroleum ether, 1:4) yielded 2-
allyloxybenzaldehyde (182a) (0.481 g, 99%) as a colourless oil. Spectroscopic 
data were consistent with the literature.173 Rf 0.68 (50% diethyl ether/petroleum 
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ether); δH (400 MHz, CDCl3) 4.66 (2H, dt, J 5.1, 1.5 Hz, 2’-H2), 5.34 (1H, dq, J 
10.5, 1.5 Hz, 4’-HH), 5.45 (1H, dq, J 17.3, 1.5 Hz, 4’-HH), 6.08 (1H, ddt, J 17.3, 
10.5, 5.1 Hz, 3’-H), 6.98 (1H, d, J 8.4 Hz, 3-H), 7.03 (1H, br t, J 7.5 Hz, 5-H), 7.53 
(1H, ddd, J 8.4, 7.5, 1.9 Hz, 4-H), 7.84 (1H, dd, J 7.5, 1.9 Hz, 6-H), 10.54 (1H, d, J 
0.7 Hz, CHO); δC (101 MHz, CDCl3) 69.4 (CH2), 113.0 (CH), 118.2 (CH2), 121.0 
(CH), 125.3 (C), 128.6 (CH), 132.6 (CH), 135.9 (CH), 161.1 (C), 189.9 (CH); m/z 
(CI) 163 (MH+, 100%), 135 (34), 121 (8), 85 (12), 79 (11). 
 
2-Allyloxy-5-methylbenzaldehyde (182b)236 
  
The reaction was carried out as described for the synthesis of 2-
allyloxybenzaldehyde (182a) using 2-hydroxy-5-methylbenzaldehyde (180b) 
(0.136 g, 1.00 mmol). Purification by column chromatography using (diethyl 
ether/petroleum ether, 1:4) gave 2-allyloxy-5-methylbenzaldehyde (182b) (0.173 g, 
98%) as a colourless oil. Spectroscopic data was consistent with literature.236 Rf 
0.7 (50% diethyl ether/petroleum ether); δH (500 MHz, CDCl3) 2.31 (3H, s, 5-CH3), 
4.63 (2H, dt, J 5.2, 1.6 Hz, 2’-H2), 5.32 (1H, dq, J 10.6, 1.6 Hz, 4’-HH), 5.44 (1H, 
dq, J 17.3, 1.6 Hz, 4’-HH), 6.07 (1H, ddt, J 17.3, 10.6, 5.2 Hz, 3’-H), 6.88 (1H, d, J 
8.5 Hz, 3-H), 7.33 (1H, ddd, J 8.5, 2.3, 0.6 Hz, 4-H), 7.64 (1H, d, J 2.3 Hz, 6-H), 
10.51 (1H, s, CHO); δC (126 MHz, CDCl3) 20.3 (CH3), 69.3 (CH2), 113.0 (CH), 
117.9 (CH2), 124.9 (C), 128.5 (CH), 130.3 (C), 132.6 (CH), 136.5 (CH), 159.1 (C), 
189.9 (CH); m/z (ESI) 199 (MNa+, 100%), 190 (3), 185 (4), 171 (5), 158 (16), 136 
(2). 
 
2-Allyloxy-4-chlorobenzaldehyde (182c) 
 
The reaction was carried out as described for the synthesis of 2-
allyloxybenzaldehyde (182a) using 4-chloro-2-hydroxybenzaldehyde (180c) (0.936 
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g, 6.00 mmol). Purification by column chromatography using (diethyl ether/ 
petroleum ether, 1:4) gave 2-allyloxy-4-chlorobenzaldehyde (182c) (1.17 g, 
quantitative) as a white solid. Mp 48–49 °C; Rf 0.75 (50% diethyl ether/petroleum 
ether); max/cm
−1 (neat) 2867 (CH), 1685 (CO), 1589, 1413, 1240, 1222, 996, 904; 
δH (400 MHz, CDCl3) 4.67 (2H, dt, J 5.2, 1.5 Hz, 2’-H2), 5.39 (1H, dq, J 10.5, 1.5 
Hz, 4’-HH), 5.48 (1H, dq, J 17.2, 1.5 Hz, 4’-HH), 6.08 (1H, ddt, J 17.2, 10.5, 5.2 
Hz, 3’-H), 6.95 (1H, d, J 1.7 Hz, 3-H), 7.03 (1H, ddd, J 8.3, 1.7, 0.7 Hz, 5-H), 7.79 
(1H, d, J 8.3 Hz, 6-H), 10.46 (1H, d, J 0.7 Hz, CHO); δC (101 MHz, CDCl3) 69.5 
(CH2), 113.5 (CH), 118.6 (CH2), 121.4 (CH), 123.6 (C), 129.5 (CH), 131.7 (CH), 
141.8 (C), 161.2 (C), 188.4 (CH); m/z (EI) 196.0288 (M+, C10H9
35ClO2 requires 
196.0291), 167 (38%), 155 (100), 126 (30), 99 (32), 63 (29), 53 (6). 
2- Allyloxy-3,5-dichlorobenzaldehyde (182d)    
 
The reaction was carried out as described for the synthesis of 2-
allyloxybenzaldehyde (182a) using 3,5-dichloro-2-hydroxybenzaldehyde (180d) 
(0.573 g, 3.00 mmol). Purification by column chromatography using (diethyl 
ether/petroleum ether, 1:4) gave 2-allyloxy-3,5-dichlorobenzaldehyde (182d) 
(0.693 g, quantitative) as a white solid. Mp 39–41 °C; Rf 0.80 (50% diethyl 
ether/petroleum ether); max/cm
−1 (neat) 2871 (CH), 1693 (CO), 1438, 1213, 1167, 
754; δH (500 MHz, CDCl3) 4.63 (2H, dt, J 6.2, 1.3 Hz, 2’-H2), 5.35 (1H, dq, J 10.6, 
1.3 Hz, 4’-HH), 5.40 (1H, dq, J 17.3, 1.3 Hz, 4’-HH), 6.08 (1H, ddt, J 17.3, 10.6, 
6.2 Hz, 3’-H), 7.63 (1H, d, J 2.6 Hz, 4-H), 7.71 (1H, d, J 2.6 Hz, 6-H), 10.29 (1H, s, 
CHO); δC (126 MHz, CDCl3) 76.5 (CH2), 120.0 (CH2), 126.4 (CH), 129.9 (C), 130.3 
(C), 131.6 (C), 131.8 (CH), 135.4 (CH), 156.1 (C), 187.5 (CH); m/z (CI) 230.9982 
(MH+, C10H9
35Cl2O2 requires 230.9980), 203 (14%), 191 (5), 81 (7), 69 (9). 
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2-Allyloxy-4,5-difluorobenzaldehyde (182e)   
 
The reaction was carried out as described for the synthesis of 2-
allyloxybenzaldehyde (182a) using 4,5-difluoro-2-hydroxybenzaldehyde (180e) 
(0.079 g, 0.500 mmol). Purification by column chromatography using (diethyl 
ether/petroleum ether, 1:4) gave 2-allyloxy-4,5-difluorobenzaldehyde (182e)  
(0.099 g, quantitative) as white crystals. Mp 35–36 °C; Rf 0.72 (50% diethyl 
ether/petroleum ether); max/cm
−1 (neat) 2872 (CH), 1686 (CO), 1604 (C=C), 1511, 
1434, 1323, 1203, 990, 893, 758; δH (500 MHz, CDCl3) 4.63 (2H, dt, J 5.2, 1.6 Hz, 
2’-H2), 5.38 (1H, dq, J 10.6, 1.6 Hz, 4’-HH), 5.46 (1H, dq, J 17.3, 1.6 Hz, 4’-HH), 
6.05 (1H, ddt, J 17.3, 10.6, 5.2 Hz, 3’-H), 6.81 (1H, dd, 3JHF 11.5, 
4JHF 5.2 Hz, 3-H), 
7.66 (1H, dd, 3JHF 11.5, 
4JHF 9.4 Hz, 6-H), 10.39 (1H, d, 
5JHF 3.1 Hz, CHO); δC (126 
MHz, CDCl3) 70.2 (CH2), 103.0 (d, 
2JCF 21.1 Hz, CH), 116.4 (dd, 
2JCF 18.5, 
3JCF 2.9 
Hz, CH), 118.9 (CH2), 121.5 (t, 
3JCF 3.2 Hz, C), 131.6 (CH), 145.2 (dd, 
1JCF 244.6, 
2JCF 13.0 Hz, C), 154.9 (dd, 
1JCF 258.5, 
2JCF 14.5 Hz, C), 157.8 (dd, 
3JCF 8.2, 
4JCF 
1.8 Hz, C), 187.2 (CH); m/z (EI) 198.0489 (M+, C10H8F2O2 requires 198.0492), 156 
(11%), 119 (4), 101 (6), 84 (100). 
 
2-Allyloxy-3-methoxy-5-nitrobenzaldehyde (182f)    
 
The reaction was carried out as described for the synthesis of 2-
allyloxybenzaldehyde (182a) using 2-hydroxy-3-methoxy-5-nitrobenzaldehyde 
(180f) (0.197 g, 1.00 mmol). Purification by column chromatography using (diethyl 
ether/petroleum ether, 1:4) gave 2-allyloxy-3-methoxy-5-nitrobenzaldehyde (182f) 
(0.209 g, 88%) as a white solid. Mp 82–84 °C; Rf 0.48 (50% diethyl 
ether/petroleum ether); max/cm
−1 (neat) 3101, 2898 (CH), 1695 (CO), 1684, 1583 
(C=C), 1527, 1480, 1336, 1278, 1230, 1091, 954, 938, 743; δH (500 MHz, CDCl3) 
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4.02 (3H, s, 3-OCH3), 4.84 (2H, dt, J 6.2, 1.3 Hz, 2’-H2), 5.32 (1H, dq, J 10.3, 1.3 
Hz, 4’-HH), 5.38 (1H, dq, J 17.1, 1.3 Hz, 4’-HH), 6.05 (1H, ddt, J 17.1, 10.3, 6.2 
Hz, 3’-H), 7.96 (1H, d, J 2.7 Hz, 4-H), 8.33 (1H, d, J 2.7 Hz, 6-H), 10.43 (1H, s, 
CHO); δC (126 MHz, CDCl3) 56.6 (CH3), 75.4 (CH2), 111.5 (CH), 115.0 (CH), 120.0 
(CH2), 129.3 (C), 132.3 (CH), 143.6 (C), 153.3 (C), 155.8 (C), 188.2 (CH); m/z (EI) 
237.0630 (M+, C11H11NO5 requires 237.0637), 220 (4%), 196 (27), 180 (27), 150 
(15), 122 (11), 84 (100). 
 
2-Allyloxy-1-naphthaldehyde (182g)173  
 
The reaction was carried out as described for the synthesis of 2-
allyloxybenzaldehyde (182a) using 2-hydroxy-1-naphthaldehyde (180g) (0.172 g, 
1.00 mmol). Purification by column chromatography using (diethyl ether/petroleum 
ether, 1:4) gave 2-allyloxy-1-naphthaldehyde (182g) (0.208 g, 98%) as a white 
solid. Mp 72–74 °C (lit.170 79–80 °C); Rf 0.62 (50% diethyl ether/petroleum ether); 
Spectroscopic data was consistent with literature.173 δH (400 MHz, CDCl3) 4.83 
(2H, dt, J 5.2, 1.6 Hz, 2’-H2), 5.39 (1H, dq, J 10.6, 1.6 Hz, 4’-HH), 5.50 (1H, dq, J 
17.3, 1.6 Hz, 4’-HH), 6.13 (1H, ddt, J 17.3, 10.6, 5.2 Hz, 3’-H), 7.30 (1H, d, J 9.3 
Hz, 3-H), 7.45 (1H, ddd, J 8.5, 8.4, 1.3 Hz, 6-H), 7.65 (1H, ddd, J 8.5, 8.4, 1.3 Hz, 
7-H), 7.80 (1H, br d, J 8.4 Hz, 5-H), 8.06 (1H, d, J 9.3 Hz, 4-H), 9.31 (1H, br d, J 
8.4 Hz, 8-H), 10.98 (1H, s, CHO); δC (101 MHz, CDCl3) 69.9 (CH2), 113.7 (CH), 
116.8 (C), 118.1 (CH2), 124.7 (CH), 124.9 (CH), 128.3 (CH), 128.5 (C), 129.7 
(CH), 131.5 (C), 132.4 (CH), 137.4 (CH), 163.0 (C), 191.8 (CH); m/z (ESI) 235 
(MNa+, 100%), 218 (6), 194 (16). 
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Ethyl (2E)-3-(2’-allyloxyphenyl)prop-2-enoate (183a)237  
 
Lithium bromide (1.043 g, 12.0 mmol) was added to a solution of triethyl 
phosphonoacetate (2.02 mL, 10.2 mmol) and 1,8-diazabicyclo[5.4.0]undec-7-ene 
(1.52 mL, 10.2 mmol) in acetonitrile (50 mL) and stirred at room temperature for 
0.5 h. 2-Allyloxybenzaldehyde (182a) (0.480 g, 3.00 mmol) was added and the 
solution was stirred at room temperature for 2 h. The reaction was quenched by 
the addition of a saturated solution of ammonium chloride (10 mL), concentrated to 
half volume in vacuo and extracted with diethyl ether (3 × 50 mL). The combined 
organic layers were washed with water (100 mL), brine (100 mL), dried (MgSO4), 
filtered and concentrated in vacuo. Purification by column chromatography (diethyl 
ether/petroleum ether, 1:10) yielded ethyl (2E)-3-(2’-allyloxyphenyl)prop-2-enoate 
(183a)  (0.731 g, 100%) as a pale yellow oil. Spectroscopic data was consistent 
with literature.237 Rf 0.65 (50% diethyl ether/petroleum ether); δH (400 MHz, CDCl3) 
1.34 (3H, t, J 7.1 Hz, OCH2CH3), 4.26 (2H, q, J 7.1 Hz, OCH2CH3), 4.63 (2H, dt, J 
5.2, 1.6 Hz, 2’’-H2), 5.31 (1H, dq, J 10.6, 1.6 Hz, 4’’-HH), 5.43 (1H, dq, J 17.3, 1.6 
Hz, 4’’-HH), 6.08 (1H, ddt, J 17.3, 10.6, 5.2 Hz, 3’’-H), 6.52 (1H, d, J 16.2 Hz, 2-H), 
6.90 (1H, d, J 8.4 Hz, 3’-H), 6.96 (1H, br t, J 7.5 Hz, 5’-H), 7.32 (1H, ddd, J 8.4, 
7.5, 1.7 Hz, 4’-H), 7.52 (1H, dd, J 7.5, 1.7 Hz, 6’-H), 8.04 (1H, d, J 16.2 Hz, 3-H); 
δC (126 MHz, CDCl3) 14.4 (CH3), 60.3 (CH2), 69.2 (CH2), 112.6 (CH), 117.8 (CH2), 
118.9 (CH), 120.9 (CH), 123.8 (C), 128.8 (CH), 131.3 (CH), 132.9 (CH), 139.9 
(CH), 157.3 (C), 167.5 (C); m/z (EI) 232 (M+, 38%), 187 (20), 175 (14), 159 (28), 
131 (23), 118 (70), 86 (100). 
 
Ethyl (2E)-3-(2’-allyloxy-5’-methylphenyl)prop-2-enoate (183b)   
 
The reaction was carried out as described for the synthesis of ethyl (2E)-3-(2’-
allyloxyphenyl)prop-2-enoate (183a) using 2-allyloxy-5-methylbenzaldehyde 
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(182b) (0.167 g, 0.950 mmol). Purification by column chromatography (diethyl 
ether/petroleum ether, 1:10) yielded ethyl (2E)-3-(2’-allyloxy-5’-methylphenyl)prop-
2-enoate (183b)  (0.206 g, 88%) as an oil. Rf 0.7 (50% diethyl ether/petroleum 
ether); max/cm
−1 (neat) 3021 (CH), 1701 (CO), 1631 (C=C), 1494, 1217, 1178, 
750; δH (400 MHz, CDCl3) 1.33 (3H, t, J 7.1 Hz, OCH2CH3), 2.29 (3H, s, 5’-CH3), 
4.25 (2H, q, J 7.1 Hz, OCH2CH3), 4.59 (2H, dt, J 5.2, 1.6 Hz, 2’’-H2), 5.29 (1H, dq, 
J 10.6, 1.6 Hz, 4’’-HH), 5.41 (1H, dq, J 17.3, 1.6 Hz, 4’’-HH), 6.07 (1H, ddt, J 17.3, 
10.6, 5.2 Hz, 3’’-H), 6.51 (1H, d, J 16.2 Hz, 2-H), 6.80 (1H, d, J 8.4 Hz, 3’-H), 7.11 
(1H, dd, J 8.4, 2.0 Hz, 4’-H), 7.32 (1H, d, J 2.0 Hz, 6’-H), 8.01 (1H, d, J 16.2 Hz, 3-
H); δC (101 MHz, CDCl3) 14.4 (CH3), 20.4 (CH3), 60.3 (CH2), 69.4 (CH2), 112.6 
(CH), 117.6 (CH2), 118.6 (CH), 123.5 (C), 129.2 (CH), 130.1 (C), 131.8 (CH), 
133.1 (CH), 140.0 (CH), 155.3 (C), 167.5 (C); m/z (ESI) 269.1139 (MNa+, 
C15H18NaO3 requires 269.1148), 236 (6%), 228 (4), 218 (2). 
 
Ethyl (2E)-3-(2’-allyloxy-4’-chlorophenyl)prop-2-enoate (183c) 
 
The reaction was carried out as described for the synthesis of ethyl (2E)-3-(2’-
allyloxyphenyl)prop-2-enoate (183a) using 2-allyloxy-4-chlorobenzaldehyde (182c)  
(0.150 g, 0.760 mmol). Purification by column chromatography (diethyl 
ether/petroleum ether, 1:10) yielded ethyl (2E)-3-(2’-allyloxy-4’-chlorophenyl)prop-
2-enoate (183c) (0.192 g, 94%) as an oil. Rf 0.73 (50% diethyl ether/petroleum 
ether); max/cm
−1 (neat) 2989 (CH), 1707 (CO), 1632 (C=C), 1592, 1486, 1312, 
1178, 908, 732; δH (500 MHz, CDCl3) 1.35 (3H, t, J 7.1 Hz, OCH2CH3), 4.27 (2H, 
q, J 7.1 Hz, OCH2CH3), 4.63 (2H, dt, J 5.2, 1.3 Hz, 2’’-H2), 5.36 (1H, dq, J 17.2, 
1.3 Hz, 4’’-HH), 5.46 (1H, dq, J 10.6, 1.3 Hz, 4’’-HH), 6.08 (1H, ddt, J 17.2, 10.6, 
5.2 Hz, 3’’-H), 6.51 (1H, d, J 16.2 Hz, 2-H), 6.91 (1H, d, J 1.9 Hz, 3’-H), 6.97 (1H, 
dd, J 8.3, 1.9 Hz, 5’-H), 7.45 (1H, d, J 8.3 Hz, 6’-H), 7.96 (1H, d, J 16.2 Hz, 3-H); 
δC (126 MHz, CDCl3) 14.3 (CH3), 60.4 (CH2), 69.5 (CH2), 113.2 (CH), 118.3 (CH2), 
119.2 (CH), 121.2 (CH), 122.3 (C), 129.5 (CH), 132.2 (CH), 136.6 (C), 138.8 (CH), 
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157.5 (C), 167.1 (C); m/z (ESI) 289.0595 (MNa+, C14H15
35ClO3 requires 289.0602), 
286 (27%), 279 (5), 275 (1), 270 (1), 262 (5). 
 
Ethyl (2E)-3-(2’-allyloxy-3’,5’-dichlorophenyl)prop-2-enoate (183d)    
 
The reaction was carried out as described for the synthesis of ethyl (2E)-3-(2’-
allyloxyphenyl)prop-2-enoate (183a) using 2-allyloxy-3,5-dichlorobenzaldehyde 
(182d) (0.693 g, 3.00 mmol). Purification by column chromatography using (diethyl 
ether/petroleum ether, 1:10) gave ethyl (2E)-3-(2’-allyloxy-3’,5’-
dichlorophenyl)prop -2-enoate (183d) (0.903 g, 100%) as a white solid. Mp 44–46 
°C; Rf 0.80 (50% diethyl ether/petroleum); max/cm
−1 (neat) 2984 (CH), 1724 (CO), 
1639 (C=C), 1448, 1310, 1183, 1166, 974; δH (400 MHz, CDCl3) 1.34 (3H, t, J 7.1 
Hz, OCH2CH3), 4.27 (2H, q, J 7.1 Hz, OCH2CH3), 4.48 (2H, dt, J 6.0, 1.3 Hz, 2’’-
H2), 5.31 (1H, dq, J 10.6, 1.3 Hz, 4’’-HH), 5.42 (1H, dq, J 17.3, 1.3 Hz, 4’’-HH), 
6.10 (1H, ddt, J 17.3, 10.6, 6.0 Hz, 3’’-H), 6.46 (1H, d, J 16.2 Hz, 2-H), 7.40 (1H, d, 
J 2.5 Hz, 4'-H), 7.43 (1H, d, J 2.5 Hz, 6'-H), 7.86 (1H, d, J 16.2 Hz, 3-H); δC (126 
MHz, CDCl3) 14.3 (CH3), 60.8 (CH2), 75.4 (CH2), 119.3 (CH2), 121.8 (CH), 125.9 
(CH), 129.8 (C), 129.9 (C), 131.3 (CH), 131.5 (C), 132.5 (CH), 137.6 (CH), 152.5 
(C), 166.3 (C); m/z (ESI) 323.0202 (MNa+, C14H14
35Cl2NaO3 requires 323.0212). 
 
Ethyl (2E)-3-(2’-allyloxy-4’,5’-difluorophenyl)prop-2-enoate (183e)   
 
The reaction was carried out as described for the synthesis of ethyl (2E)-3-(2’-
allyloxyphenyl)prop-2-enoate (183a) using 2-allyloxy-4,5-difluorobenzaldehyde 
(182e) (0.093 g, 0.470 mmol). Purification by column chromatography using 
(diethyl ether/petroleum ether, 1:10) gave ethyl (2E)-3-(2’-allyloxy-4’,5’-
difluorophenyl)prop -2-enoate (183e)  (0.117 g, 93%) as white crystals. Mp 52–53 
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°C; Rf 0.72 (50% diethyl ether/petroleum ether); max/cm
−1 (neat) 2985 (CH), 1690 
(CO), 1599 (C=C), 1511, 1273, 1224, 1174, 987, 857; δH (500 MHz, CDCl3) 1.33 
(3H, t, J 7.1 Hz, OCH2CH3), 4.26 (2H, q, J 7.1 Hz, OCH2CH3), 4.57 (2H, dt, J 5.2, 
1.6 Hz, 2’’-H2), 5.34 (1H, dq, J 10.6, 1.6 Hz, 4’’-HH), 5.43 (1H, dq, J 17.3, 1.6 Hz, 
4’’-HH), 6.04 (1H, ddt, J 17.3, 10.6, 5.2 Hz, 3’’-H), 6.41 (1H, d, J 16.2 Hz, 2-H), 
6.72 (1H, dd, 3JHF 11.5, 
4JHF 5.2 Hz, 3'-H), 7.32 (1H, dd, 
3JHF 11.5, 
4JHF 9.0 Hz, 6'-
H), 7.91 (1H, dd, J 16.2, 5JHF 1.0 Hz, 3-H); δC (101 MHz, CDCl3) 14.3 (CH3), 60.5 
(CH2), 70.2 (CH2), 102.6 (d, 
2JCF 20.9 Hz, CH), 116.2 (dd, 
2JCF 18.6, 
3JCF 1.8 Hz, 
CH), 118.5 (CH2), 119.4 (CH), 120.1 (dd, 
3JCF 5.8, 
4JCF 4.3 Hz, C), 132.1 (CH), 
137.8 (CH), 144.8 (dd, 1JCF 241.6, 
2JCF 13.1 Hz, C), 151.5 (dd, 
1JCF 253.1, 
2JCF 
14.0 Hz, C), 153.7 (dd, 3JCF 7.3, 
4JCF 1.6 Hz, C), 167.0 (C); m/z (ESI) 291.0797 
(MNa+, C14H14F2NaO3 requires 291.0803), 236 (100%), 218 (5). 
 
Ethyl (2E)-3-(2’-allyloxy-3’-methoxy-5’-nitrophenyl)prop-2-enoate (183f)    
 
The reaction was carried out as described for the synthesis of ethyl (2E)-3-(2’-
allyloxyphenyl)prop-2-enoate (183a) using 2-allyloxy-3-methoxy-5-
nitrobenzaldehyde (182f) (0.617 g, 2.60 mmol). Purification by column 
chromatography using (diethyl ether/petroleum ether, 1:10) gave ethyl (2E)-3-(2’-
allyloxy-3’-methoxy-5’-nitrophenyl)prop-2-enoate (183f) (0.798 g, 100%) as a white 
solid. Mp 82–83 °C; Rf 0.58 (50% diethyl ether/petroleum ether); max/cm
−1 (neat) 
3022 (CH), 1711 (CO), 1641 (C=C), 1582, 1527, 1466, 1340, 1278, 1179, 979; δH 
(500 MHz, CDCl3) 1.35 (3H, t, J 7.1 Hz, OCH2CH3), 3.97 (3H, s, 3’-OCH3), 4.28 
(2H, q, J 7.1 Hz, OCH2CH3), 4.69 (2H, dt, J 6.1, 1.3 Hz, 2’’-H2), 5.28 (1H, dq, J 
10.3, 1.3 Hz, 4’’-HH), 5.37 (1H, dq, J 17.2, 1.3 Hz, 4’’-HH), 6.05 (1H, ddt, J 17.2, 
10.3, 6.1 Hz, 3’’-H), 6.56 (1H, d, J 16.2 Hz, 2-H), 7.77 (1H, d, J 2.6 Hz, 4'-H), 7.99 
(1H, d, J 16.2 Hz, 3-H), 8.10 (1H, d, J 2.6 Hz, 6'-H); δC (126 MHz, CDCl3) 14.3 
(CH3), 56.4 (CH3), 60.7 (CH2), 74.8 (CH2), 108.0 (CH), 114.9 (CH), 119.2 (CH2), 
121.9 (CH), 129.1 (C), 132.9 (CH), 137.5 (CH), 143.7 (C), 151.8 (C), 153.1 (C), 
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166.3 (C); m/z (ESI) 330.0934 (MNa+, C15H17NNaO6 requires 330.0948), 284 
(2%), 236 (10). 
 
Ethyl (2E)-3-(2’-allyloxynaphthalen-1’-yl)prop-2-enoate (183g)  
 
The reaction was carried out as described for the synthesis of ethyl (2E)-3-(2’-
allyloxyphenyl)prop-2-enoate (183a) using 2-allyloxy-1-naphthaldehyde (182g) 
(0.620 g, 2.94 mmol). Purification by column chromatography using (diethyl 
ether/petroleum ether, 1:10) gave ethyl (2E)-3-(2’-allyloxynaphthalen-1’-yl)prop-2-
enoate (183g) (0.760 g, 92%) as a white solid. Mp 46–48 °C; Rf 0.65 (50% diethyl 
ether/petroleum ether); max/cm
−1 (neat) 2981 (CH), 1701 (CO), 1617 (C=C), 1264, 
1159, 907, 727; δH (400 MHz, CDCl3) 1.37 (3H, t, J 7.1 Hz, OCH2CH3), 4.32 (2H, 
q, J 7.1 Hz, OCH2CH3), 4.75 (2H, dt, J 5.2, 1.6 Hz, 2’’-H2), 5.31 (1H, dq, J 10.6, 
1.6 Hz, 4’’-HH), 5.44 (1H, dq, J 17.3, 1.6 Hz, 4’’-HH), 6.10 (1H, ddt, J 17.3, 10.6, 
5.2 Hz, 3’’-H), 6.77 (1H, d, J 16.2 Hz, 2-H), 7.25 (1H, d, J 9.3 Hz, 3'-H), 7.38 (1H, 
ddd, J 8.5, 8.4, 1.0 Hz, 6'-H), 7.52 (1H, ddd, J 8.5, 8.4, 1.0 Hz, 7'-H), 7.78 (1H, dd, 
J 8.4, 1.0 Hz, 5'-H), 7.81 (1H, d, J 9.3 Hz, 4'-H), 8.19 (1H, dd, J 8.4, 1.0 Hz, 8'-H), 
8.36 (1H, d, J 16.2 Hz, 3-H); δC (101 MHz, CDCl3) 14.4 (CH3), 60.4 (CH2), 70.0 
(CH2), 114.3 (CH), 117.5 (C), 117.8 (CH2), 123.5 (CH), 123.7 (CH), 124.0 (CH), 
127.3 (CH), 128.5 (CH), 129.1 (C), 131.3 (CH), 132.8 (C), 133.1 (CH), 137.7 (CH), 
155.6 (C), 167.8 (C); m/z (ESI) 305.1139 (MNa+, C18H18NaO3 requires 305.1148), 
246 (12%), 227 (3), 191 (2). 
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(2E)-3-(2’-Allyloxyphenyl)prop-2-en-1-ol (184a)237  
 
Diisobutylaluminium hydride (3.21 mL, 2.82 mmol, 1 M in hexane) was added 
dropwise with stirring, to a solution of ethyl (2E)-3-(2’-allyloxyphenyl)prop-2-enoate 
(183a) (0.298 g, 1.28 mmol) in diethyl ether (30 mL) at −78 °C. The solution was 
stirred at −78 °C for 3 h, then allowed to return to room temperature over 15 h. 
The reaction was quenched with 10% aqueous potassium sodium tartrate solution 
(30 mL), extracted with diethyl ether (2 × 20 mL), washed with water (100 mL), 
brine (100 mL), dried (MgSO4), filtered and concentrated in vacuo. Purification by 
column chromatography (diethyl ether/petroleum ether, 1:3) yielded (2E)-3-(2’-
allyloxyphenyl)prop-2-en-1-ol (184a) (0.211 g, 87%) as a white solid. Mp 44–46 
°C; Rf 0.28 (50% diethyl ether/petroleum ether); Spectroscopic data was in 
accordance with literature values.237 δH (500 MHz, CDCl3) 1.46 (1H, t, J 5.9 Hz, 
OH), 4.33 (2H, td, J 5.9, 0.8 Hz, 1-H2), 4.58 (2H, dt, J 5.2, 1.5 Hz, 2’’-H2), 5.29 (1H, 
dq, J 10.5, 1.5 Hz, 4’’-HH), 5.42 (1H, dq, J 17.3, 1.5 Hz, 4’’-HH), 6.08 (1H, ddt, J 
17.3, 10.5, 5.2 Hz, 3’’-H), 6.40 (1H, dt, J 16.0, 5.9 Hz, 2-H), 6.86 (1H, d, J 8.2 Hz, 
3’-H), 6.93 (1H, t, J 7.5 Hz, 5’-H), 6.96 (1H, br d, J 16.0 Hz, 3-H), 7.21 (1H, ddd, J 
8.2, 7.5, 1.7 Hz, 4’-H), 7.46 (1H, dd, J 7.5, 1.7 Hz, 6’-H); δC (126 MHz, CDCl3) 64.3 
(CH2), 69.2 (CH2), 112.4 (CH), 117.5 (CH2), 120.9 (CH), 126.0 (C), 126.3 (CH), 
127.0 (CH), 128.7 (CH), 129.2 (CH), 133.4 (CH), 155.8 (C); m/z (EI) 190 (57%), 
149 (59), 131 (92), 121 (60), 119 (46), 91 (100), 77 (40). 
 
(2E)-3-(2’-Allyloxy-5’-methylphenyl)prop-2-en-1-ol (184b)   
 
The reaction was carried out as described for the synthesis of (2E)-3-(2’-
allyloxyphenyl)prop-2-en-1-ol (184a) using ethyl (2E)-3-(2’-allyloxy-5’-
methylphenyl)-prop-2-enoate (183b) (0.198 g, 0.750 mmol). Purification by flash 
column chromatography (diethyl ether/petroleum ether, 1:3) yielded (2E)-3-(2’-
allyloxy-5’-methylphenyl)prop-2-en-1-ol (184b) (0.164 g, quantitative) as a 
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colourless oil. Rf 0.32 (50% diethyl ether/petroleum ether); max/cm
−1 (neat) 3370 
(OH), 2922 (CH), 1494, 1243, 1220, 997, 909; δH (500 MHz, CDCl3) 1.39 (1H, br s, 
OH), 2.29 (3H, s, 5’-CH3), 4.32 (2H, d, J 5.2 Hz, 1-H2), 4.54 (2H, dt, J 5.2, 1.6 Hz, 
2’’-H2), 5.27 (1H, dq, J 10.6, 1.6 Hz, 4’’-HH), 5.40 (1H, dq, J 17.3, 1.6 Hz, 4’’-HH), 
6.07 (1H, ddt, J 17.3, 10.6, 5.2 Hz, 3’’-H), 6.38 (1H, dt, J 16.2, 5.2 Hz, 2-H), 6.76 
(1H, d, J 8.3 Hz, 3’-H), 6.94 (1H, d, J 16.2 Hz, 3-H), 7.00 (1H, dd, J 8.3, 2.1 Hz, 4’-
H), 7.27 (1H, d, J 2.1 Hz, 6’-H); δC (126 MHz, CDCl3) 20.6 (CH3), 64.2 (CH2), 69.4 
(CH2), 112.5 (CH), 117.4 (CH2), 125.8 (C), 126.2 (CH), 127.6 (CH), 129.1 (2 × 
CH), 130.1 (C), 133.6 (CH), 153.8 (C); m/z (EI) 204.1153 (M+, C13H16O2 requires 
204.1150), 163 (31%), 145 (61), 133 (64), 105 (97), 84 (100), 77 (24), 69 (13). 
 
(2E)-3-(2’-Allyloxy-4’-chlorophenyl)prop-2-en-1-ol (184c) 
 
The reaction was carried out as described for the synthesis of (2E)-3-(2’-
allyloxyphenyl)prop-2-en-1-ol (184a) using ethyl (2E)-3-(2’-allyloxy-4’-
chlorophenyl)prop-2-enoate (183c) (0.193 g, 0.720 mmol). Purification by column 
chromatography (diethyl ether/petroleum ether, 1:3) yielded (2E)-3-(2’-allyloxy-4’-
chlorophenyl)prop-2-en-1-ol (184c) (0.138 g, 85%) as a white solid. Mp 45–47 °C; 
Rf 0.32 (50% diethyl ether/petroleum ether); max/cm
−1 (neat) 3350 (OH), 2869 
(CH), 1590 (C=C), 1485, 1408, 1245, 1226, 1015, 998, 972, 905, 730; δH (400 
MHz, CDCl3) 1.59 (1H, t, J 5.1 Hz, OH), 4.34 (2H, br t, J 5.1 Hz, 1-H2), 4.57 (2H, 
dt, J 5.2, 1.4 Hz, 2’’-H2), 5.33 (1H, dq, J 10.6, 1.4 Hz, 4’’-HH), 5.44 (1H, dq, J 17.2, 
1.4 Hz, 4’’-HH), 6.07 (1H, ddt, J 17.2, 10.6, 5.2 Hz, 3’’-H), 6.38 (1H, dt, J 16.0, 5.1 
Hz, 2-H), 6.86 (1H, d, J 1.8 Hz, 3’-H), 6.88–6.94 (2H, m, 3-H and 5’-H), 7.37 (1H, 
d, J 8.3 Hz, 6’-H), δC (126 MHz, CDCl3) 64.1 (CH2), 69.4 (CH2), 112.8 (CH), 117.9 
(CH2), 120.9 (CH), 124.6 (C), 125.1 (CH), 127.7 (CH), 129.6 (CH), 132.6 (CH), 
133.8 (C),156.1 (C); m/z (EI) 224.0600 (M+, C12H13
35ClO2 requires 224.0604), 183 
(99%), 165 (73), 155 (100), 125 (55), 120 (10), 91 (48), 77 (14). 
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(2E)-3-(2’-Allyloxy-3’,5’-dichlorophenyl)prop-2-en-1-ol (184d)    
 
The reaction was carried out as described for the synthesis of (2E)-3-(2’-
allyloxyphenyl)prop-2-en-1-ol (184a) using ethyl (2E)-3-(2’-allyloxy-3’,5’-dichloro-
phenyl)prop-2-enoate (183d) (0.903 g, 3.00 mmol). Purification by column 
chromatography using (diethyl ether/petroleum ether, 1:3) gave (2E)-3-(2’-allyloxy-
3’,5’-dichlorophenyl)prop-2-en-1-ol (184d) (0.691 g, 89%) as a white solid. Mp 49–
51 °C; Rf 0.30 (50% diethyl ether/petroleum ether); max/cm
−1 (neat) 3245 (OH), 
2857 (CH), 1643, 1555, 1441, 1262, 1014, 970, 858; δH (400 MHz, CDCl3) 1.47 
(1H, t, J 5.6 Hz, OH), 4.35 (2H, td, J 5.6, 1.6 Hz, 1-H2), 4.43 (2H, dt, J 5.6, 1.3 Hz, 
2’’-H2), 5.28 (1H, dq, J 10.6, 1.3 Hz, 4’’-HH), 5.41 (1H, dq, J 17.3, 1.3 Hz, 4’’-HH), 
6.09 (1H, ddt, J 17.3, 10.6, 5.6 Hz, 3’’-H), 6.40 (1H, dt, J 16.2, 5.6 Hz, 2-H), 6.83 
(1H, dt, J 16.2, 1.6 Hz, 3-H), 7.28 (1H, d, J 2.5 Hz, 4'-H), 7.36 (1H, d, J 2.5 Hz, 6'-
H); δC (101 MHz, CDCl3) 63.5 (CH2), 74.7 (CH2), 118.5 (CH2), 123.8 (CH), 125.1 
(CH), 128.9 (CH), 129.4 (C), 129.6 (C), 132.4 (CH), 133.0 (CH), 133.5 (C), 151.1 
(C); m/z (EI) 258.0218 (M+, C12H12
35Cl2O2 requires 258.0214), 227 (5%), 199 (57), 
187 (43), 159 (44), 154 (12), 125 (21), 84 (100). 
 
(2E)-3-(2’-Allyloxy-4’,5’-difluorophenyl)prop-2-en-1-ol (184e)    
 
The reaction was carried out as described for the synthesis of (2E)-3-(2’-
allyloxyphenyl)prop-2-en-1-ol (184a) using ethyl (2E)-3-(2’-allyloxy-4’,5’-difluoro-
phenyl)prop-2-enoate (183e) (0.090 g, 0.340 mmol). Purification by column 
chromatography using (diethyl ether/petroleum ether, 1:3) gave (2E)-3-(2’-allyloxy-
4’,5’-difluorophenyl)prop-2-en-1-ol (184e) (0.071 g, 94%) as a yellow oil. Rf 0.32 
(50% diethyl ether/petroleum ether); max/cm
−1 (neat) 3341 (OH), 2867 (CH), 1610 
(C=C), 1507, 1422, 1192, 991, 969; δH (400 MHz, CDCl3) 1.57 (1H, br s, OH), 4.32 
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(2H, br d, J 5.2 Hz, 1-H2), 4.51 (2H, dt, J 5.2, 1.6 Hz, 2’’-H2), 5.31 (1H, dq, J 10.6, 
1.6 Hz, 4’’-HH), 5.41 (1H, dq, J 17.3, 1.6 Hz, 4’’-HH), 6.03 (1H, ddt, J 17.3, 10.6, 
5.2 Hz, 3’’-H), 6.28 (1H, dt, J 16.0, 5.2 Hz, 2-H), 6.67 (1H, dd, 3JHF 11.5, 
4JHF 5.2 
Hz, 3'-H), 6.85 (1H, dd, J 16.0, 1.6 Hz, 3-H), 7.23 (1H, dd, 3JHF 11.5, 
4JHF 9.0 Hz, 
6'-H); δC (101 MHz, CDCl3)  63.9 (CH2), 70.1 (CH2), 102.5 (d, 
2JCF 20.8 Hz, CH), 
114.7 (dd, 2JCF 18.3, 
3JCF 1.4 Hz, CH), 118.1 (CH2), 122.5 (dd, 
3JCF 5.1, 
4JCF 3.8 
Hz, C), 124.2 (CH), 129.9 (d, 4JCF 2.2 Hz, CH), 132.6 (CH), 144.8 (dd, 
1JCF 240.5, 
2JCF 13.0 Hz, C), 149.7 (dd, 
1JCF 248.7, 
2JCF 13.9 Hz, C), 151.8 (dd, 
3JCF 7.1, 
4JCF 
1.8 Hz, C); m/z (EI) 226.0806 (M+, C12H12F2O2 requires 226.0805), 185 (74%), 167 
(100), 157 (60), 127 (94), 119 (22), 84 (97). 
 
(2E)-3-(2’-Allyloxy-3’-methoxy-5’-nitrophenyl)prop-2-en-1-ol (184f)    
 
The reaction was carried out as described for the synthesis of (2E)-3-(2’-
allyloxyphenyl)prop-2-en-1-ol (184a) using ethyl (2E)-3-(2’-allyloxy-3’-methoxy-5’-
nitrophenyl)prop-2-enoate (183f) (0.798 g, 2.59 mmol). Purification by column 
chromatography using (diethyl ether/petroleum ether, 1:2) gave (2E)-3-(2’-allyloxy-
3’-methoxy-5’-nitrophenyl)prop-2-en-1-ol (184f) (0.604 g, 88%) as a white solid. 
Mp 58–60 °C; Rf 0.2 (50% diethyl ether/petroleum ether); max/cm
−1 (neat) 3267 
(OH), 2933 (CH), 1657, 1579, 1511, 1471, 1336, 1265, 1210, 1104, 1071, 977; δH 
(500 MHz, CDCl3) 1.59 (1H, t, J 5.6 Hz, OH), 3.95 (3H, s, 3’-OCH3), 4.38 (2H, td, J 
5.6, 1.6 Hz, 1-H2), 4.60 (2H, dt, J 6.0, 1.3 Hz, 2’’-H2), 5.26 (1H, dq, J 10.5, 1.3 Hz, 
4’’-HH), 5.37 (1H, dq, J 17.1, 1.3 Hz, 4’’-HH), 6.06 (1H, ddt, J 17.1, 10.5, 6.0 Hz, 
3’’-H), 6.50 (1H, dt, J 16.2, 5.6 Hz, 2–H), 6.95 (1H, dt, J 16.2, 1.6 Hz, 3-H), 7.66 
(1H, d, J 2.6 Hz, 4'-H), 8.04 (1H, d, J 2.6 Hz, 6'-H); δC (126 MHz, CDCl3) 56.2 
(CH3), 63.3 (CH2), 74.4 (CH2), 105.9 (CH), 114.1 (CH), 118.7 (CH2), 123.4 (CH), 
131.5 (C), 132.7 (CH), 133.3 (CH), 143.8 (C), 150.3 (C), 153.0 (C); m/z (ESI) 
288.0837 (MNa+, C13H15NNaO5 requires 288.0842). 
 
153 
 
(2E)-3-(2’-Allyloxynaphthalen-1’-yl)prop-2-en-1-ol (184g)  
 
The reaction was carried out according to the procedure described for the 
synthesis of (2E)-3-(2’-allyloxyphenyl)prop-2-en-1-ol (184a) using ethyl (2E)-3-(2’-
allyloxynaphthalen-1’-yl)prop-2-enoate (183g) (0.760 g, 2.69 mmol). Purification by 
column chromatography using (diethyl ether/petroleum ether, 1:3) gave (2E)-3-(2’-
allyloxynaphthalen-1’-yl)prop-2-en-1-ol (184g) (0.592 g, 92%) as a yellow solid. 
Mp 56–58 °C; Rf 0.28 (50% diethyl ether/petroleum ether); max/cm
−1 (neat) 3391 
(OH), 2865 (CH), 1591 (C=C), 1510, 1217, 1011, 805; δH (500 MHz, CDCl3) 1.52 
(1H, t, J 6.0 Hz, OH), 4.47 (2H, td, J 6.0, 1.6 Hz, 1-H2), 4.70 (2H, dt, J 5.2, 1.6 Hz, 
2’’-H2), 5.29 (1H, dq, J 10.5, 1.6 Hz, 4’’-HH), 5.44 (1H, dq, J 17.3, 1.6 Hz, 4’’-HH), 
6.10 (1H, ddt, J 17.3, 10.5, 5.2 Hz, 3’’-H), 6.46 (1H, dt, J 16.2, 6.0 Hz, 2-H), 7.04 
(1H, dt, J 16.2, 1.6 Hz, 3-H), 7.25 (1H, d, J 9.0 Hz, 3'-H), 7.35 (1H, ddd, J 8.5, 8.4, 
1.0 Hz, 6'-H), 7.46 (1H, ddd, J 8.5, 8.4, 1.0 Hz, 7'-H), 7.74 (1H, d, J 9.0 Hz, 4'-H), 
7.78 (1H, dd, J 8.4, 1.0 Hz, 5'-H), 8.16 (1H, dd, J 8.4, 1.0 Hz, 8'-H); δC (126 MHz, 
CDCl3) 64.4 (CH2), 70.2 (CH2), 114.9 (CH), 117.5 (CH2), 120.7 (C), 123.7 (CH), 
123.9 (CH), 124.3 (CH), 126.5 (CH), 128.3 (CH), 128.8 (CH), 129.4 (C), 132.6 (C), 
133.6 (CH), 135.3 (CH), 153.5 (C); m/z (EI) 240.1153 (M+, C16H16O2 requires 
240.1150), 199 (25%), 181 (56), 169 (93), 141 (100), 115 (38), 83 (95), 69 (10). 
 
5-(2’,2’,2’-Trichloromethylcarbonylamino)-2,5-dihydro-1-benzoxepine (187a) 
 
(2E)-3-(2’-Allyloxyphenyl)prop-2-en-1-ol (184a) (0.050 g, 0.260 mmol) was 
dissolved in dichloromethane (15 mL) and cooled to 0 °C under argon with stirring. 
Trichloroacetonitrile (0.040 mL, 0.400 mmol) was added to the solution, followed 
by 1,8-diazabicyclo[5.4.0]undec-7-ene (0.020 mL, 0.130 mmol) and the reaction 
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was allowed to return to room temperature over 1 h. The reaction mixture was 
filtered through a short pad of alumina (neutral, Brockman V) with diethyl ether 
(150 mL) and concentrated in vacuo to yield the crude allylic trichloroacetimidate 
(185) as a yellow oil which was used without further purification. The allylic 
trichloroacetimidate was transferred to a dry Schlenk tube containing a stirrer bar 
and potassium carbonate (15 mg, 3 mg/mL) to which p-xylene (5 mL) was then 
added. The tube was purged with argon, sealed and heated to 140 °C for 18 h. 
The reaction was allowed to cool to room temperature and Grubbs 2nd generation 
catalyst (0.110 g, 0.013 mmol, 5 mol%) was added. The reaction mixture was 
heated to 50 °C for 24 h. The reaction mixture was concentrated in vacuo and 
purified by column chromatography (diethyl ether/petroleum ether, 1:10) gave 5-
(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-benzoxepine (187a) (0.055 g, 
68%) as a white solid. Mp 96–98 °C; Rf 0.62 (50% diethyl ether/petroleum 
ether); max/cm
−1 (neat) 3260 (NH), 3055 (CH), 1686 (CO), 1539, 1269, 1227, 
1072, 822, 725; δH (400 MHz, CDCl3) 4.44 (1H, dddd, J 17.6, 2.6, 2.0, 1.0 Hz, 2-
HH), 4.82 (1H, dddd, J 17.6, 3.5, 2.0, 1.0 Hz, 2-HH), 5.41 (1H, br t, J 7.7 Hz, 5-H), 
5.67–5.73 (1H, m, 3-H), 6.11 (1H, ddt, J 11.5, 7.7, 2.0 Hz, 4-H), 7.10–7.16 (2H, m, 
8-H and 9-H), 7.27–7.34 (2H, m, 6-H and 7-H), 7.63 (1H, br d, J 7.7 Hz, NH); δC 
(101 MHz, CDCl3) 51.5 (CH), 71.1 (CH2), 92.7 (C), 122.1 (CH), 125.1 (CH), 126.0 
(CH), 128.3 (CH), 130.1 (CH), 131.6 (CH), 134.9 (C), 157.3 (C), 160.6 (C); m/z 
(CI) 307.9830 (MH+. C12H11
35Cl2
37ClNO2 requires 307.9827), 272 (37%), 257 (62), 
197 (13), 157 (28), 145 (64), 113 (35), 71 (53). 
 
7-Methyl-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-
benzoxepine (187b)    
  
The reaction was carried out as described for the synthesis of 5-(2’,2’,2’-
trichloromethylcarbonylamino)-2,5-dihydro-1-benzoxepine (187a) using (2E)-3-(2’-
allyloxyphenyl-5’-methyl)prop-2-en-1-ol (184b)  (0.150 g, 0.730 mmol). Purification 
155 
 
by column chromatography using (diethyl ether/petroleum ether, 1:10) gave 7-
methyl-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-benzoxepine (187b) 
(0.173 g, 73%) as a white solid. Mp 146–148 °C; Rf 0.62 (50% diethyl 
ether/petroleum ether); max/cm
−1 (neat) 3306 (NH), 1713 (CO), 1530, 1494, 1234, 
1064, 825; δH (500 MHz, CDCl3) 2.31 (3H, s, 7-CH3), 4.40 (1H, br dt, J 17.6, 2.1 
Hz, 2-HH), 4.79 (1H, ddd, J 17.6, 3.5, 2.1 Hz, 2-HH), 5.33 (1H, t, J 8.1 Hz, 5-H), 
5.66–5.72 (1H, m, 3-H), 6.11 (1H, ddt, J 11.5, 8.1, 2.1 Hz, 4-H), 7.01 (1H, d, J 8.3 
Hz, 9-H), 7.08–7.12 (2H, m, 6-H and 8-H), 7.65 (1H, d, J 8.1 Hz, NH); δC (126 
MHz, CDCl3) 20.8 (CH3), 51.5 (CH), 71.2 (CH2), 92.7 (C), 121.7 (CH), 126.0 (CH), 
128.9 (CH), 130.4 (CH), 131.7 (CH), 134.5 (C), 134.7 (C), 155.0 (C), 160.6 (C); 
m/z (ESI) 341.9811 (MNa+, C13H12
35Cl3NaNO2 requires 341.9826), 236 (5%), 218 
(1), 159 (2). 
 
8-Chloro-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-
benzoxepine (187c) 
 
The reaction was carried out as described for the synthesis of 5-(2’,2’,2’-
trichloromethylcarbonylamino)-2,5-dihydro-1-benzoxepine (187a) using (2E)-3-(2’-
allyloxy-4’-chlorophenyl)prop-2-en-1-ol (184c) (0.130 g, 0.580 mmol). The 
Overman rearrangement step was heated to 140 °C for 24 h. Flash column 
chromatography using (diethyl ether/petroleum ether, 1:10) gave 8-chloro-5-
(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-benzoxepine (187c) (0.141 g, 
71%) as a yellow oil. Rf 0.57 (50% diethyl ether/petroleum ether); max/cm
−1 (neat) 
3416 (NH), 2960 (CH), 1700 (CO), 1598 (C=C), 1490, 1480, 1271, 1225, 1077, 
906, 836, 821, 731; δH (400 MHz, CDCl3) 4.45 (1H, br dt, J 17.6, 2.1 Hz, 2-HH), 
4.82 (1H, ddd, J 17.6, 3.4, 2.1 Hz, 2-HH), 5.38  (1H, t, J 7.8 Hz, 5-H), 5.69–5.75 
(1H, m, 3-H), 6.07 (1H, ddt, J 11.5, 7.8, 2.1 Hz, 4-H), 7.11 (1H, dd, J 8.1, 2.0 Hz, 
7-H), 7.14 (1H, d, J 2.0 Hz, 9-H), 7.23 (1H, d, J 8.1 Hz, 6-H), 7.50 (1H, d, J 7.8 Hz, 
NH); δC (101 MHz, CDCl3) 51.0 (CH), 71.2 (CH2), 92.5 (C), 122.8 (CH), 125.2 
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(CH), 125.6 (CH), 129.2 (CH), 131.5 (CH), 133.5 (C), 134.8 (C), 157.8 (C), 160.7 
(C); m/z (ESI) 361.9264 (MNa+, C12H9
35Cl4NaNO2 requires 361.9280). 
 
7,9-Dichloro-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-
benzoxepine (187d)    
 
The reaction was carried out as described for the synthesis of 5-(2’,2’,2’-
trichloromethylcarbonylamino)-2,5-dihydro-1-benzoxepine (187a) using (2E)-3-(2'-
allyloxy-3’,5’-dichlorophenyl)prop-2-en-1-ol (184d) (0.230 g, 0.890 mmol). 
Purification by column chromatography using (diethyl ether/petroleum ether, 1:30) 
gave 7,9-dichloro-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-
benzoxepine (187d) (0.113 g, 34%) as a white solid. Mp 58–60 °C; Rf 0.58 (50% 
diethyl ether/petroleum ether); max/cm
−1 (neat) 3320 (NH), 2920 (CH), 1701 (CO), 
1513, 1463, 1173, 908, 839; δH (500 MHz, CDCl3) 4.47 (1H, ddd, J 17.8, 3.5, 2.1 
Hz, 2-HH), 4.85 (1H, ddd, J 17.8, 3.5, 2.1 Hz, 2-HH), 5.39 (1H, t, J 8.0 Hz, 5-H), 
5.70–5.77 (1H, m, 3-H), 6.06 (1H, ddt, J 11.6, 8.0, 2.1 Hz, 4-H), 7.20 (1H, d, J 2.4 
Hz, 8-H), 7.38 (1H, d, J 2.4 Hz, 6-H), 7.54 (1H, br d, J 8.0 Hz, NH); δC (126 MHz, 
CDCl3) 50.7 (CH), 70.1 (CH2), 92.3 (C), 125.3 (CH), 126.8 (CH), 128.5 (C), 130.0 
(CH), 130.4 (C), 131.4 (CH), 137.8 (C), 151.4 (C), 160.9 (C); m/z (ESI) 395.8878 
(MNa+, C12H8
35Cl5NNaO2 requires 395.8890). 
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7,8-Difluoro-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-
benzoxepine (187e)    
 
The reaction was carried out as described for the synthesis of 5-(2’,2’,2’-
trichloromethylcarbonylamino)-2,5-dihydro-1-benzoxepine (187a) using (2E)-3-(2’-
allyloxy-4’,5’-difluorophenyl)prop-2-en-1-ol (184e) (0.040 g, 0.180 mmol). The 
Overman rearrangement step was heated to 140 °C for 24 h. Purification by 
column chromatography using (diethyl ether/petroleum ether, 1:30) gave 7,8-
difluoro-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-benzoxepine 
(187e) (0.042 g, 68%) as a white solid. Mp 106–108 °C; Rf 0.45 (50% diethyl 
ether/petroleum ether); max/cm
−1 (neat) 3264 (NH), 2925 (CH), 1711 (CO), 1691 
(C=C), 1620, 1542, 1500, 1267, 1161, 888; δH (500 MHz, CDCl3) 4.44 (1H, ddd, J 
17.6, 3.5, 2.1 Hz, 2-HH), 4.79 (1H, ddd, J 17.6, 2.8, 2.1 Hz, 2-HH), 5.34 (1H, t, J 
7.8 Hz, 5-H), 5.70–5.76 (1H, m, 3-H), 6.05 (1H, ddt, J 11.5, 7.8, 2.1 Hz, 4-H), 6.97 
(1H, dd, 3JHF 10.2, 
4JHF 6.8 Hz, 9-H), 7.14 (1H, dd, 
3JHF 10.2, 
4JHF 8.7 Hz, 6-H), 
7.47 (1H, d, J 7.8 Hz, NH); δC (101 MHz, CDCl3) 50.7 (CH), 71.3 (CH2), 92.4 (C), 
111.8 (d, 2JCF 18.3 Hz, CH), 116.8 (dd, 
2JCF 19.0, 
3JCF 1.4 Hz, CH), 125.4 (CH), 
131.3 (dd, 3JCF 5.1, 
4JCF 3.6 Hz, C), 131.6 (CH), 147.0 (dd, 
1JCF 247.0, 
2JCF 12.5 
Hz, C), 150.1 (dd, 1JCF 251.6, 
2JCF 13.7 Hz, C), 153.1 (dd, 
3JCF 8.3, 
4JCF 3.1 Hz, C), 
160.8 (C); m/z (CI) 341.9665 (MH+, C12H9
35Cl3F2NO2 requires 341.9667), 308 
(49%), 274 (8), 238 (18), 181 (96), 81 (20), 69 (28). 
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9-Methoxy-7-nitro-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-
benzoxepine (187f)    
 
The reaction was carried out as described for the synthesis of 5-(2’,2’,2’-
trichloromethylcarbonylamino)-2,5-dihydro-1-benzoxepine (187a) using (2E)-3-(2'-
allyloxy-3’-methoxy-5’-nitrophenyl)prop-2-en-1-ol (184f) (0.215 g, 0.810 mmol). 
The Overman rearrangement step was heated to 140 °C for 48 h. Purification by 
column chromatography using (diethyl ether/petroleum ether, 1:2) gave 9-
methoxy-7-nitro-5-(2’,2,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-
benzoxepine (187f) (0.162 g, 52%) as a white solid. Mp 180–182 °C; Rf 0.2 (50% 
diethyl ether/petroleum ether); max/cm
−1 (neat) 3327 (NH), 2943 (CH), 1702 (CO), 
1526, 1342, 1056, 909, 822; δH (500 MHz, CDCl3) 3.99 (3H, s, 9-OMe), 4.52 (1H, 
ddd, J 17.8, 3.5, 2.1 Hz, 2-HH), 4.89 (1H, ddd, J 17.8, 2.8, 2.1 Hz, 2-HH), 5.54 
(1H, t, J 8.1 Hz, 5-H), 5.73–5.79 (1H, m, 3-H), 6.09 (1H, ddt, J 11.6, 8.1, 2.1 Hz, 4-
H), 7.54 (1H, br d, J 8.1 Hz, NH), 7.83 (1H, d, J 2.5 Hz, 8-H), 7.86 (1H, d, J 2.5 Hz, 
6-H); δC (126 MHz, CDCl3) 50.8 (CH), 56.6 (CH3), 70.4 (CH2), 92.3 (C), 108.1 
(CH), 115.3 (CH), 125.4 (CH), 131.4 (CH), 137.3 (C), 144.6 (C), 150.7 (C), 152.9 
(C), 160.9 (C); m/z (ESI) 402.9609 (MNa+, C13H11
35Cl3NaN2O5 requires 402.9626), 
363 (2%), 301 (1), 236 (11), 227 (9), 218 (2), 159 (2). 
 
5-(2’,2’,2’-Trichloromethylcarbonylamino)-2,5-dihydro-1-naphtho[2,1-
b]oxepine (187g)  
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The reaction was carried out as described for the synthesis of 5-(2’,2’,2’-
trichloromethylcarbonylamino)-2,5-dihydro-1-benzoxepine (187a) using (2E)-3-(2’-
allyloxynaphthyl)prop-2-en-1-ol (184g) (0.205 g, 0.850 mmol). Purification by 
column chromatography using (diethyl ether/petroleum ether, 1:30) gave 5-
(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-naphth[2,1-b]oxepine (187g) 
(0.140 g. 46%) as a white solid. Mp 136–138 °C; Rf 0.65 (50% diethyl 
ether/petroleum ether); max/cm
−1 (neat) 3406 (NH), 2940 (CH), 1701 (CO), 1492, 
1220, 1045, 818; δH (400 MHz, CDCl3) 4.48 (1H, br dt, J 17.6, 2.1 Hz, 2-HH), 4.93 
(1H, ddd, J 17.6, 3.5, 2.1 Hz, 2-HH), 5.74–5.79 (1H, m, 3-H), 6.25–6.30 (1H, m, 4-
H), 6.32 (1H, br t, J 8.4 Hz, 5-H), 7.32 (1H, d, J 8.4 Hz, 11-H), 7.47 (1H, ddd, J 8.5, 
8.4, 1.3 Hz, 8-H), 7.60 (1H, ddd, J 8.5, 8.4, 1.3 Hz, 7-H), 7.83–7.87 (2H, m, 9-H 
and 10-H), 7.99 (1H, d, J 8.4 Hz, NH), 8.29 (1H, br d, J 8.4 Hz, 6-H); δC (126 MHz, 
CDCl3) 44.9 (CH), 70.5 (CH2), 92.7 (C), 121.5 (CH), 122.9 (CH), 125.4 (CH), 126.0 
(CH), 127.4 (CH), 128.6 (CH), 129.7 (C), 130.6 (C), 130.8 (CH), 131.4 (C), 131.8 
(CH), 155.4 (C), 160.8 (C); m/z (ESI) 377.9808 (MNa+, C16H12
35Cl3NaNO2 requires 
377.9826).  
  
8-Chloro-5-(2’,2’-dichloromethylcarbonylamino)-2,3,4,5-tetrahydro-1-
benzoxepine (188) 
 
20% Palladium on charcoal (0.03 g) was added to a solution of 8-chloro-5-(2’,2’,2’-
trichloromethylcarbonylamino)-2,5-dihydro-1-benzoxepine (187c) (0.120 g, 0.350 
mmol) in ethyl acetate (7 mL). The mixture was stirred under an atmosphere of 
hydrogen at room temperature for 1.5 h. The reaction mixture was filtered through 
a short pad of Celite® with diethyl ether (100 mL), concentrated in vacuo and 
purified by column chromatography (diethyl ether/petroleum ether, 1:10). This 
gave 8-chloro-5-(2’,2’-dichloromethylcarbonylamino)-2,3,4,5-tetrahydro-1-
benzoxepine (188) (0.102 g, 94%) as a white solid. Mp 106–108 °C; max/cm
−1 
(neat) 3263 (NH), 2936 (CH), 1670 (CO), 1561, 1479, 1284, 1223, 1213, 1080, 
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1042, 983, 952, 808; δH (500 MHz, CDCl3) 1.73–1.93 (2H, m, 3-HH and 4-HH), 
2.18–2.30 (2H, m, 3-HH and 4-HH), 3.76 (1H, td, J 12.0, 2.0 Hz, 2-HH), 4.38 (1H, 
dt, J 12.0, 1.1 Hz, 2-HH), 5.16 (1H, ddd, J 7.8, 6.2, 1.6 Hz, 5-H), 5.94 (1H, s, 
CHCl2), 7.05 (1H, dd, J 8.0, 2.1 Hz, 7-H), 7.07 (1H, d, J 2.1 Hz, 9-H), 7.17 (1H, d, J 
8.0 Hz, 6-H), 7.20 (1H, d, J 7.8 Hz, NH); δC (126 MHz, CDCl3) 26.4 (CH2), 29.8 
(CH2), 53.2 (CH), 66.5 (CH), 74.1 (CH2), 122.9 (CH), 124.6 (CH), 130.3 (CH), 
132.3 (C), 134.5 (C), 160.1 (C), 163.0 (C); m/z (ESI) 329.9812 (MNa+, 
C12H12
35Cl3NaNO2 requires 329.9826). 
 
5-Amino-8-chloro-2,3,4,5-tetrahydro-1-benzoxepine (189) 
 
A solution of 8-chloro-5-(2’,2’-dichloromethylcarbonylamino)-2,3,4,5-tetrahydro-1-
benzoxepine (188) (0.163 g, 0.530 mmol) and 6M aqueous hydrochloric acid (10 
mL) in methanol (1 mL) was stirred at 100 °C for 144 h. The methanol was 
removed in vacuo and the aqueous layer was extracted with diethyl ether (3 × 10 
mL). The remaining aqueous layer was basified by adding aqueous sodium 
carbonate solution and extracted with diethyl ether (3 × 10 mL). The combined 
organic extracts were concentrated to afford 5-amino-8-chloro-2,3,4,5-tetrahydro-
1-benzoxepine (189) (0.081 g, 78%) as a white solid. Mp 90–92 °C; max/cm
−1 
(neat) 3412 (NH), 2938 (CH), 1594 (C=C), 1478, 1228, 1082, 946, 906, 729; δH 
(400 MHz, CDCl3) 1.72 (2H, br s, NH2), 1.80–1.96 (3H, m, 3-HH and 4-H2), 2.13–
2.22 (1H, m, 3-HH), 3.92 (1H, ddd, J 10.8, 8.0, 2.4 Hz, 5-H), 4.04–4.09 (2H, m, 2-
H2), 7.00 (1H, d, J 2.1 Hz, 9-H), 7.02 (1H, dd, J 8.0, 2.1 Hz, 7-H), 7.20 (1H, d, J 8.0 
Hz, 6-H); δC (126 MHz, CDCl3) 27.2 (CH2), 33.8 (CH2), 54.1 (CH), 73.8 (CH2), 
122.4 (CH), 123.9 (CH), 128.4 (CH), 132.7 (C), 135.8 (C), 159.5 (C); m/z (CI) 
198.0695 (MH+, C10H13
35ClNO requires 198.0686), 181 (100%), 165 (7), 153 (7), 
125 (2), 91 (4), 85 (49), 69 (22). 
 
161 
 
5-N,N’-Bis(tert-butoxycarbonyl)guanidino-8-chloro-2,3,4,5-tetrahydro-1-
benzoxepine (191) 
 
Diisopropylethylamine (0.168 mL, 0.960 mmol), and N,N’-bis(tert-butoxycarbonyl-
1H-pyrazole-1-carboxamidine (190) (0.056 g, 0.180 mmol) were added to a 
solution of 5-amino-8-chloro-2,3,4,5-tetrahydro-1-benzoxepine (189) (0.024 g, 
0.120 mmol) in methanol (10 mL) and stirred for 48 h at room temperature. The 
methanol was removed in vacuo. The resulting residue was dissolved in diethyl 
ether (10 mL) and acidified by 0.2M aqueous hydrochloric acid (1 mL). The 
organic layer was washed with brine (10 mL), dried (MgSO4) and concentrated in 
vacuo. Purification by column chromatography (diethyl ether/petroleum ether, 
1:15) gave 5-N,N’-bis(tert-butoxycarbonyl)guanidino-8-chloro-2,3,4,5-tetrahydro-1-
benzoxpine (191) (0.043 g, 80%) as a white solid. Mp 169–171 °C 
(decomposition); Rf 0.73 (50% diethyl ether/petroleum ether); max/cm
−1 (neat) 
3321 (NH), 2981 (CH), 1722 (CO), 1637, 1612 (C=C), 1560, 1479, 1412, 1324, 
1227, 1154, 1124, 1057, 909, 732; δH (400 MHz, CDCl3) 1.48 (9H, s, O
tBu), 1.50 
(9H, s, OtBu), 1.72–1.80 (1H, m, 4-HH), 1.85–1.93 (1H, m, 4-HH), 2.15–2.27 (2H, 
m, 3-H2), 3.80 (1H, ddd, J 12.0, 10.1, 2.1 Hz, 2-HH), 4.31 (1H, dt, J 12.0, 4.2 Hz, 
2-HH), 5.50 (1H, ddd, J 9.0, 6.6, 2.0 Hz, 5-H), 7.02 (1H, dd, J 8.1, 2.1 Hz, 7-H), 
7.05 (1H, d, J 2.1 Hz, 9-H), 7.24 (1H, d, J 8.1 Hz, 6-H), 9.01 (1H, d, J 9.0 Hz, NH), 
11.46 (1H, s, NH); δC (101 MHz, CDCl3) 26.9 (CH2), 28.1 (3 × CH3), 28.3 (3 × 
CH3), 30.4 (CH2), 52.5 (CH), 73.9 (CH2), 79.1 (C), 83.0 (C), 122.7 (CH), 124.1 
(CH), 130.5 (CH), 133.1 (C), 133.8 (C), 153.0 (C), 155.1 (C), 160.3 (C), 163.7 (C); 
m/z (EI) 439.1873 (M+, C21H30
35ClN3O5 requires 439.1874), 383 (8%), 327 (63), 
266 (35), 196 (11), 181 (24), 82 (44), 59 (100). 
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8-Chloro-5-guanidino-2,3,4,5-tetrahydro-1-benzoxepine trifluoroacetic acid 
(175) 
 
A solution of 5-N,N’-bis(tert-butoxycarbonyl)guanidino-8-chloro-2,3,4,5-tetrahydro-
1-benzoxpine (191) (0.012 g, 0.027 mmol) in dichloromethane (0.450 mL) and 
trifluoroacetic acid (0.011 mL, 0.140 mmol) was stirred at 45 °C for 48 h. The 
reaction mixture was concentrated in vacuo to afford 8-chloro-5-guanidino-2,3,4,5-
tetrahydro-1-benzoxepine trifluoroacetic acid (175) (0.096 g, quantitative) as a 
white solid. Mp 229–231 °C (decomposition); max/cm
−1 (neat) 3364 (NH), 3160 
(NH), 2925 (CH), 1679, 1613, 1481, 1201, 1187, 1144, 972, 843, 801, 724; δH 
(400 MHz, CDCl3) 1.96–2.16 (2H, m, 3-H2 and 4-H2), 4.00 (1H, ddd, J 9.6, 5.2, 2.4 
Hz, 2-HH), 4.07 (1H, ddd, J 9.6, 5.6, 2.8 Hz, 2-HH), 4.84 (1H, t, J 4.0 Hz, 5-H), 
7.08 (1H, d, J 2.1 Hz, 9-H), 7.12 (1H, dd, J 8.2, 2.1 Hz, 7-H), 7.21 (1H, d, J 8.2 Hz, 
6-H); δC (101 MHz, CDCl3) 27.2 (CH2), 31.2 (CH2), 53.7 (CH), 73.2 (CH2), 122.4 
(CH), 123.9 (CH), 128.1 (CH), 132.5 (C), 133.9 (C), 156.5 (C), 159.7 (C); m/z 
(ESI) 240.0902 (MH+, C11H15
35ClN3O requires 240.0898).  
 
(3R*,4S*,5S*)-3,4-Dihydroxy-7-methyl-5-(2’,2’,2’-
trichloromethylcarbonylamino)-2,3,4,5-tetrahydro-1-benzoxepine (193b)  
 
Tetramethylethylenediamine (0.013 mL, 0.080 mmol) was added to a solution of 7-
methyl-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-benzoxepine (187b) 
(0.024 g, 0.076 mmol) in dichloromethane (2 mL) and cooled to −78 °C. After 0.2 
h, a solution of osmium tetroxide (0.021 g, 0.080 mmol) in dichloromethane (1 mL) 
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was added dropwise. The solution was stirred at −78 °C for 1 h, allowed to return 
to room temperature over 2 h and then concentrated in vacuo. The residue was 
taken up in a solution of methanol (4 mL) and 12M aqueous hydrochloric acid (0.5 
mL) and stirred at room temperature for 2 h. The reaction mixture was 
concentrated in vacuo. The resulting residue was purified by column 
chromatography (ethyl acetate/petroleum ether, 1:1) to yield (3R*,4S*,5S*)-3,4-
dihydroxy-7-methyl-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,3,4,5-tetrahydro-1-
benzoxepine (193b) (0.016 g, 61%) as a white solid. Mp 146–148 °C; Rf 0.15 
(75% diethyl ether/petroleum ether); max/cm
–1 (neat) 3413 (NH and OH), 2927 
(CH), 1707 (CO), 1510, 1500, 1215, 828, 756; δH (400 MHz, CDCl3) 2.31 (3H, s, 7-
CH3), 2.98 (1H, d, J 2.2 Hz, OH), 3.13 (1H, d, J 5.4 Hz, OH), 3.89 (1H, d, J 13.2 
Hz, 2-HH), 4.07–4.12 (1H, m, 4-H), 4.20–4.26 (1H, m, 3-H), 4.43 (1H, dd, J 13.2, 
3.6 Hz, 2-HH), 5.15 (1H, dd, J 8.1, 2.1 Hz, 5-H), 6.96 (1H, d, J 8.2, 9-H), 7.08 (1H, 
dd, J 8.2, 2.0 Hz, 8-H), 7.14 (1H, d, 2.0 Hz, 6-H), 8.75 (1H, br d, J 8.1 Hz, NH); δC 
(126 MHz, CDCl3) 20.8 (CH3), 60.1 (CH), 71.1 (CH), 73.8 (CH2), 77.2 (CH), 92.6 
(C), 121.8 (CH), 128.3 (C), 130.8 (CH), 131.3 (CH), 134.6 (C), 157.5 (C), 162.3 
(C); m/z (ESI) 375.9866 (MNa+, C13H14
35Cl3NNaO4 requires 375.9881). 
 
(3R*,4S*,5S*)-3,4-Dihydroxy-9-methoxy-7-nitro-5-(2’,2’,2’-
trichloromethylcarbonylamino)-2,3,4,5-tetrahydro-1-benzoxepine (193f)  
  
The reaction was carried out as described for the synthesis of (3R*,4S*,5S*)-3,4-
dihydroxy-7-methyl-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,3,4,5-tetrahydro-1-
benzoxepine (193b) using 9-methoxy-7-nitro-5-(2’,2’,2’-
trichloromethylcarbonylamino)-2,5-dihydro-1-benzoxepine (187f) (0.043 g, 0.11 
mmol). Purification by column chromatography (ethyl acetate/petroleum ether, 1:1) 
gave (3R*,4S*,5S*)-3,4-dihydroxy-9-methoxy-7-nitro-5-(2’,2’,2’-
trichloromethylcarbonyl-amino)-2,3,4,5-tetrahydro-1-benzoxepine (193f) (0.034 g, 
74%) as a white foam. Rf 0.10 (50% diethyl ether/petroleum ether); max/cm
–1 
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(neat) 3344 (NH and OH), 2926 (CH), 1704 (CO), 1528, 1345, 1215, 756; δH (400 
MHz, CDCl3) 2.47 (1H, br s, OH), 2.71 (1H, br s, OH), 3.98 (3H, s, OCH3), 4.03 
(1H, dd, J 12.0, 8.9 Hz, 2-HH), 4.20 (1H, dd, J 12.0, 2.8 Hz, 2-HH), 4.24–4.31 (2H, 
m, 3-H and 4-H), 5.38 (1H, t, J 7.6 Hz, 5-H), 7.34 (1H, d, J 7.6 Hz, NH), 7.82 (1H, 
d, J 2.3 Hz, 8-H), 7.88 (1H, d, J 2.3 Hz, 6-H); δC (101 MHz, CDCl3) 54.5 (CH), 56.6 
(CH3), 69.3 (CH), 69.5 (CH), 72.3 (CH2), 92.1 (C), 108.0 (CH), 116.9 (CH), 131.4 
(C), 144.6 (C), 152.4 (C), 152.6 (C), 161.9 (C); m/z (ESI) 436.9671 (MNa+, 
C13H13
35Cl3N2NaO7 requires 436.9681). 
 
(3R*,4S*,5S*)-3,4-Dihydroxy-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,3,4,5-
tetrahydro-1-naphtho[2,1-b]oxepine (193g)  
  
The reaction was carried out as described for the synthesis of (3R*,4S*,5S*)-3,4-
dihydroxy-7-methyl-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,3,4,5-tetrahydro-1-
benzoxepine (193b) using 5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-
naphtho[2,1-b]oxepine (187g) (0.027 g, 0.080 mmol). Purification by column 
chromatography (ethyl acetate/petroleum ether, 1:1) gave (3R*,4S*,5S*)-3,4-
dihydroxy-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,3,4,5-tetrahydro-1-
naphtho[2,1-b]oxepine (193g) (0.030 g, quantitative) as a white foam. Rf 0.42 
(50% ethyl acetate/petroleum ether); max/cm
–1 (neat) 3354 (NH and OH), 2922 
(CH), 1690 (CO), 1508, 1218, 1066, 835, 815, 755, 728; δH (400 MHz, CDCl3) 
2.39 (1H, d, J 8.5 Hz, OH), 2.50 (1H, d, J 5.2 Hz, OH), 3.76 (1H, t, J 12.0 Hz, 2-
HH), 4.28–4.48 (2H, m, 2-HH and 3-H), 4.68 (1H, br s, 4-H), 6.40 (1H, t, J 7.6 Hz, 
5-H), 7.29 (1H, d, J 8.5 Hz, 11-H), 7.45–7.72 (3H, m, 7-H, 8-H and NH), 7.88 (2H, 
d, J 8.5 Hz, 9-H and 10-H), 8.23 (1H, d, J 8.5 Hz, 6-H); δC (101 MHz, CDCl3) 49.3 
(CH), 68.7 (CH), 68.8 (CH), 71.0 (CH2), 92.2 (C), 121.6 (CH), 122.4 (C), 122.7 
(CH), 125.4 (CH), 127.8 (CH), 128.9 (CH), 131.5 (C), 131.6 (CH), 133.1 (C), 157.3 
(C), 161.7 (C); m/z (ESI) 411.9861 (MNa+, C16H14
35Cl3NNaO4 requires 411.9881). 
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(3S*,4S*,5S*)-3,4-Dihydroxy-7-methyl-5-(2’,2’,2’-
trichloromethylcarbonylamino)-2,3,4,5-tetrahydro-1-benzoxepine (199b)  
 
3-Chloroperbenzoic acid (0.112 g, 0.70 mmol) was added to a stirred solution of 7-
methyl-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-benzoxepine (187b) 
(0.042 g, 0.13 mmol) in dichloromethane (3 mL) at 0 °C. The reaction mixture was 
stirred from 0 °C to room temperature over 18 h then cooled to 0 °C before 3-
chloroperbenzoic acid (0.112 g, 0.70 mmol) was added. The reaction mixture was 
stirred for a further 24 h, quenched by the addition of an aqueous saturated 
solution of sodium sulfite (5 mL) and extracted with dichloromethane (2 × 5 mL). 
The combined organic layers were washed with an aqueous saturated solution of 
sodium hydrogen carbonate (3 × 10 mL), water (10 mL) and brine (10 mL), then 
dried (MgSO4), filtered and concentrated in vacuo. 1M Aqueous sulfuric acid (2 
mL) was added to the resulting white solid in 1,4-dioxane (2 mL) and stirred at 
room temperature for 24 h. The reaction was quenched by addition of an aqueous 
saturated solution of sodium hydrogen carbonate (3 mL) and extracted with diethyl 
ether (2 × 10 mL). The organic layer was washed with water (10 mL), brine (10 
mL), then dried (MgSO4), filtered and concentrated in vacuo. Purification by 
column chromatography (ethyl acetate/petroleum ether, 1:1) gave (3S*,4S*,5S*)-
3,4-dihydroxy-7-methyl-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,3,4,5-
tetrahydro-1-benzoxepine (199b) (0.027 g, 58%) as a white foam. Rf 0.10 (75% 
diethyl ether/petroleum ether); max/cm
–1 (neat) 3413 (NH and OH), 2927 (CH), 
1707 (CO), 1510, 1500, 1215, 828, 756; δH (400 MHz, CDCl3) 2.33 (3H, s, CH3), 
2.70 (1H, d, J 3.1 Hz, OH), 3.47 (1H, d, J 6.0 Hz, OH), 3.65 (1H, dd, J 12.2, 9.5 
Hz, 2-HH), 3.78–3.85 (1H, m, 4-H), 4.06–4.15 (1H, m, 3-H), 4.40 (1H, dd, J 12.2, 
4.2 Hz, 2-HH), 5.28 (1H, dd, J 7.8, 1.6 Hz, 5-H), 6.99 (1H, d, J 8.2, 9-H), 7.08–7.15 
(2H, m, 6-H and 8-H), 7.33 (1H, d, J 7.8 Hz, NH); δC (126 MHz, CDCl3) 20.7 (CH3), 
58.3 (CH), 71.0 (CH), 74.1 (CH2), 76.5 (CH), 92.2, (C), 122.1 (CH), 128.1 (C), 
130.5 (CH), 131.2 (CH), 135.1 (C), 156.5 (C), 163.2 (C); m/z (ESI) 375.9874 
(MNa+, C13H14
35Cl3NNaO4 requires 375.9881). 
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(3S*,4S*,5S*)-3,4-Dihydroxy-7,8-difluoro-5-(2’,2’,2’-
trichloromethylcarbonylamino)-2,3,4,5-tetrahydro-1-benzoxepine (199e)  
 
The reaction was carried out as described for the synthesis of (3S*,4S*,5S*)-3,4-
dihydroxy-7-methyl-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,3,4,5-tetrahydro-1-
benzoxepine (199b) using 7,8-difluoro-5-(2’,2’,2’-trichloromethylcarbonylamino)-
2,5-dihydro-1-benzoxepine (187e) (0.026 g, 0.080 mmol). Purification by column 
chromatography (ethyl acetate/petroleum ether, 1:1) gave (3S*,4S*,5S*)-3,4-
dihydroxy-7,8-difluoro-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,3,4,5-tetrahydro-
1-benzoxepine (199e) (0.017 g, 62%) as a white foam. max/cm
–1 (neat) 3426 (NH 
and OH), 2937 (CH), 1669 (CO), 1504, 1162, 905, 727; δH (400 MHz, CDCl3) 2.75 
(1H, d, J 4.0 Hz, OH), 3.32 (1H, d, J 4.9 Hz, OH), 3.82 (1H, dd, J 12.4, 7.9 Hz, 2-
HH), 3.88–3.95 (1H, m, 4-H), 4.01–4.09 (1H, m, 3-H), 4.32 (1H, dd, J 12.4, 3.4 Hz, 
2-HH), 5.33 (1H, dd, J 8.2, 1.6 Hz, 5-H), 6.97 (1H, dd, 3JHF 10.3, 
4JHF 6.9 Hz, 9-H), 
7.11 (1H, dd, 3JHF 10.3, 
4JHF 8.5 Hz, 6-H), 7.36 (1H, d, J 8.2 Hz, NH); δC (126 MHz, 
CDCl3) 55.9 (CH), 70.9 (CH), 73.6 (CH2), 75.1 (CH), 92.1 (C), 112.0 (d, 
2JCF 18.3 
Hz, CH), 117.7 (d, 2JCF 21.3 Hz, CH), 125.3 (d, 
3JCF 5.0 Hz, C), 147.4 (dd, 
1JCF  
247.3, 2JCF 12.5 Hz, C), 150.2 (dd, 
1JCF 253.5, 
2JCF 14.4 Hz, C), 154.3 (dd, 
3JCF 
8.1, 4JCF 2.9 Hz, C), 162.9 (C); m/z (ESI) 397.9522 (MNa
+, C12H10
35Cl3F2NNaO4 
requires 397.9536). 
 
(3S*,4S*,5S*)-3,4-Dihydroxy-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,3,4,5-
tetrahydro-1-naphtho[2,1-b]oxepine (199g)  
 
The reaction was carried out as described for the synthesis of (3S*,4S*,5S*)-3,4-
dihydroxy-7-methyl-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,3,4,5-tetrahydro-1-
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benzoxepine (199b) using 5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1-
naphtho[2,1-b]oxepine (187g) (0.060 g, 0.17 mmol), except that the second step 
was heated at 50 °C. Purification by column chromatography (ethyl 
acetate/petroleum ether, 1:1) gave (3S*,4S*,5S*)-3,4-dihydroxy-5-(2’,2’,2’-
trichloromethylcarbonylamino)-2,3,4,5-tetrahydro-1-naphtho[2,1-b]oxepine (199g) 
(0.029 g, 44%) as a white solid. Mp 170 °C (decomposition); Rf 0.12 (75% diethyl 
ether/petroleum ether); max/cm
–1 (neat) 3427 (NH and OH), 2930 (CH), 1696 (CO), 
1514, 1067, 1047, 907, 822, 732, 649; δH (400 MHz, CDCl3) 2.12 (1H, d, J 6.4 Hz, 
OH), 2.37 (1H, d, J 3.6 Hz, OH), 4.09–4.14 (1H, m, 3-H), 4.22 (2H, dd, J 13.0, 2.1 
Hz, 2-HH), 4.41 (1H, ddd, J 13.0, 3.5, 0.8 Hz, 2-HH), 4.47–4.53 (1H, m, 4-H), 6.21 
(1H, dd, J 8.4, 5.6 Hz, 5-H), 7.29 (1H, d, J 8.8 Hz, 11-H), 7.47 (1H, ddd, J 8.3, 6.9, 
0.8 Hz, 8-H), 7.61 (1H, ddd, J 8.6, 6.9, 1.4 Hz, 7-H), 7.84–7.86 (2H, m, 9-H and 
10-H), 8.30 (1H, dd, J 8.6, 0.8 Hz, 6-H), 8.64 (1H, d, J 8.4 Hz, NH); δC (101 MHz, 
CDCl3) 52.6 (CH), 69.9 (CH), 72.2 (CH2), 74.0 (CH), 92.0 (C), 121.7 (CH), 122.8 
(C), 123.1 (CH), 125.3 (CH), 127.6 (CH), 128.8 (CH), 131.4 (C), 131.5 (CH), 133.4 
(C), 157.6 (C), 161.7 (C); m/z (ESI) 411.9867 (MNa+, C16H14
35Cl3NaNO4 requires 
411.9881). 
 
2-Iodo-4-methylaniline (203b)187 
 
Iodine (7.12 g, 28.0 mmol) was added to a stirred solution of 4-methylaniline 
(202b) (2.00 g, 18.7 mmol) and sodium hydrogencarbonate (2.35 g, 28.1 mmol) in 
toluene and water (52 mL, 9:1) and warmed to 50 °C for 24 h. The mixture was 
diluted with 5% aqueous sodium thiosulfate solution (50 mL) and extracted with 
ethyl acetate (100 mL). The organic layer was washed with brine (50 mL), dried 
(MgSO4), filtered and concentrated in vacuo. Purification by column 
chromatography (diethyl ether/petroleum ether, 1:40) yielded 2-iodo-4-
methylaniline (203b) (4.03 g, 93%) as a brown oil. Spectroscopic data were 
consistent with the literature.187 Rf 0.63 (50% diethyl ether/petroleum ether); δH 
(400 MHz, CDCl3) 2.20 (3H, s, CH3), 3.93 (2H, br s, NH2), 6.66 (1H, d, J 8.0 Hz, 6-
H), 6.94 (1H, dd, J 8.0, 1.5 Hz, 5-H), 7.47 (1H, d, J 1.5 Hz, 3-H); δC (101 MHz, 
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CDCl3) 19.8 (CH3), 84.3 (C), 114.7 (CH), 129.5 (C), 130.1 (CH), 139.0 (CH), 144.3 
(C); m/z (EI) 233 (M+, 100%), 232 (16), 157 (5), 127 (5), 106 (20), 77 (8), 51 (5). 
 
2-Iodo-4-methoxyaniline (203c)188 
 
Fuming nitric acid (0.0630 g, 1.00 mmol) and concentrated sulfuric acid (2 drops) 
were added to 3-iodoanisole (205) (0.234 g, 1.00 mmol) at 0 °C and the reaction 
mixture was stirred for 6 h. The mixture was allowed to warm to room temperature 
and stirred for 18 h. The mixture was diluted with water (5 mL) and extracted with 
ethyl acetate (50 mL), washed with brine (5 mL), dried (MgSO4), filtered and 
concentrated in vacuo to yield 2-iodo-4-methoxy-1-nitrobenzene as a brown oil 
which was used without further purification. Iron (0.558 g, 10.0 mmol) and 
ammonium chloride (0.214 g, 4.00 mmol) were added to 2-iodo-4-methoxy-1-
nitrobenzene in methanol (9 mL) and water (3 mL) and warmed to 50 °C for 24 h. 
The reaction mixture was cooled to room temperature and filtered. The liquid 
phase was diluted with water (10 mL), extracted with ethyl acetate (50 mL), 
washed with brine (5 mL), dried (MgSO4), filtered, concentrated in vacuo. 
Purification by column chromatography (diethyl ether/petroleum ether, 1:20) gave 
2-iodo-4-methoxyaniline (203c) (0.076 g, 30%) as a brown oil. Spectroscopic data 
were consistent with the literature.188 Rf 0.45 (50% diethyl ether/petroleum ether); 
δH (400 MHz, CDCl3) 3.72 (3H, s, OCH3), 3.75 (2H, br s, NH2), 6.69 (1H, d, J 8.7 
Hz, 6-H), 6.77 (1H, dd, J 8.7, 2.8 Hz, 5-H), 7.20 (1H, d, J 2.8 Hz, 3-H); δC (101 
MHz, CDCl3) 56.0 (CH3), 84.3 (C), 115.4 (CH), 116.2 (CH), 123.6 (CH), 140.9 (C), 
152.7 (C); m/z (ESI) 250 (MH+, 100%), 227 (5), 122 (20), 108 (15). 
 
4-Fluoro-2-iodoaniline (203d)187 
 
The reaction was carried out as described for the synthesis of 2-iodo-4-
methylaniline (203b) using 4-fluoroaniline (202d) (3.00 g, 27.0 mmol), iodine (13.7 
g, 54.0 mmol) and sodium hydrogencarbonate (4.50 g, 54.0 mmol). The reaction 
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was heated to 70 °C for 60 h. Purification by column chromatography (diethyl 
ether/petroleum ether, 1:30) gave 4-fluoro-2-iodoaniline (203d) (5.18 g, 81%) as a 
brown oil. Spectroscopic data were consistent with the literature.187 Rf 0.55 (50% 
diethyl ether/petroleum ether); δH (400 MHz, CDCl3) 3.94 (2H, br s, NH2), 6.68 
(1H, dd, J 8.8, 4JHF 4.9 Hz, 6-H), 6.89 (1H, ddd, J 8.8, 
3JHF 8.0, 2.8 Hz, 5-H), 7.37 
(1H, dd, 3JHF 7.9, J 2.8 Hz, 3-H); δC (101 MHz, CDCl3) 82.7 (d, 
3JCF 8.8 Hz, C), 
114.7 (d, 3JCF 7.5 Hz, CH), 116.2 (d, 
2JCF 22.3 Hz, CH), 125.1 (d, 
2JCF 24.7 Hz, 
CH), 143.3 (d, 4JCF 2.2 Hz, C), 155.3 (d, 
1JCF 240.7 Hz, C); m/z (ESI) 238 (MH
+, 
100%). 
 
5-Fluoro-2-iodoaniline (203e)238 
 
The reaction was carried out as described for the synthesis of 2-iodo-4-
methylaniline (203b) using 3-fluoroaniline (202e) (3.00 g, 27.0 mmol), iodine (13.7 
g, 54.0 mmol) and sodium hydrogencarbonate (4.50 g, 54.0 mmol). The reaction 
was heated to 70 °C for 50 h. Purification by column chromatography (diethyl 
ether/petroleum ether, 1:30) gave 5-fluoro-2-iodoaniline (203e) (0.93 g, 15%) as a 
brown oil. Spectroscopic data were consistent with the literature.238 Rf 0.60 (50% 
diethyl ether/petroleum ether); δH (400 MHz, CDCl3) 4.18 (2H, br s, NH2), 6.25 
(1H, ddd, J 8.7, 3JHF 8.3, 2.8 Hz, 4-H), 6.46 (1H, dd, 
3JHF 10.5, J 2.8, Hz, 6-H), 7.54 
(1H, dd, J 8.7, 4JHF 6.2 Hz, 3-H); δC (101 MHz, CDCl3) 76.9 (d, 
4JCF 3.0 Hz, C), 
101.5 (d, 2JCF 25.6 Hz, CH), 107.2 (d, 
2JCF 22.3 Hz, CH), 139.7 (d, 
3JCF 9.6 Hz, 
CH), 148.1 (d, 3JCF 11.0 Hz, C), 164.0 (d, 
1JCF 244.7 Hz, C); m/z (EI) 237 (M
+, 
100%), 184 (3), 156 (11), 127 (4), 110 (20), 83 (12), 65 (5). 
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4-Chloro-2-iodoaniline (203f)187 
 
The reaction was carried out as described for the synthesis of 2-iodo-4-
methylaniline (203b) using 4-chloroaniline (202f) (3.00 g, 23.5 mmol), iodine (12.0 
g, 47.0 mmol) and sodium hydrogencarbonate (4.00 g, 47.0 mmol). The reaction 
was heated to 70 °C for 90 h. Purification by column chromatography (diethyl 
ether/petroleum ether, 1:30) gave 4-chloro-2-iodoaniline (203f) (3.51 g, 59%) as a 
brown oil. Spectroscopic data were consistent with the literature.187 Rf 0.50 (50% 
diethyl ether/petroleum ether); δH (400 MHz, CDCl3) 4.08 (2H, br s, NH2), 6.66 
(1H, d, J 8.6 Hz, 6-H), 7.10 (1H, dd, J 8.6, 2.3 Hz, 5-H), 7.60 (1H, d, J 2.3 Hz, 3-
H); δC (101 MHz, CDCl3) 83.5 (C), 115.0 (CH), 123.2 (C), 129.3 (CH), 137.8 (CH), 
145.6 (C); m/z (CI) 254 (MH+, 10%), 184 (5), 133 (23), 128 (49), 113 (100), 109 
(12), 97 (56), 85 (41), 71 (80). 
 
Methyl (2E)-3-(2’-aminophenyl)prop-2-enoate (206a)187 
 
Methyl acrylate (1.53 mL, 18.3 mmol) was added to a solution of 2-iodoaniline 
(203a) (2.00 g, 9.13 mmol), palladium acetate (0.110 g, 0.460 mmol), 
triphenylphosphine (0.239 g, 0.913 mmol), potassium carbonate (1.26 g, 9.13 
mmol) and tetrabutylammonium bromide (0.741 g, 2.30 mmol) in N,N’-
dimethylformamide (90 mL). The reaction mixture was stirred at 80 °C for 2 h. The 
mixture was cooled to room temperature, diluted with water (50 mL) and extracted 
with diethyl ether (3 × 50 mL). The organic layer was washed with 5% aqueous 
lithium chloride solution (10 mL) and brine (10 mL), dried (MgSO4), filtered and 
concentrated in vacuo. The residue was purified by column chromatography 
(diethyl ether/petroleum ether, 1:4) to give methyl (2E)-3-(2’-aminophenyl)prop-2-
enoate (206a) (1.59 g, 99%) as a yellow solid. Mp 64–66 °C; Spectroscopic data 
were consistent with the literature.187 Rf 0.33 (50% diethyl ether/petroleum ether; 
δH (400 MHz, CDCl3) 3.80 (3H, s, OCH3), 3.98 (2H, br s, NH2), 6.36 (1H, d, J 15.8 
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Hz, 2-H), 6.70 (1H, dd, J 8.0, 1.3 Hz, 3’-H), 6.77 (1H, ddd, J 8.0, 7.3, 1.3 Hz, 4’-H), 
7.17 (1H, ddd, J 7.9, 7.3, 1.3 Hz, 5’-H), 7.38 (1H, dd, J 7.9, 1.3 Hz, 6’-H), 7.83 (1H, 
d, J 15.8 Hz, 3-H); δC (101 MHz, CDCl3) 51.7 (CH3), 116.7 (CH), 117.7 (CH), 
119.0 (CH), 119.9 (C), 128.1 (CH), 131.3 (CH), 140.3 (CH), 145.6 (C), 167.7 (C); 
m/z (ESI) 200 (MNa+, 4%), 168 (26), 159 (3), 146 (100), 128 (31). 
 
Methyl (2E)-3-(2’-amino-5’-methylphenyl)prop-2-enoate (206b)239 
  
The reaction was carried out as described for the synthesis of methyl (2E)-3-(2’-
aminophenyl)prop-2-enoate (206a) using 4-methyl-2-iodoaniline (203b) (2.00 g, 
8.58 mmol). Purification by column chromatography (diethyl ether/petroleum ether, 
1:3) gave methyl (2E)-3-(2’-amino-5’-methylphenyl)prop-2-enoate (206b) (1.64 g, 
quantitative) as a yellow solid. Mp 84–86 °C; Spectroscopic data were consistent 
with the literature.239 Rf 0.28 (50% diethyl ether/petroleum ether); δH (400 MHz, 
CDCl3) 2.24 (3H, s, 5’-CH3), 3.79 (3H, s, OCH3), 3.86 (2H, br s, NH2), 6.34 (1H, d, 
J 15.8 Hz, 2-H), 6.62 (1H, d, J 8.1 Hz, 3’-H), 6.99 (1H, dd, J 8.1, 1.5 Hz, 4’-H), 
7.19 (1H, d, J 1.5 Hz, 6’-H), 7.82 (1H, d, J 15.8 Hz, 3-H); δC (101 MHz, CDCl3) 
20.4 (CH3), 51.6 (CH3), 117.0 (CH), 117.4 (CH), 119.9 (C), 128.2 (C), 128.2 (CH), 
132.3 (CH), 140.4 (CH), 143.3 (C), 167.8 (C); m/z (ESI) 214 (MNa+, 100%), 192 
(11), 182 (23). 
 
Methyl (2E)-3-(2’-amino-5’-methoxyphenyl)prop-2-enoate (206c)240 
 
The reaction was carried out as described for the synthesis of methyl (2E)-3-(2’-
aminophenyl)prop-2-enoate (206a) using 4-methoxy-2-iodoaniline (203c) (0.170 g, 
0.680 mmol) and potassium carbonate (0.188 g, 1.36 mmol). Purification by 
column chromatography (diethyl ether/petroleum ether, 1:3) gave methyl (2E)-3-
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(2’-amino-5’-methoxyphenyl)prop-2-enoate (206c) (0.141 g, quantitative) as a 
yellow solid. Mp 93–95 °C; Spectroscopic data were consistent with the 
literature.240 Rf 0.20 (50% diethyl ether/petroleum ether); δH (400 MHz, CDCl3) 
3.71 (2H, br s, NH2), 3.76 (3H, s, OCH3), 3.81 (3H, s, OCH3), 6.35 (1H, d, J 15.8 
Hz, 2-H), 6.67 (1H, d, J 8.7 Hz, 3’-H), 6.82 (1H, dd, J 8.7, 2.9 Hz, 4’-H), 6.92 (1H, 
d, J 2.9 Hz, 6’-H), 7.82 (1H, d, J 15.8 Hz, 3-H); δC (101 MHz, CDCl3) 51.7 (CH3), 
55.8 (CH3), 111.6 (CH), 117.9 (CH), 118.4 (CH), 118.7 (CH), 120.8 (C), 139.6 (C), 
140.2 (CH), 152.9 (C), 167.6 (C); m/z (ESI) 208 (MH+, 100%). 
 
Methyl (2E)-3-(2’-amino-5’-fluorophenyl)prop-2-enoate (206d)187 
 
The reaction was carried out as described for the synthesis of methyl (2E)-3-(2’-
aminophenyl)prop-2-enoate (206a) using 4-fluoro-2-iodoaniline (203d) (3.77 g, 
16.0 mmol) and potassium carbonate (4.40 g, 32.0 mmol). Purification by column 
chromatography (ethyl acetate/petroleum ether, 1:3) gave methyl (2E)-3-(2’-
amino-5’-fluorophenyl)prop-2-enoate (206d) (2.50 g, 81%) as a yellow solid. Mp 
96–98 °C (lit.187 93–95 °C); Rf 0.28 (50% diethyl ether/petroleum ether); δH (400 
MHz, CDCl3) 3.80 (3H, s, OCH3), 3.86 (2H, br s, NH2), 6.33 (1H, d, J 15.8 Hz, 2-
H), 6.65 (1H, dd, J 8.7, 4JHF 4.8 Hz, 3’-H), 6.90 (1H, td, J 8.7, 2.9 Hz, 4’-H), 7.08 
(1H, dd, 3JHF 9.5, J 2.9 Hz, 6’-H), 7.76 (1H, dd, J 15.8, 
5JHF 1.1 Hz, 3-H); δC (101 
MHz, CDCl3) 51.8 (CH3), 113.4 (d,
 2JCF 22.7 Hz, CH), 118.0 (d,
 3JCF 7.7 Hz, CH), 
118.3 (d, 2JCF 23.0 Hz, CH), 118.9 (CH), 120.8 (d,
 3JCF 7.2 Hz, C), 139.1 (d,
 4JCF 2.2 
Hz, CH), 141.8 (C), 156.2 (d, 1JCF 237.0 Hz, C), 167.3 (C); m/z (ESI) 218 (MNa
+, 
100%), 169 (25), 186 (13), 164 (20). 
 
Methyl (2E)-3-(2’-amino-4’-fluorophenyl)prop-2-enoate (206e)240 
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The reaction was carried out as described for the synthesis of methyl (2E)-3-(2’-
aminophenyl)prop-2-enoate (206a) using 5-fluoro-2-iodoaniline (203e) (0.926 g, 
3.90 mmol) and potassium carbonate (1.08 g, 7.80 mmol). Purification by column 
chromatography (ethyl acetate/petroleum ether, 1:3) gave methyl (2E)-3-(2’-
amino-4’-fluorophenyl)prop-2-enoate (206e) (0.639 g, 84%) as a yellow solid. Mp 
107–109 °C; Spectroscopic data were consistent with the literature.240 Rf 0.25 
(50% diethyl ether/petroleum ether); δH (400 MHz, CDCl3) 3.80 (3H, s, OCH3), 
4.11 (2H, br s, NH2), 6.29 (1H, d, J 15.8 Hz, 2-H), 6.39 (1H, dd, 
3JHF 10.5, J 2.5 Hz, 
3’-H), 6.47 (1H, td, J 8.7, 2.5 Hz, 5’-H), 7.34 (1H, dd, J 8.7, 4JHF 6.4 Hz, 6’-H), 7.74 
(1H, d, J 15.8 Hz, 3-H); δC (101 MHz, CDCl3) 51.7 (CH3), 102.9 (d,
 2JCF 24.8 Hz, 
CH), 106.3 (d, 2JCF 22.2 Hz, CH), 116.0 (d,
 4JCF 2.4 Hz, C), 117.2 (CH), 130.0 (d,
 
3JCF 10.6 Hz, CH), 139.3 (CH), 147.4 (d,
 3JCF 11.5 Hz, C), 164.9 (d,
 1JCF 248.9 Hz, 
C), 167.6 (C); m/z (ESI) 218 (MNa+, 100%), 186 (59), 164 (6). 
 
Methyl (2E)-3-(2’-amino-5’-chlorophenyl)prop-2-enoate (206f)187 
 
The reaction was carried out as described for the synthesis of methyl (2E)-3-(2’-
aminophenyl)prop-2-enoate (206a) using 4-chloro-2-iodoaniline (203f) (0.975 g, 
3.90 mmol) and potassium carbonate (1.08 g, 7.80 mmol). The reaction mixture 
was stirred at 80 °C for 8 h. Purification by column chromatography (ethyl 
acetate/petroleum ether, 1:3) gave methyl (2E)-3-(2’-amino-5’-chlorophenyl)prop-
2-enoate (206f) (0.622 g, 76%) as a yellow solid. Mp 92–94 °C; Spectroscopic 
data were consistent with the literature.187 Rf 0.18 (50% diethyl ether/petroleum 
ether); δH (400 MHz, CDCl3) 3.81 (3H, s, OCH3), 3.97 (2H, br s, NH2), 6.34 (1H, d, 
J 15.8 Hz, 2-H), 6.64 (1H, d, J 8.6 Hz, 3’-H), 7.12 (1H, dd, J 8.6, 2.4 Hz, 4’-H), 
7.34 (1H, d, J 2.4 Hz, 6’-H), 7.73 (1H, d, J 15.8 Hz, 3-H); δC (101 MHz, CDCl3) 
51.8 (CH3), 117.9 (CH), 119.0 (CH), 121.1 (C), 123.7 (C), 127.3 (CH), 131.0 (CH), 
138.9 (CH), 144.0 (C), 167.3 (C); m/z (ESI) 234 (MNa+, 64%), 202 (46), 186 (100). 
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Methyl (2E)-3-(2’-[N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate (207a)241 
 
p-Toluenesulfonyl chloride (2.50 g, 13 mmol) was added to a solution of methyl 
(2E)-3-(2’-aminophenyl)prop-2-enoate (206a) (1.53 g, 8.70 mmol) in pyridine (43 
mL) at 0 °C. The reaction mixture was allowed to warm to room temperature and 
stirred for 1 h. The reaction mixture was diluted with water (50 mL) and extracted 
with dichloromethane (3 × 50 mL), washed with aqueous lithium chloride solution 
(10 mL) and brine (10 mL), dried (MgSO4), filtered and concentrated in vacuo. 
Flash column chromatography (diethyl ether/petroleum ether, 1:1) afforded methyl 
(2E)-3-(2’-[N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate (207b) (2.66 g, 93%) 
as a white solid. Mp 156–158 °C (lit.241 160–162 °C); Rf 0.13 (50% diethyl 
ether/petroleum ether); δH (400 MHz, CDCl3) 2.35 (3H, s, CH3), 3.77 (3H, s, 
OCH3), 6.11 (1H, d, J 15.8 Hz, 2-H), 7.17 (2H, d, J 8.2 Hz, 2 × ArH), 7.20–7.27 
(2H, m, NH and 5’-H), 7.34 (1H, td, J 8.0, 1.5 Hz, 4’-H), 7.40 (1H, dd, J 8.0, 1.2 Hz, 
3’-H), 7.45 (1H, dd, J 8.0, 1.5 Hz, 6’-H), 7.54 (2H, d, J 8.2 Hz, 2 × ArH), 7.62 (1H, 
d, J 15.8 Hz, 3-H); δC (101 MHz, CDCl3) 21.5 (CH3), 51.9 (CH3), 120.2 (CH), 127.1 
(CH), 127.2 (CH), 127.3 (2 × CH), 127.6 (CH), 129.6 (2 × CH), 130.6 (C), 130.9 
(CH), 134.8 (C), 135.9 (C), 139.3 (CH), 144.0 (C), 167.0 (C); m/z (ESI) 354 (MNa+, 
100%), 233 (8). 
 
Methyl (2E)-3-(5’-methyl-2’-[N-(p-toluenesulfonyl)amino]phenyl)prop-2-
enoate (207b)242 
  
The reaction was carried out as described for the synthesis of methyl (2E)-3-(2’-
[N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate (207a) using methyl (2E)-3-(2’-
amino-5’-methylphenyl)prop-2-enoate (206b) (1.50 g, 7.84 mmol). Purification by 
column chromatography (ethyl acetate/petroleum ether, 1:4) gave methyl (2E)-3-
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(5’-methyl-2’-[N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate (207a) (2.68 g, 
99%) as a white solid. Mp 164–166 °C (lit.242 160–162 °C); Rf 0.20 (50% diethyl 
ether/petroleum ether); δH (400 MHz, CDCl3) 2.32 (3H, s, CH3), 2.35 (3H, s, CH3), 
3.77 (3H, s, OCH3), 6.10 (1H, d, J 15.9 Hz, 2-H), 6.99 (1H, br s, NH), 7.12–7.19 
(3H, m, 3’-H and 2 × ArH), 7.23–7.26 (2H, m, 4’-H and 6’-H), 7.50–7.57 (3H, m, 3-
H and 2 × ArH); δC (101 MHz, CDCl3) 21.0 (CH3), 21.5 (CH3), 51.8 (CH3), 119.7 
(CH), 127.3 (2 × CH), 127.4 (CH), 128.0 (CH), 129.6 (2 × CH), 130.7 (C), 131.8 
(CH), 132.1 (C), 135.9 (C), 137.4 (C), 139.4 (CH), 143.8 (C), 167.0 (C); m/z (ESI) 
368 (MNa+, 100%). 
 
Methyl (2E)-3-(5’-methoxy-2’-[N-(p-toluenesulfonyl)amino]phenyl)prop-2-
enoate (207c) 
 
The reaction was carried out as described for the synthesis of methyl (2E)-3-(2’-
[N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate (207a) using methyl (2E)-3-(2’-
amino-5’-methoxyphenyl)prop-2-enoate (206c) (0.014 g, 0.070 mmol). Purification 
by column chromatography (ethyl acetate/petroleum ether, 1:4) gave methyl (2E)-
3-(5’-methoxy-2’-[N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate (207c) (0.023 
g, 93%) as a white solid. Mp 162–164 °C; Rf 0.23 (33% ethyl acetate/petroleum 
ether); max/cm
−1 (neat) 3256 (NH), 3023 (CH), 1701 (CO), 1637 (C=C), 1495, 
1214, 1325, 1161, 750; δH (500 MHz, CDCl3) 2.37 (3H, s, CH3), 3.78 (3H, s, 
OCH3), 3.81 (3H, s, OCH3), 6.09 (1H, d, J 15.9 Hz, 2-H), 6.53 (1H, br s, NH), 6.89 
(1H, dd, J 8.8, 2.9 Hz, 4’-H), 6.95 (1H, d, J 2.9 Hz, 6’-H), 7.19 (2H, d, J 8.2 Hz, 2 × 
ArH), 7.23 (1H, d, J 8.8 Hz, 3’-H), 7.46 (1H, d, J 15.9 Hz, 3-H), 7.52 (2H, d, J 8.2 
Hz, 2 × ArH); δC (101 MHz, CDCl3) 21.5 (CH3), 51.8 (CH3), 55.5 (CH3), 111.4 
(CH), 116.7 (CH), 120.1 (CH), 127.3 (C), 127.4 (2 × CH), 129.6 (2 × CH), 130.6 
(CH), 133.1 (C), 135.8 (C), 139.2 (CH), 143.9 (C), 158.9 (C), 166.7 (C); m/z (ESI) 
384.0864 (MNa+, C18H19NNaO5S requires 384.0876). 
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Methyl (2E)-3-(5’-fluoro-2’-[N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate 
(207d)242 
 
The reaction was carried out as described for the synthesis of methyl (2E)-3-(2’-
[N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate (207a) using methyl (2E)-3-(2’-
amino-5’-fluorophenyl)prop-2-enoate (206d) (2.50 g, 13.0 mmol). Purification by 
column chromatography (ethyl acetate/petroleum ether, 1:5) gave methyl (2E)-3-
(5’-fluoro-2’-[N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate (207d) (3.94 g, 
88%) as a white solid. Mp 156–158 °C (lit.242 156–158 °C); Rf 0.13 (50% diethyl 
ether/petroleum ether); δH (400 MHz, CDCl3) 2.36 (3H, s, CH3), 3.78 (3H, s, 
OCH3), 6.07 (1H, d, J 15.8 Hz, 2-H), 6.96 (1H, br s, NH), 7.06 (1H, ddd, J 8.8, 
3JHF 
7.7, J 2.9 Hz, 4’-H), 7.14 (1H, dd, 3JHF 9.2, J 2.9 Hz, 6’-H), 7.19 (2H, d, J 8.1 Hz, 2 
× ArH), 7.35 (1H, dd, J 8.8, 4JHF 5.2 Hz, 3’-H), 7.50 (1H, dd, J 15.8, 
5JHF 1.5 Hz, 3-
H), 7.52 (2H, d, J 8.1 Hz, 2 × ArH); δC (101 MHz, CDCl3) 21.5 (CH3), 52.0 (CH3), 
113.3 (d, 2JCF 23.5 Hz, CH), 117.9 (d,
 2JCF 22.7 Hz, CH), 121.2 (CH), 127.3 (2 × 
CH), 129.7 (2 × CH), 130.6 (d, 4JCF 2.9 Hz, C), 130.7 (d,
 3JCF 8.8 Hz, CH), 133.4 (d,
 
3JCF 8.4 Hz, C), 135.6 (C), 138.2 (d,
 4JCF 2.2 Hz, CH), 144.2 (C), 161.5 (d,
 1JCF 
248.4 Hz, C), 166.5 (C); m/z (ESI) 372 (MNa+, 100%). 
 
Methyl (2E)-3-(4’-fluoro-2’-[N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate 
(207e)240 
 
The reaction was carried out as described for the synthesis of methyl (2E)-3-(2’-
[N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate (207a) using methyl (2E)-3-(2’-
amino-4’-fluorophenyl)prop-2-enoate (206e) (0.620 g, 3.20 mmol). Purification by 
column chromatography (ethyl acetate/petroleum ether, 1:5) gave methyl (2E)-3-
(4’-fluoro-2’-[N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate (207e) (1.08 g, 
97%) as a yellow solid. Mp 157–159 °C; Spectroscopic data were consistent with 
the literature.240 Rf 0.13 (50% diethyl ether/petroleum ether); δH (400 MHz, CDCl3) 
177 
 
2.38 (3H, s, CH3), 3.79 (3H, s, OCH3), 6.11 (1H, d, J 15.8 Hz, 2-H), 6.92 (1H, td, J 
8.7, 2.6 Hz, 5’-H), 7.00 (1H, br s, NH), 7.20–7.26 (3H, m, 3’-H and 2 × ArH), 7.41 
(1H, dd, J 8.7, 4JHF 6.1 Hz, 6’-H), 7.48 (1H, d, J 15.8 Hz, 3-H), 7.63 (2H, d, J 8.3 
Hz, 2 × ArH); δC (101 MHz, CDCl3) 21.5 (CH3), 51.9 (CH3), 112.8 (d,
 2JCF 24.9 Hz, 
CH), 114.1 (d, 2JCF 21.8 Hz, CH), 120.5 (CH), 125.1 (d,
 4JCF 3.4 Hz, C), 127.3 (2 × 
CH), 128.9 (d, 3JCF 9.5 Hz, CH), 129.9 (2 × CH), 135.7 (C), 136.5 (d,
 3JCF 10.8 Hz, 
C), 137.8 (CH), 144.4 (C), 163.8 (d, 1JCF 251.8 Hz, C), 166.7 (C); m/z (ESI) 372 
(MNa+, 100%), 363 (37). 
 
Methyl (2E)-3-(5’-chloro-2’-[N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate 
(207f)242 
 
The reaction was carried out as described for the synthesis of methyl (2E)-3-(2’-
[N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate (207a) using methyl (2E)-3-(2’-
amino-5’-chlorophenyl)prop-2-enoate (206f) (0.406 g, 1.90 mmol). The reaction 
mixture was stirred at room temperature for 18 h. Purification by column 
chromatography (ethyl acetate/petroleum ether, 1:5) gave methyl (2E)-3-(5’-
chloro-2’-[N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate (207f) (0.638 g, 91%) 
as a yellow solid. Mp 152–154 °C (lit.242 149–151 °C); Rf 0.43 (33% ethyl 
acetate/petroleum ether); δH (400 MHz, CDCl3) 2.36 (3H, s, CH3), 3.78 (3H, s, 
OCH3), 6.09 (1H, d, J 15.8 Hz, 2-H), 7.19 (2H, d, J 8.0 Hz, 2 × ArH), 7.28 (1H, br 
s, NH), 7.31 (1H, dd, J 8.6, 2.4 Hz, 4’-H), 7.36 (1H, d, J 8.6 Hz, 3’-H), 7.40 (1H, d, 
J 2.4 Hz, 6’-H), 7.50–7.56 (3H, m, 3-H and 2 × ArH); δC (101 MHz, CDCl3) 21.5 
(CH3), 52.1 (CH3), 121.3 (CH), 126.9 (CH), 127.3 (2 × CH), 129.1 (CH), 129.8 (2 × 
CH), 130.8 (CH), 132.2 (C), 133.1 (C), 133.3 (C), 135.6 (C), 138.1 (CH), 144.2 (C), 
166.7 (C); m/z (ESI) 388 (MNa+, 100%). 
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Methyl (2E)-3-(2’-[N-allyl-N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate 
(208a) 
 
Allyl bromide (0.830 mL, 9.60 mmol) was added to a stirred solution of methyl 
(2E)-3-(2’-[N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate (207a) (2.66 g, 8.00 
mmol) and potassium carbonate (2.21 g, 16.0 mmol) in N,N’-dimethylformamide 
(50 mL). The reaction mixture was heated to 70 °C for 1 h. The reaction mixture 
was cooled to room temperature, diluted with 5% aqueous lithium chloride solution 
(20 mL) and extracted with diethyl ether (50 mL). The organic layer was washed 
with 5% aqueous lithium chloride solution (3 × 10 mL), brine (10 mL), dried 
(MgSO4), filtered and concentrated in vacuo. Purification by column 
chromatography (diethyl ether/petroleum ether, 1:1) gave methyl (2E)-3-(2’-[N-
allyl-N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate (208a) (2.98 g, quantitative) 
as a white solid. Mp 104–106 °C; Rf 0.38 (50% diethyl ether/petroleum ether); 
max/cm
−1 (neat) 2951 (CH), 1716 (CO), 1636 (C=C), 1436, 1319, 1164, 763; δH 
(400 MHz, CDCl3) 2.42 (3H, s, CH3), 3.79 (3H, s, OCH3), 4.02 (1H, br s, 2’’-HH), 
4.27 (1H, br s, 2’’-HH), 4.93–5.02 (2H, m, 4’’-H2), 5.74 (1H, ddt, J 17.0, 10.0, 6.8 
Hz, 3’’-H), 6.33 (1H, d, J 16.1 Hz, 2-H), 6.84 (1H, dd, J 7.8, 1.1 Hz, 3’-H), 7.24–
7.35 (4H, m, 4’-H, 5’-H and 2 × ArH), 7.56 (2H, d, J 8.2 Hz, 2 × ArH), 7.64 (1H, dd, 
J 7.8, 1.5 Hz, 6’-H), 7.86 (1H, d, J 16.1 Hz, 3-H); δC (101 MHz, CDCl3) 21.6 (CH3), 
51.7 (CH3), 54.9 (CH2), 119.7 (CH), 119.8 (CH2), 127.1 (CH), 128.0 (2 × CH), 
128.8 (CH), 129.6 (2 × CH), 129.9 (CH), 130.4 (CH), 132.2 (CH), 135.6 (C), 135.7 
(C), 138.3 (C), 140.3 (CH), 143.8 (C), 166.9 (C); m/z (ESI) 394.1067 (MNa+, 
C20H21NNaO4S requires 394.1083). 
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Methyl (2E)-3-(2’-[N-allyl-N-(p-toluenesulfonyl)amino]-5’-methylphenyl)prop-
2-enoate (208b) 
  
The reaction was carried out as described for the synthesis of methyl (2E)-3-(2’-
[N-allyl-N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate (208a) using methyl 
(2E)-3-(5’-methyl-2’-[N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate (207b) 
(2.00 g, 5.79 mmol) and a reaction time of 3 h. Purification by column 
chromatography (ethyl acetate/petroleum ether, 1:5) gave methyl (2E)-3-(2’-[N-
allyl-N-(p-toluenesulfonyl)amino]-5’-methylphenyl)prop-2-enoate (208b) (2.03 g, 
91%) as a white solid. Mp 118–120 °C; Rf 0.25 (50% diethyl ether/petroleum 
ether); max/cm
−1 (neat) 2950 (CH), 1717 (CO), 1639 (C=C), 1435, 1347, 1160, 
759; δH (400 MHz, CDCl3) 2.34 (3H, s, CH3), 2.42 (3H, s, CH3), 3.78 (3H, s, 
OCH3), 3.99 (1H, br s, 2’’-HH), 4.26 (1H, br s, 2’’-HH), 4.93–5.02 (2H, m, 4’’-H2), 
5.74 (1H, ddt, J 17.0, 10.1, 6.8 Hz, 3’’-H), 6.31 (1H, d, J 16.1 Hz, 2-H), 6.71 (1H, d, 
J 8.1 Hz, 3’-H), 7.08 (1H, dd, J 8.1, 1.6 Hz, 4’-H), 7.26 (2H, d, J 8.2 Hz, 2 × ArH), 
7.43 (1H, d, J 1.6 Hz, 6’-H), 7.56 (2H, d, J 8.2 Hz, 2 × ArH), 7.82 (1H, d, J 16.1 Hz, 
3-H); δC (101 MHz, CDCl3) 21.2 (CH3), 21.5 (CH3), 51.7 (CH3), 54.9 (CH2), 119.4 
(CH), 119.6 (CH2), 127.6 (CH), 128.0 (2 × CH), 129.6 (2 × CH), 129.6 (CH), 131.3 
(CH), 132.3 (CH), 135.2 (C), 135.7 (C), 135.7 (C), 138.7 (C), 140.5 (CH), 143.7 
(C), 167.0 (C); m/z (ESI) 408.1220 (MNa+, C21H23NNaO4S requires 408.1240). 
 
Methyl (2E)-3-(2’-[N-allyl-N-(p-toluenesulfonyl)amino]-5’-methoxyphenyl)prop 
-2-enoate (208c) 
 
The reaction was carried out as described for the synthesis of methyl (2E)-3-(2’-
[N-allyl-N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate (208a) using methyl 
(2E)-3-(5’-methoxy-2’-[N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate (207c) 
(0.145 g, 0.400 mmol) and a reaction time of 2 h. Purification by column 
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chromatography (ethyl acetate/petroleum ether, 1:5) gave methyl (2E)-3-(2’-[N-
allyl-N-(p-toluenesulfonyl)amino]-5’-methoxyphenyl)prop-2-enoate (208c) (0.149 g, 
92%) as a white solid. Mp 153–155 °C; Rf 0.40 (33% ethyl acetate/petroleum 
ether); max/cm
−1 (neat) 3022 (CH), 1709 (CO), 1642 (C=C), 1495, 1289, 1215, 
1163, 751; δH (400 MHz, CDCl3) 2.42 (3H, s, CH3), 3.79 (3H, s, OCH3), 3.81 (3H, 
s, OCH3), 3.96–4.01 (1H, m, 2’’-HH), 4.24–4.29 (1H, m, 2’’-HH), 4.93–5.03 (2H, m, 
4’’-H2), 5.74 (1H, ddt, J 16.9, 10.1, 6.8 Hz, 3’’-H), 6.29 (1H, d, J 16.1 Hz, 2-H), 6.74 
(1H, d, J 8.8 Hz, 3’-H), 6.81 (1H, dd, J 8.8, 2.8 Hz, 4’-H), 7.09 (1H, d, J 2.8 Hz, 6’-
H), 7.26 (2H, d, J 8.2 Hz, 2 × ArH), 7.56 (2H, d, J 8.2 Hz, 2 × ArH), 7.79 (1H, d, J 
16.1 Hz, 3-H); δC (101 MHz, CDCl3) 21.6 (CH3), 51.7 (CH3), 55.0 (CH2), 55.5 
(CH3), 111.2 (CH), 116.5 (CH), 119.7 (CH2), 119.8 (CH), 128.0 (2 × CH), 129.6 (2 
× CH), 131.0 (CH), 132.3 (CH), 135.7 (C), 136.6 (C), 140.4 (CH), 143.7 (2 × C), 
159.3 (C), 166.8 (C); m/z (ESI) 424.1176 (MNa+, C21H23NNaO5S requires 
424.1189). 
 
Methyl (2E)-3-(2’-[N-allyl-N-(p-toluenesulfonyl)amino]-5’-fluorophenyl)prop-2-
enoate (208d) 
 
The reaction was carried out as described for the synthesis of methyl (2E)-3-(2'-[N-
allyl-N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate (208a) using methyl (2E)-3-
(5’-fluoro-2’-[N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate (207d) (3.74 g, 
11.0 mmol). Purification by column chromatography (ethyl acetate/petroleum 
ether, 1:7) gave methyl (2E)-3-(2’-[N-allyl-N-(p-toluenesulfonyl)amino]-5’-
fluorophenyl)prop-2-enoate (208d) (3.50 g, 84%) as a white solid. Mp 108–110 °C; 
Rf 0.43 (50% diethyl ether/petroleum ether); max/cm
−1 (neat) 2951 (CH), 1718 
(CO), 1650 (C=C), 1488, 1323, 1275, 1160, 862, 728; δH (400 MHz, CDCl3) 2.40 
(3H, s, CH3), 3.77 (3H, s, OCH3), 3.95 (1H, br s, 2’’-HH), 4.25 (1H, br s, 2’’-HH), 
4.95 (1H, dd, J 17.0, 1.2 Hz, 4’’-HH), 5.00 (1H, dd, J 10.1, 1.2 Hz, 4’’-HH), 5.71 
(1H, ddt, J 17.0, 10.1, 6.8 Hz, 3’’-H), 6.28 (1H, d, J 16.1 Hz, 2-H), 6.80 (1H, dd, J 
8.8, 4JHF 5.3 Hz, 3’-H), 6.95 (1H, ddd, J 8.8, 
3JHF 7.6, J 2.9 Hz, 4’-H), 7.26 (2H, d, J 
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8.2 Hz, 2 × ArH), 7.28 (1H, dd, 3JHF 9.4, J 2.9 Hz, 6’-H), 7.54 (2H, d, J 8.2 Hz, 2 × 
ArH), 7.76 (1H, dd, J 16.1, 5JHF 1.6 Hz, 3-H); δC (101 MHz, CDCl3) 21.5 (CH3), 
51.8 (CH3), 55.0 (CH2), 113.5 (d,
 2JCF 23.4 Hz, CH), 117.4 (d,
 2JCF 23.0 Hz, CH), 
120.1 (CH2), 120.9 (CH), 127.9 (2 × CH), 129.7 (2 × CH), 131.8 (d,
 3JCF 8.9 Hz, 
CH), 131.9 (CH), 134.2 (d, 4JCF 3.1 Hz, C), 135.3 (C), 137.8 (d,
 3JCF 8.5 Hz, C), 
139.2 (d, 4JCF 2.0 Hz, CH), 144.0 (C), 162.0 (d,
 1JCF 249.4 Hz, C), 166.5 (C); m/z 
(ESI) 412.0969 (MNa+, C20H20FNNaO4S requires 412.0989). 
 
Methyl (2E)-3-(2’-[N-allyl-N-(p-toluenesulfonyl)amino]-4’-fluorophenyl)prop-2-
enoate (208e) 
 
The reaction was carried out as described for the synthesis of methyl (2E)-3-(2’-
[N-allyl-N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate (208a) using methyl 
(2E)-3-(4’-fluoro-2’-[N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate (207e) (1.07 
g, 3.00 mmol). Purification by column chromatography (ethyl acetate/petroleum 
ether, 1:7) gave methyl (2E)-3-(2’-[N-allyl-N-(p-toluenesulfonyl)amino]-4’-
fluorophenyl)prop-2-enoate (208e) (0.946 g, 79%) as a white solid. Mp 111–113 
°C; Rf 0.38 (50% diethyl ether/petroleum ether); max/cm
−1 (neat) 2951 (CH), 1712 
(CO), 1602 (C=C), 1497, 1353, 1256, 1164, 908, 730; δH (400 MHz, CDCl3) 2.43 
(3H, s, CH3), 3.78 (3H, s, OCH3), 4.02 (1H, br s, 2’’-HH), 4.21 (1H, br s, 2’’-HH), 
4.95–5.05 (2H, m, 4’’-H2), 5.72 (1H, ddt, J 16.9, 10.1, 6.8 Hz, 3’’-H), 6.27 (1H, d, J 
16.1 Hz, 2-H), 6.57 (1H, dd, 3JHF 9.2, J 2.8 Hz, 3’-H), 7.06 (1H, td, J 8.8, 2.8 Hz, 5’-
H), 7.29 (2H, d, J 8.2 Hz, 2 × ArH), 7.58 (2H, d, J 8.2 Hz, 2 × ArH), 7.62 (1H, dd, J 
8.8, 4JHF 6.2 Hz, 6’-H), 7.78 (1H, d, J 16.1 Hz, 3-H); δC (101 MHz, CDCl3) 21.6 
(CH3), 51.7 (CH3), 54.9 (CH2), 116.4 (d,
 2JCF 21.6 Hz, CH), 117.0 (d,
 2JCF 21.9 Hz, 
CH), 119.5 (CH), 120.2 (CH2), 128.0 (2 × CH), 128.6 (d,
 3JCF 9.4 Hz, CH), 129.7 (2 
× CH), 131.7 (CH), 132.1 (d, 4JCF 3.7 Hz, C), 135.2 (C), 139.3 (CH), 139.8 (d,
 3JCF 
9.2 Hz, C), 144.2 (C), 163.1 (d, 1JCF 253.1 Hz, C), 166.8 (C); m/z (ESI) 412.0970 
(MNa+, C20H20FNNaO4S requires 412.0989). 
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Methyl (2E)-3-(2’-[N-allyl-N-(p-toluenesulfonyl)amino]-5’-chlorophenyl)prop-
2-enoate (208f) 
 
The reaction was carried out as described for the synthesis of methyl (2E)-3-(2’-
[N-allyl-N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate (208a) using methyl 
(2E)-3-(5’-chloro-2’-[N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate (207f) 
(0.600 g, 1.60 mmol). Purification by column chromatography (ethyl 
acetate/petroleum ether, 1:5) gave methyl (2E)-3-(2’-[N-allyl-N-(p-
toluenesulfonyl)amino]-5’-chlorophenyl)prop-2-enoate (208f) (0.664 g, 
quantitative) as a yellow solid. Mp 104–106 °C; Rf 0.58 (33% ethyl 
acetate/petroleum ether); max/cm
−1 (neat) 2951 (CH), 1720 (CO), 1610 (C=C), 
1353, 1164, 908, 730; δH (400 MHz, CDCl3) 2.44 (3H, s, CH3), 3.80 (3H, s, OCH3), 
3.99 (1H, br s, 2’’-HH), 4.26 (1H, br s, 2’’-HH), 4.97 (1H, dd, J 17.0, 1.1 Hz, 4’’-
HH), 5.03 (1H, dd, J 10.1, 1.1 Hz, 4’’-HH), 5.73 (1H, ddt, J 17.0, 10.1, 6.8 Hz, 3’’-
H), 6.31 (1H, d, J 16.1 Hz, 2-H), 6.78 (1H, d, J 8.6 Hz, 3’-H), 7.24 (1H, dd, J 8.6, 
2.4 Hz, 4’-H), 7.29 (2H, d, J 8.2 Hz, 2 × ArH), 7.57 (2H, d, J 8.2 Hz, 2 × ArH), 7.60 
(1H, d, J 2.4 Hz, 6’-H), 7.75 (1H, d, J 16.1 Hz, 3-H); δC (101 MHz, CDCl3) 21.6 
(CH3), 51.8 (CH3), 54.9 (CH2), 120.2 (CH2), 121.0 (CH), 127.1 (CH), 128.0 (2 × 
CH), 129.7 (2 × CH), 130.3 (CH), 131.2 (CH), 131.8 (CH), 134.7 (C), 135.3 (C), 
136.7 (C), 137.4 (C), 139.0 (CH), 144.1 (C), 166.5 (C); m/z (ESI) 428.0673 (MNa+, 
C20H20
35ClNNaO4S requires 428.0694). 
 
(2E)-3-(2’-[N-Allyl-N-(p-toluenesulfonyl)amino]phenyl)prop-2-en-1-ol (209a) 
 
Diisobutylaluminium hydride (4.1 mL, 4.1 mmol, 1 M in hexane) was added 
dropwise with stirring to a solution of methyl (2E)-3-(2’-[N-allyl-N-(p-
toluenesulfonyl)amino]phenyl)prop-2-enoate (208a) (0.690 g, 1.86 mmol) in 
dichloromethane (19 mL) at −78 °C. The solution was stirred at −78 °C for 2 h, 
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then allowed to warm to room temperature over 16 h. The reaction was quenched 
with 10% aqueous potassium sodium tartrate solution (5 mL), extracted with 
diethyl ether (2 × 10 mL), washed with water (20 mL), brine (20 mL), dried 
(MgSO4), filtered and concentrated in vacuo. Purification by column 
chromatography (ethyl acetate/petroleum ether, 1:2) gave (2E)-3-(2’-[N-allyl-N-(p-
toluenesulfonyl)amino]phenyl)prop-2-en-1-ol (209a) (0.611 g, 96%) as a colourless 
oil. Rf 0.13 (50% diethyl ether/petroleum ether); max/cm
−1 (neat) 3491 (OH), 2924 
(CH), 1597 (C=C), 1341, 1161, 726; δH (400 MHz, CDCl3) 1.97 (1H, br s, OH), 
2.43 (3H, s, CH3), 4.00 (1H, br s, 2’’-HH), 4.18–4.29 (3H, m, 1-H2 and 2’’-HH), 
4.93–5.01 (2H, m, 4’’-H2), 5.72 (1H, ddt, J 16.9, 10.2, 6.7 Hz, 3’’-H), 6.33 (1H, dt, J 
16.0, 5.4 Hz, 2-H), 6.68 (1H, dd, J 7.8, 1.3 Hz, 3’-H), 6.83 (1H, d, J 16.0 Hz, 3-H), 
7.12 (1H, td, J 7.8, 1.3 Hz, 5’-H), 7.23–7.30 (3H, m, 4’-H and 2 × ArH), 7.55–7.61 
(3H, m, 6’-H and 2 × ArH); δC (101 MHz, CDCl3) 21.6 (CH3), 54.8 (CH2), 63.8 
(CH2), 119.4 (CH2), 126.5 (CH), 126.7 (CH), 127.8 (CH), 127.9 (2 × CH), 128.6 
(CH), 129.4 (CH), 129.5 (2 × CH), 130.8 (CH), 132.4 (CH), 136.1 (C), 136.6 (C), 
137.8 (C), 143.6 (C); m/z (ESI) 366.1119 (MNa+, C19H21NNaO3S requires 
366.1134). 
 
(2E)-3-(2’-[N-Allyl-N-(p-toluenesulfonyl)amino]-5’-methylphenyl)prop-2-en-1-
ol (209b) 
  
The reaction was carried out as described for the synthesis of (2E)-3-(2’-[N-allyl-N-
(p-toluenesulfonyl)amino]phenyl)prop-2-en-1-ol (209a) using methyl (2E)-3-(2’-[N-
allyl-N-(p-toluenesulfonyl)amino]-5’-methylphenyl)prop-2-enoate (208b) (1.50 g, 
3.89 mmol). Purification by column chromatography (ethyl acetate/petroleum 
ether, 1:2) gave (2E)-3-(2’-[N-allyl-N-(p-toluenesulfonyl)amino]-5’-
methylphenyl)prop-2-en-1-ol (209b) (1.37 g, 98%) as a colourless oil. Rf 0.10 (50% 
diethyl ether/petroleum ether); max/cm
−1 (neat) 3510 (OH), 2921 (CH), 1598 
(C=C), 1491, 1340, 1159, 859, 734; δH (400 MHz, CDCl3) 2.15 (1H, br s, OH), 2.31 
(3H, s, CH3), 2.42 (3H, s, CH3), 3.96 (1H, br s, 2’’-HH), 4.19–4.28 (3H, m, 1-H2 and 
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2’’-HH), 4.93–5.01 (2H, m, 4’’-H2), 5.72 (1H, ddt, J 16.9, 10.2, 6.7 Hz, 3’’-H), 6.31 
(1H, dt, J 16.0, 5.7 Hz, 2-H), 6.56 (1H, d, J 8.1 Hz, 3’-H), 6.79 (1H, d, J 16.0 Hz, 3-
H), 6.92 (1H, dd, J 8.1, 1.3 Hz, 4’-H), 7.27 (2H, d, J 8.2 Hz, 2 × ArH), 7.40 (1H, d, J 
1.3 Hz, 6’-H), 7.57 (2H, d, J 8.2 Hz, 2 × ArH); δC (101 MHz, CDCl3) 21.3 (CH3), 
21.5 (CH3), 54.8 (CH2), 63.8 (CH2), 119.3 (CH2), 126.7 (CH), 127.0 (CH), 127.9 (2 
× CH), 128.7 (CH), 129.1 (CH), 129.5 (2 × CH), 130.5 (CH), 132.5 (CH), 134.1 (C), 
136.2 (C), 137.3 (C), 138.4 (C), 143.5 (C); m/z (ESI) 380.1279 (MNa+, 
C20H23NNaO3S requires 380.1291). 
 
(2E)-3-(2’-[N-Allyl-N-(p-toluenesulfonyl)amino]-5’-methoxyphenyl)prop-2-en-
1-ol (209c) 
 
The reaction was carried out as described for the synthesis of (2E)-3-(2’-[N-allyl-N-
(p-toluenesulfonyl)amino]phenyl)prop-2-en-1-ol (209a) using methyl (2E)-3-(2’-[N-
allyl-N-(p-toluenesulfonyl)amino]-5’-methoxyphenyl)prop-2-enoate (208c) (0.140 g, 
0.350 mmol). Purification by column chromatography (ethyl acetate/petroleum 
ether, 1:2) gave (2E)-3-(2’-[N-allyl-N-(p-toluenesulfonyl)amino]-5’-
methoxyphenyl)prop-2-en-1-ol (209c) (0.104 g, 80%) as a colourless oil. Rf 0.18 
(33% ethyl acetate/petroleum ether); max/cm
−1 (neat) 3523 (OH), 2944 (CH), 1601 
(C=C), 1495, 1345, 1161, 752; δH (400 MHz, CDCl3) 2.07 (1H, t, J 5.4 Hz, OH), 
2.42 (3H, s, CH3), 3.79 (3H, s, OCH3), 3.91–3.98 (1H, m, 2’’-HH), 4.18–4.28 (3H, 
m, 1-H2 and 2’’-HH), 4.93–5.01 (2H, m, 4’’-H2), 5.72 (1H, ddt, J 16.9, 10.2, 6.7 Hz, 
3’’-H), 6.30 (1H, dt, J 16.0, 5.4 Hz, 2-H), 6.58 (1H, d, J 8.8 Hz, 3’-H), 6.65 (1H, dd, 
J 8.8, 2.9 Hz, 4’-H), 6.77 (1H, dt, J 16.0, 1.5 Hz, 3-H), 7.07 (1H, d, J 2.9 Hz, 6’-H), 
7.27 (2H, d, J 8.2 Hz, 2 × ArH), 7.57 (2H, d, J 8.2 Hz, 2 × ArH); δC (101 MHz, 
CDCl3) 21.5 (CH3), 54.9 (CH2), 55.4 (CH3), 63.7 (CH2), 110.7 (CH), 113.9 (CH), 
119.3 (CH2), 126.6 (CH), 127.9 (2 × CH), 129.4 (C), 129.7 (2 × CH), 130.5 (CH), 
130.9 (CH), 132.5 (CH), 136.2 (C), 138.9 (C), 143.5 (C), 159.2 (C); m/z (ESI) 
396.1223 (MNa+, C20H23NNaO4S requires 396.1240). 
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(2E)-3-(2’-[N-Allyl-N-(p-toluenesulfonyl)amino]-5’-fluorophenyl)prop-2-en-1-ol 
(209d) 
 
The reaction was carried out as described for the synthesis of (2E)-3-(2’-[N-allyl-N-
(p-toluenesulfonyl)amino]phenyl)prop-2-en-1-ol (209a) using methyl (2E)-3-(2’-[N-
allyl-N-(p-toluenesulfonyl)amino]-5’-fluorophenyl)prop-2-enoate (208d) (3.30 g, 
8.50 mmol). Purification by column chromatography (ethyl acetate/petroleum 
ether, 1:3) gave (2E)-3-(2’-[N-allyl-N-(p-toluenesulfonyl)amino]-5’-
fluorophenyl)prop-2-en-1-ol (209d) (2.99 g, 98%) as a colourless oil. Rf 0.10 (50% 
diethyl ether/petroleum ether); max/cm
−1 (neat) 3507 (OH), 2920 (CH), 1600 
(C=C), 1488, 1345, 1161, 752; δH (400 MHz, CDCl3) 2.35 (1H, t, J 5.6 Hz, OH), 
2.42 (3H, s, CH3), 3.95 (1H, dd, J 13.4, 6.8, 2’’-HH), 4.17–4.28 (3H, m, 1-H2 and 
2’’-HH), 4.91–5.01 (2H, m, 4’’-H2), 5.70 (1H, ddt, J 16.9, 10.1, 6.8 Hz, 3’’-H), 6.30 
(1H, dt, J 16.0, 5.5 Hz, 2-H), 6.65 (1H, dd, J 8.8, 4JHF 5.4 Hz, 3’-H), 6.73–6.83 (2H, 
m, 3-H and 4’-H), 7.24 (1H, dd, 3JHF 10.0, J 2.9 Hz, 6’-H), 7.27 (2H, d, J 8.3 Hz, 2 
× ArH), 7.56 (2H, d, J 8.3 Hz, 2 × ArH); δC (101 MHz, CDCl3) 21.5 (CH3), 54.9 
(CH2), 63.4 (CH2), 112.8 (d,
 2JCF 23.3 Hz, CH), 114.7 (d,
 2JCF 23.1 Hz, CH), 119.7 
(CH2), 125.4 (d,
 4JCF 1.7 Hz, CH), 127.9 (2 × CH), 129.6 (2 × CH), 131.2 (d,
 3JCF 
9.1 Hz, CH), 132.1 (CH), 132.3 (CH), 132.4 (d, 4JCF 2.8 Hz, C), 135.9 (C), 140.2 (d,
 
3JCF 8.6 Hz, C), 143.8 (C), 162.2 (d,
 1JCF 247.9 Hz, C); m/z (ESI) 384.1023 (MNa
+, 
C19H20FNNaO3S requires 384.1040). 
 
(2E)-3-(2’-[N-Allyl-N-(p-toluenesulfonyl)amino]-4’-fluorophenyl)prop-2-en-1-ol 
(209e) 
 
The reaction was carried out as described for the synthesis of (2E)-3-(2’-[N-allyl-N-
(p-toluenesulfonyl)amino]phenyl)prop-2-en-1-ol (209a) using methyl (2E)-3-(2’-[N-
allyl-N-(p-toluenesulfonyl)amino]-4’-fluorophenyl)prop-2-enoate (208e) (0.790 g, 
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2.00 mmol). Purification by column chromatography (ethyl acetate/petroleum 
ether, 1:3) gave (2E)-3-(2’-[N-allyl-N-(p-toluenesulfonyl)amino]-4’-
fluorophenyl)prop-2-en-1-ol (209e) (0.728 g, 99%) as a colourless oil. Rf 0.08 
(50% diethyl ether/petroleum ether); max/cm
−1 (neat) 3507 (OH), 2923 (CH), 1600 
(C=C), 1495, 1347, 1161, 908, 727; δH (400 MHz, CDCl3) 2.18 (1H, t, J 5.6 Hz, 
OH), 2.43 (3H, s, CH3), 3.96 (1H, br s, 2’’-HH), 4.09–4.27 (3H, m, 1-H2 and 2’’-
HH), 4.94–5.03 (2H, m, 4’’-H2), 5.69 (1H, ddt, J 16.9, 10.1, 6.7 Hz, 3’’-H), 6.25 (1H, 
dt, J 16.0, 5.3 Hz, 2-H), 6.41 (1H, dd, 3JHF 9.3, J 2.6 Hz, 3’-H), 6.75 (1H, d, J 16.0 
Hz, 3-H), 6.99 (2H, td, J 8.6, 2.6 Hz, 5’-H), 7.29 (2H, d, J 8.2 Hz, 2 × ArH), 7.55 
(1H, dd, J 8.6, 4JHF 6.3 Hz, 6’-H), 7.58 (2H, d, J 8.2 Hz, 2 × ArH); δC (101 MHz, 
CDCl3) 21.6 (CH3), 54.7 (CH2), 63.6 (CH2), 116.0 (d,
 2JCF 21.2 Hz, CH), 116.2 (d,
 
2JCF 21.2 Hz, CH), 119.8 (CH2), 125.7 (CH), 127.7 (d,
 3JCF 8.9 Hz, CH), 127.9 (2 × 
CH), 129.7 (2 × CH), 130.7 (d, 5JCF 1.8 Hz, CH), 132.0 (CH), 134.3 (d,
 4JCF 3.7 Hz, 
C), 135.7 (C), 137.7 (d, 3JCF 8.8 Hz, C), 144.0 (C), 161.5 (d,
 1JCF 248.9 Hz, C); m/z 
(ESI) 384.1023 (MNa+, C19H20FNNaO3S requires 384.1040). 
 
(2E)-3-(2’-[N-Allyl-N-(p-toluenesulfonyl)amino]-5’-chlorophenyl)prop-2-en-1-
ol (209f) 
 
The reaction was carried out as described for the synthesis of (2E)-3-(2’-[N-allyl-N-
(p-toluenesulfonyl)amino]phenyl)prop-2-en-1-ol (209a) using methyl (2E)-3-(2’-[N-
allyl-N-(p-toluenesulfonyl)amino]-5’-chlorophenyl)prop-2-enoate (208f) (0.660 g, 
1.60 mmol). Purification by column chromatography (ethyl acetate/petroleum 
ether, 1:3) gave (2E)-3-(2’-[N-allyl-N-(p-toluenesulfonyl)amino]-5’-
chlorophenyl)prop-2-en-1-ol (209f) (0.566 g, 92%) as a colourless oil. Rf 0.28 
(33% ethyl acetate/petroleum ether); max/cm
−1 (neat) 3505 (OH), 2923 (CH), 1597 
(C=C), 1478, 1343, 1161, 907, 727; δH (400 MHz, CDCl3) 2.23 (1H, br s, OH), 2.43 
(3H, s, CH3), 3.94 (1H, br s, 2’’-HH), 4.17–4.29 (3H, m, 1-H2 and 2’’-HH), 4.92–
5.02 (2H, m, 4’’-H2), 5.69 (1H, ddt, J 17.0, 10.1, 6.8 Hz, 3’’-H), 6.32 (1H, dt, J 16.0, 
5.1 Hz, 2-H), 6.60 (1H, d, J 8.6 Hz, 3’-H), 6.75 (1H, dt, J 16.0, 1.5 Hz, 3-H), 7.07 
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(1H, dd, J 8.6, 2.4 Hz, 4’-H), 7.28 (2H, d, J 8.2 Hz, 2 × ArH), 7.54–7.59 (3H, m, 6’-
H and 2 × ArH); δC (101 MHz, CDCl3) 21.6 (CH3), 54.8 (CH2), 63.4 (CH2), 119.8 
(CH2), 125.2 (CH), 126.5 (CH), 127.8 (CH), 127.9 (2 × CH), 129.7 (2 × CH), 130.7 
(CH), 132.0 (CH), 132.4 (CH), 134.5 (C), 135.0 (C), 135.8 (C), 139.6 (C), 143.9 
(C); m/z (ESI) 400.0729 (MNa+, C19H20
35ClNNaO3S requires 400.0745). 
 
2-Iodo-4-nitroaniline (203g)243 
 
Silver triflimide (0.023 g, 0.058 mmol) was added to a stirred solution of 4-
nitroaniline (202g) (0.40 g, 2.9 mmol) and N-iodosuccinimide (0.65 g, 2.9 mmol) in 
dichloromethane (15 mL) and warmed to 40 °C for 24 h in the dark. The mixture 
was diluted with dichloromethane (15 mL) and washed with dilute aqueous 
solutions of sodium hydrogen carbonate (50 mL) and 5% aqueous sodium 
thiosulfate solution (50 mL) and extracted with ethyl acetate (100 mL). The organic 
layer was washed with brine (20 mL), dried (MgSO4), filtered and concentrated in 
vacuo. Purification by column chromatography (ethyl acetate/petroleum ether, 1:7) 
yielded 2-iodo-4-nitroaniline (203g) (0.76 g, 99%) as a bright yellow solid. Mp 99–
101 °C (lit.243 103−104 °C); Rf 0.38 (30% ethyl acetate/petroleum ether); δH (400 
MHz, CDCl3) 4.83 (2H, br s, NH2), 6.70 (1H, d, J 9.0 Hz, 6-H), 8.06 (1H, dd, J 9.0, 
2.5 Hz, 5-H), 8.57 (1H, d, J 2.5 Hz, 3-H); δC (126 MHz, CDCl3) 80.5 (C), 112.3 
(CH), 125.7 (CH), 135.5 (CH), 139.3 (C), 152.3 (C); m/z (EI) 264 (M+, 100%), 234 
(38), 218 (11), 127 (5), 91 (31). 
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5-Nitro-2-[N-(p-toluenesulfonyl)amino]benzaldehyde (216) 
 
p-Toluenesulfonamide (0.148 g, 0.86 mmol) was added to a solution of 2-chloro-5-
nitrobenzaldehyde (215) (0.080 g, 0.43 mmol), and potassium carbonate (0.107 g, 
0.780 mmol) in N,N’-dimethylformamide (2 mL) and heated to 90 °C for 2 h. The 
reaction mixture was cooled to room temperature, diluted with water (2 mL) and 
extracted with ethyl acetate (10 mL). The organic layer was washed with 1M 
aqueous hydrochloric acid solution (3 × 2 mL) and brine (2 mL), dried (MgSO4), 
filtered and concentrated in vacuo. Purification by column chromatography (ethyl 
acetate/petroleum ether, 1:5) gave 5-nitro-2-[N-(p-
toluenesulfonyl)amino]benzaldehyde (216) (0.122 g, 86%) as a white solid. Mp 
172–174 °C; Rf 0.38 (33% ethyl acetate/petroleum ether); max/cm
−1 (neat) 3164 
(NH), 1673 (CO), 1586 (C=C), 1345, 1215, 1164, 749; δH (400 MHz, CDCl3) 2.40 
(3H, s, CH3), 7.31 (2H, d, J 8.2 Hz, 2 × ArH), 7.81 (1H, d, J 9.3 Hz, 3-H), 7.83 (2H, 
d, J 8.2 Hz, 2 × ArH), 8.34 (1H, dd, J 9.3, 2.6 Hz, 4-H), 8.54 (1H, d, J 2.6 Hz, 6-H), 
9.94 (1H, d, J 0.6 Hz, N-H), 11.19 (1H, br s, CHO); δC (101 MHz, CDCl3) 21.6 
(CH3), 117.3 (CH), 120.5 (C), 127.4 (2 × CH), 130.2 (2 × CH), 130.5 (CH), 131.5 
(CH), 135.6 (C), 142.1 (C), 145.0 (C), 145.3 (C), 193.5 (CH); m/z (ESI) 343.0350 
(MNa+, C14H12N2NaO5S requires 343.0359). 
 
Ethyl (2E)-3-(5’-nitro-2’-[N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate 
(217) 
 
Lithium bromide (0.043 g, 0.50 mmol) was added to a solution of triethyl 
phosphonoacetate (0.085 mL, 0.43 mmol) and 1,8-diazabicyclo[5.4.0]undec-7-ene 
(0.064 mL, 0.430 mmol) in acetonitrile (2 mL) and stirred at room temperature for 
0.5 h. 5-nitro-2-[N-(p-toluenesulfonyl)amino]benzaldehyde (216) (0.040 g, 0.130 
mmol) was added and the solution was stirred at room temperature for 3 h. The 
reaction was quenched with 10% aqueous potassium sodium tartrate solution (2 
189 
 
mL), concentrated to half volume in vacuo and extracted with diethyl ether (3 × 5 
mL). The combined organic layers were washed with water (2 mL), brine (2 mL), 
dried (MgSO4), filtered and concentrated in vacuo. Purification by column 
chromatography (ethyl acetate/petroleum ether, 1:3) gave ethyl (2E)-3-(5’-nitro-2’-
[N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate (217) (0.048 g, 99%) as a white 
solid. Mp 158–160 °C; Rf 0.28 (33% ethyl acetate/petroleum ether); max/cm
−1 
(neat) 3255 (NH), 2980 (CH), 1700 (CO), 1640 (C=C), 1527, 1344, 1166, 908, 
757; δH (400 MHz, CDCl3) 1.34 (3H, t, J 7.1 Hz, OCH2CH3), 2.38 (3H, s, CH3), 
4.27 (2H, q, J 7.1 Hz, OCH2CH3), 6.35 (1H, d, J 15.7 Hz, 2-H), 7.26 (2H, d, J 8.2 
Hz, 2 × ArH), 7.63 (1H, d, J 15.7 Hz, 3-H), 7.65–7.72 (4H, m, 3’-H, NH and 2 × 
ArH), 8.16 (1H, dd, J 9.0, 2.6 Hz, 4’-H), 8.28 (1H, d, J 2.6 Hz, 6’-H); δC (101 MHz, 
CDCl3) 14.2 (CH3), 21.6 (CH3), 61.3 (CH2), 123.0 (CH), 123.1 (CH), 124.4 (CH), 
125.5 (CH), 127.3 (2 × CH), 127.9 (C), 130.1 (2 × CH), 135.6 (C), 136.5 (CH), 
140.6 (C), 144.7 (C), 144.9 (C), 165.9 (C); m/z (ESI) 413.0760 (MNa+, 
C18H18N2NaO6S requires 413.0778). 
 
Ethyl (2E)-3-(2’-[N-allyl-N-(p-toluenesulfonyl)amino]-5’-nitrophenyl)prop-2-
enoate (218) 
 
The reaction was carried out as described for the synthesis of methyl (2E)-3-(2’-
[N-allyl-N-(p-toluenesulfonyl)amino]phenyl)prop-2-enoate (208a) using ethyl (2E)-
3-(2’-[N-(p-toluenesulfonyl)amino]-5’-nitrophenyl)prop-2-enoate (217) (0.020 g, 
0.05 mmol). Purification by column chromatography (ethyl acetate/petroleum 
ether, 1:10) gave ethyl (2E)-3-(2’-[N-allyl-N-(p-toluenesulfonyl)amino]-5’-
nitrophenyl)prop-2-enoate (218) (0.012 g, 55%) as a white solid. Mp 128–130 °C; 
Rf 0.50 (33% ethyl acetate/petroleum ether); max/cm
−1 (neat) 2956 (CH), 1716 
(CO), 1529 (C=C), 1349, 1215, 908, 730; δH (400 MHz, CDCl3) 1.35 (3H, t, J 7.1 
Hz, OCH2CH3), 2.44 (3H, s, CH3), 4.16 (2H, br s, 2’’-H2), 4.28 (2H, q, J 7.1 Hz, 
OCH2CH3), 4.98 (1H, dd, J 17.0, 1.1 Hz, 4’’-HH), 5.04 (1H, dd, J 10.0, 1.1 Hz, 4’’-
HH), 5.72 (1H, ddt, J 17.0, 10.0, 6.8 Hz, 3’’-H), 6.47 (1H, d, J 16.1 Hz, 2-H), 7.05 
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(1H, d, J 8.8 Hz, 3’-H), 7.31 (2H, d, J 8.2 Hz, 2 × ArH), 7.57 (2H, d, J 8.2 Hz, 2 × 
ArH), 7.80 (1H, d, J 16.1 Hz, 3-H), 8.11 (1H, dd, J 8.8, 2.6 Hz, 4’-H), 8.49 (1H, d, J 
2.6 Hz, 6’-H); δC (101 MHz, CDCl3) 14.3 (CH3), 21.6 (CH3), 54.8 (CH2), 60.9 (CH2), 
120.7 (CH2), 122.3 (CH), 122.9 (CH), 124.4 (CH), 127.9 (2 × CH), 129.9 (2 × CH), 
131.1 (CH), 131.4 (CH), 134.9 (C), 137.6 (C), 138.0 (CH), 143.7 (C), 144.6 (C), 
147.4 (C), 165.7 (C); m/z (ESI) 453.1073 (MNa+, C21H22N2NaO6S requires 
453.1091). 
 
(2E)-3-(2’-[N-Allyl-N-(p-toluenesulfonyl)amino]-5’-nitrophenyl)prop-2-en-1-ol 
(209g) 
 
The reaction was carried out as described for the synthesis of (2E)-3-(2’-[N-allyl-N-
(p-toluenesulfonyl)amino]phenyl)prop-2-en-1-ol (209a) using ethyl (2E)-3-(2’-[N-
allyl-N-(p-toluenesulfonyl)amino]-5’-nitrophenyl)prop-2-enoate (218) (0.143 g, 
0.330 mmol). Purification by column chromatography (ethyl acetate/petroleum 
ether, 1:2) gave (2E)-3-(2’-[N-allyl-N-(p-toluenesulfonyl)amino]-5’-nitrophenyl)prop-
2-en-1-ol (209g) (0.110 g, 85%) as a colourless oil. Rf 0.18 (33% ethyl 
acetate/petroleum ether); max/cm
−1 (neat) 3537 (OH), 2924 (CH), 1525 (C=C), 
1347, 1162, 748; δH (400 MHz, CDCl3) 2.05 (1H, br s, OH), 2.45 (3H, s, CH3), 4.12 
(2H, br s, 2’’-H2), 4.33 (2H, br d, J 4.9 Hz, 1-H2), 4.92–5.04 (2H, m, 4’’-H2), 5.69 
(1H, ddt, J 17.0, 10.1, 6.8 Hz, 3’’-H), 6.49 (1H, dt, J 16.0, 4.9 Hz, 2-H), 6.85 (1H, 
dt, J 16.0, 1.6 Hz, 3-H), 6.86 (1H, d, J 8.8 Hz, 3’-H), 7.32 (2H, d, J 8.2 Hz, 2 × 
ArH), 7.57 (2H, d, J 8.2 Hz, 2 × ArH), 7.95 (1H, dd, J 8.8, 2.7 Hz, 4’-H), 8.43 (1H, 
d, J 2.7 Hz, 6’-H); δC (101 MHz, CDCl3) 21.6 (CH3), 54.7 (CH2), 63.2 (CH2), 120.4 
(CH2), 121.7 (CH), 122.1 (CH), 124.4 (CH), 127.9 (2 × CH), 129.9 (2 × CH), 130.5 
(CH), 131.5 (CH), 134.1 (CH), 135.4 (C), 139.9 (C), 142.0 (C), 144.4 (C), 147.5 
(C); m/z (ESI) 411.0970 (MNa+, C19H20N2NaO5S requires 411.0985). 
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N-(p-Toluenesulfonyl)-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-
1H-benzazepine (221a) 
 
(2E)-3-(2’-[N-Allyl-N-(p-toluenesulfonyl)amino]phenyl)prop-2-en-1-ol (209a) (0.313 
g, 0.911 mmol) was dissolved in dichloromethane (45 mL) and cooled to 0 °C 
under argon with stirring. Trichloroacetonitrile (0.137 mL, 1.37 mmol) was added to 
the solution, followed by 1,8-diazabicyclo[5.4.0]undec-7-ene (0.068 mL, 0.460 
mmol) and the reaction was allowed to warm to room temperature over 2 h. The 
reaction mixture was filtered through a short pad of alumina (neutral, Brockman V) 
with diethyl ether (150 mL) and concentrated in vacuo to yield the crude allylic 
trichloroacetimidate as a yellow oil which was used without further purification. The 
allylic trichloroacetimidate was transferred to a dry Schlenk tube containing a 
stirrer bar and potassium carbonate (0.030 g, 5 mg/mL) to which p-xylene (6 mL) 
was then added. The tube was purged with argon, sealed and heated to 160 °C for 
24 h. The reaction mixture was allowed to cool to room temperature and Grubbs 
2nd generation catalyst (0.039 g, 0.046 mmol, 5 mol%) and p-xylene (51 mL, 0.016 
M) were added. The reaction mixture was heated to 60 °C for 18 h. The reaction 
mixture was concentrated in vacuo and purified by column chromatography 
(diethyl ether/petroleum ether, 1:3) which gave N-(p-toluenesulfonyl)-5-(2’,2’,2’-
trichloromethylcarbonylamino)-2,5-dihydro-1H-benzazepine (221a) (0.339 g, 81%) 
as a white solid. Mp 160–163 °C (decomposition); Rf 0.28 (50% diethyl 
ether/petroleum ether); max/cm
−1 (neat) 3337 (NH), 2925 (CH), 1701 (CO), 1496, 
1341, 1159, 906, 727; δH (400 MHz, CDCl3) 2.47 (3H, s, CH3), 3.86 (1H, br s, 2-
HH), 4.66 (1H, br s, 2-HH), 5.58 (1H, br t, J 7.7 Hz, 5-H), 5.84 (1H, br d, J 9.0 Hz, 
3-H), 6.04 (1H, br s, 4-H), 6.82 (1H, br s, 9-H), 7.23 (1H, td, J 8.4, 1.6 Hz, 8-H), 
7.31 (1H, td, J 8.4, 1.3 Hz, 7-H), 7.36 (2H, d, J 8.2 Hz, 2 × ArH), 7.42 (1H, br d, J 
8.4 Hz, 6-H), 7.77 (2H, d, J 8.2 Hz, 2 × ArH), 8.37 (1H, br s, NH); δC (101 MHz, 
CDCl3) 21.6 (CH3), 49.1 (CH2), 52.7 (CH), 92.5 (C), 125.8 (CH), 127.4 (2 × CH), 
128.2 (CH), 129.3 (CH), 129.7 (CH), 130.0 (2 × CH), 130.8 (2 × CH), 137.7 (C), 
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138.1 (C), 139.2 (C), 144.2 (C), 161.4 (C); m/z (ESI) 480.9904 (MNa+, 
C19H17
35Cl3N2NaO3S requires 480.9918). 
 
7-Methyl-N-(p-toluenesulfonyl)-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-
dihydro-1H-benzazepine (221b) 
 
The reaction was carried out as described for the synthesis of N-(p-
toluenesulfonyl)-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1H-
benzazepine (221a) using (2E)-3-(2’-[N-allyl-N-(p-toluenesulfonyl)amino]-5’-
methylphenyl)-prop-2-en-1-ol (209b) (0.170 g, 0.480 mmol). Purification by column 
chromatography (diethyl ether/petroleum ether, 1:3) gave 7-methyl-N-(p-
toluenesulfonyl)-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1H-
benzazepine (221b) (0.179 g, 80%) as a white solid. Mp 174–176 °C; Rf 0.30 
(50% diethyl ether/petroleum ether); max/cm
−1 (neat) 3333 (NH), 2923 (CH), 1701 
(CO), 1505, 1340, 1155, 1112, 909, 727; δH (400 MHz, CDCl3) 2.33 (3H, s, 7-
CH3), 2.47 (3H, s, CH3), 3.82 (1H, br s, 2-HH), 4.67 (1H, br s, 2-HH), 5.53 (1H, br 
t, J 7.8 Hz, 5-H), 5.84 (1H, br d, J 8.6 Hz, 3-H), 6.04 (1H, br s, 4-H), 6.67 (1H, br s, 
9-H), 7.02 (1H, dd, J 8.1, 1.4 Hz, 8-H), 7.23 (1H, br s, 6-H), 7.36 (2H, d, J 8.2 Hz, 
2 × ArH), 7.76 (2H, d, J 8.2 Hz, 2 × ArH), 8.43 (1H, br s, NH); δC (101 MHz, CDCl3) 
21.1 (CH3), 21.6 (CH3), 49.1 (CH2), 52.7 (CH), 92.6 (C), 125.8 (CH), 127.4 (2 × 
CH), 127.9 (CH), 130.0 (2 × CH), 130.2 (2 × CH), 130.9 (CH), 135.4 (C), 137.8 
(C), 138.8 (C), 139.4 (C), 144.1 (C), 161.4 (C); m/z (ESI) 495.0053 (MNa+, 
C20H19
35Cl3N2NaO3S requires 495.0074). 
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7-Methoxy-N-(p-toluenesulfonyl)-5-(2’,2’,2’-trichloromethylcarbonylamino)-
2,5-dihydro-1H-benzazepine (221c) 
 
The reaction was carried out as described for the synthesis of N-(p-
toluenesulfonyl)-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1H-
benzazepine (221a) using (2E)-3-(2’-[N-allyl-N-(p-toluenesulfonyl)amino]-5’-
methoxyphen-yl)prop-2-en-1-ol (209c) (0.076 g, 0.20 mmol). Purification by 
column chromatography (diethyl ether/petroleum ether, 1:3) gave 7-methoxy-N-(p-
toluenesulfonyl)-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1H-
benzazepine (221c) (0.079 g, 79%) as a white solid. Mp 190–195 °C 
(decomposition); Rf 0.20 (50% diethyl ether/petroleum ether); max/cm
−1 (neat) 
3337 (NH), 2935 (CH), 1701 (CO), 1502, 1215, 1156, 749; δH (400 MHz, CDCl3) 
2.46 (3H, s, CH3), 3.61–3.84 (4H, m, 2-HH and 7-OCH3), 4.72 (1H, br s, 2-HH), 
5.51 (1H, br t, J 7.6 Hz, 5-H), 5.85 (1H, br s, 3-H), 6.05 (1H, br s, 4-H), 6.64 (1H, 
br s, 9-H), 6.71 (1H, dd, J 8.6, 2.8 Hz, 8-H), 6.93 (1H, br s, 6-H), 7.35 (2H, d, J 8.2 
Hz, 2 × ArH), 7.74 (2H, d, J 8.2 Hz, 2 × ArH), 8.58 (1H, br s, NH); δC (101 MHz, 
CDCl3) 21.6 (CH3), 49.2 (CH2), 52.9 (CH), 55.6 (CH3), 92.5 (C), 114.9 (CH), 125.5 
(CH), 127.4 (2 × CH), 129.3 (CH), 130.0 (2 × CH), 130.4 (CH), 131.2 (CH), 137.7 
(C), 140.5 (C), 144.1 (C), 159.7 (2 × C), 161.5 (C); m/z (ESI) 512.9973 (MNa+, 
C20H19
35Cl2
37ClN2NaO4S requires 512.9994). 
 
7-Fluoro-N-(p-toluenesulfonyl)-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-
dihydro-1H-benzazepine (221d) 
 
194 
 
The reaction was carried out as described for the synthesis of N-(p-
toluenesulfonyl)-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1H-
benzazepine (221a) using (2E)-3-(2’-[N-allyl-N-(p-toluenesulfonyl)amino]-5’-
fluorophenyl)-prop-2-en-1-ol (209d) (0.189 g, 0.520 mmol). Purification by column 
chromatography (diethyl ether/petroleum ether, 1:3) gave 7-fluoro-N-(p-
toluenesulfonyl)-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1H-
benzazepine (221d) (0.204 g, 82%) as a white solid. Mp 181–183 °C; Rf 0.25 
(50% diethyl ether/petroleum ether); max/cm
−1 (neat) 3333 (NH), 3034, 1705 (CO), 
1503, 1344, 1159, 907, 729; δH (400 MHz, CDCl3) 2.47 (3H, s, CH3), 3.81 (1H, br 
s, 2-HH), 4.62 (1H, br s, 2-HH), 5.52 (1H, br t, J 7.4 Hz, 5-H), 5.85 (1H, br s, 3-H), 
5.98 (1H, br s, 4-H), 6.81 (1H, br s, 9-H), 6.91 (1H, td, J 8.2, 2.9 Hz, 8-H), 7.12 
(1H, br s, 6-H), 7.36 (2H, d, J 8.2 Hz, 2 × ArH), 7.75 (2H, d, J 8.2 Hz, 2 × ArH), 
8.40 (1H, br s, NH); δC (101 MHz, CDCl3) 21.6 (CH3), 48.9 (CH2), 52.2 (CH), 92.4 
(C), 116.1 (CH), 116.4 (CH), 125.4 (CH), 127.4 (2 × CH), 130.1 (3 × CH), 131.1 
(CH), 133.9 (C), 137.3 (C), 141.7 (C), 144.4 (C), 161.4 (C), 162.1 (d, 1JCF 250.6 
Hz, C); m/z (ESI) 498.9809 (MNa+, C19H16
35Cl3FN2NaO3S requires 498.9823). 
 
8-Fluoro-N-(p-toluenesulfonyl)-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-
dihydro-1H-benzazepine (221e) 
 
The reaction was carried out as described for the synthesis of N-(p-
toluenesulfonyl)-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1H-
benzazepine (221a) using (2E)-3-(2’-[N-allyl-N-(p-toluenesulfonyl)amino]-4’-
fluorophenyl)-prop-2-en-1-ol (209e) (0.222 g, 0.610 mmol). Purification by column 
chromatography (diethyl ether/petroleum ether, 1:3) gave 8-fluoro-N-(p-
toluenesulfonyl)-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1H-
benzazepine (221e) (0.269 g, 92%) as a white solid. Mp 147–149 °C; Rf 0.28 (50% 
diethyl ether/petroleum ether); max/cm
−1 (neat) 3340 (NH), 2925 (CH), 1704 (CO), 
1599 (C=C), 1501, 1343, 1160, 909, 731; δH (400 MHz, CDCl3) 2.48 (3H, s, CH3), 
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3.86 (1H, br d, J 17.8 Hz, 2-HH), 4.62 (1H, br d, J 17.8 Hz, 2-HH), 5.56 (1H, br t, J 
7.8 Hz, 5-H), 5.85 (1H, ddd, J 11.4, 4.5, 1.8 Hz, 3-H), 6.02 (1H, dd, J 11.4, 7.8 Hz, 
4-H), 6.55 (1H, br d, 3JHF 8.0 Hz, 9-H), 7.02 (1H, td, J 8.2, 2.6 Hz, 7-H), 7.38 (2H, 
d, J 8.2 Hz, 2 × ArH), 7.41 (1H, dd, J 8.2, 4JHF 6.4 Hz, 6-H), 7.77 (2H, d, J 8.2 Hz, 
2 × ArH), 8.24 (1H, br s, NH); δC (101 MHz, CDCl3) 21.7 (CH3), 48.8 (CH2), 52.1 
(CH), 92.4 (C), 115.6 (d, 2JCF 22.9 Hz, CH), 116.2 (d, 
2JCF 21.0 Hz, CH), 125.6 
(CH), 127.4 (2 × CH), 130.2 (2 × CH), 130.7 (CH), 132.0 (CH), 135.3 (d, 4JCF 3.5 
Hz, C), 137.2 (C), 139.4 (d, 3JCF 9.9 Hz, C), 144.6 (C), 161.3 (C), 162.5 (d, 
1JCF 
230.0 Hz, C); m/z (ESI) 498.9804 (MNa+, C19H16
35Cl3FN2NaO3S requires 
498.9823). 
 
7-Chloro-N-(p-toluenesulfonyl)-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-
dihydro-1H-benzazepine (221f) 
 
The reaction was carried out as described for the synthesis of N-(p-
toluenesulfonyl)-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1H-benzaze-
pine (221a) using (2E)-3-(2’-[N-allyl-N-(p-toluenesulfonyl)amino]-5’-chlorophenyl)-
prop-2-en-1-ol (209f) (0.290 g, 0.770 mmol). The RCM step was heated to 60 °C 
for 24 h. Purification by column chromatography (diethyl ether/petroleum ether, 
1:3) gave 7-chloro-N-(p-toluenesulfonyl)-5-(2’,2’,2’-trichloromethylcarbonylamino)-
2,5-dihydro-1H-benzazepine (221f) (0.300 g, 79%) as a white solid. Mp 158–160 
°C; Rf 0.25 (50% diethyl ether/petroleum ether); max/cm
−1 (neat) 3341 (NH), 2925 
(CH), 1705 (CO), 1495, 1343, 1159, 908, 730; δH (400 MHz, CDCl3) 2.47 (3H, s, 
CH3), 3.88 (1H, br s, 2-HH), 4.60 (1H, br s, 2-HH), 5.51 (1H, br t, J 7.6 Hz, 5-H), 
5.84 (1H, br d, J 9.0 Hz, 3-H), 5.97 (1H, br s, 4-H), 6.79 (1H, br s, 9-H), 7.20 (1H, 
dd, J 8.4, 2.4 Hz, 8-H), 7.36 (2H, d, J 8.2 Hz, 2 × ArH), 7.40 (1H, br s, 6-H), 7.75 
(2H, d, J 8.2 Hz, 2 × ArH), 8.26 (1H, br s, NH); δC (101 MHz, CDCl3) 21.7 (CH3), 
48.9 (CH2), 52.1 (CH), 92.3 (C), 125.4 (CH), 127.4 (2 × CH), 129.6 (2 × CH), 130.2 
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(2 × CH), 131.0 (2 × CH), 134.9 (C), 136.5 (C), 137.2 (C), 141.0 (C), 144.5 (C), 
161.4 (C); m/z (ESI) 514.9515 (MNa+, C19H16
35Cl4N2NaO3S requires 514.9528). 
 
7-Nitro-N-(p-toluenesulfonyl)-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-
dihydro-1H-benzazepine (221g) 
 
The reaction was carried out as described for the synthesis of N-(p-
toluenesulfonyl)-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1H-
benzazepine (221a) using (2E)-3-(2’-[N-allyl-N-(p-toluenesulfonyl)amino]-5’-
nitrophenyl)-prop-2-en-1-ol (209g) (0.084 g, 0.216 mmol).  The Overman 
rearrangement was heated to 160 °C for 43 h and the RCM step was heated to 60 
°C for 31 h. Purification by column chromatography (diethyl ether/petroleum ether, 
1:3) gave 7-nitro-N-(p-toluenesulfonyl)-5-(2’,2’,2’-trichloromethylcarbonylamino)-
2,5-dihydro-1H-benzazepine (221g) (0.053 g, 49%) as a white solid. Mp 180–185 
°C (decomposition); Rf 0.28 (50% diethyl ether/petroleum ether); max/cm
−1 (neat) 
3335 (NH), 3020, 1709 (CO), 1592 (C=C), 1530, 1350, 1215, 1161, 749; δH (400 
MHz, CDCl3) 2.49 (3H, s, CH3), 4.03 (1H, br d, J 18.5 Hz, 2-HH), 4.54 (1H, br d, J 
18.5 Hz, 2-HH), 5.64 (1H, br t, J 7.2 Hz, 5-H), 5.86 (1H, br d, J 11.4 Hz, 3-H), 
5.95–6.02 (1H, m, 4-H), 7.18 (1H, d, J 8.6 Hz, 9-H), 7.41 (2H, d, J 8.2 Hz, 2 × 
ArH), 7.79 (2H, d, J 8.2 Hz, 2 × ArH), 7.98 (1H, br s, NH), 8.13 (1H, dd, J 8.6, 2.6 
Hz, 8-H), 8.29 (1H, d, J 2.6 Hz, 6-H); δC (101 MHz, CDCl3) 21.7 (CH3), 48.7 (CH2), 
51.8 (CH), 92.1 (C), 124.6 (2 × CH), 125.1 (CH), 127.4 (2 × CH), 129.6 (CH), 
130.4 (2 × CH), 130.7 (CH), 136.8 (C), 141.2 (C), 143.8 (C), 145.0 (C), 147.4 (C), 
161.5 (C); m/z (ESI) 525.9761 (MNa+, C19H16
35Cl3FN3NaO5S requires 525.9768). 
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5-tert-Butoxycarbonylamino-N-(p-toluenesulfonyl)-2,5-dihydro-1H-
benzazepine (226) 
 
2M Aqueous sodium hydroxide (5 mL) was added to a solution of N-(p-
toluenesulfonyl)-5-(2’,2’,2’-trichloromethylcarbonylamino)-2,5-dihydro-1H-
benzazepine (221a) (0.165 g, 0.359 mmol) in methanol (3 mL) at 60 °C and stirred 
for 18 h. The mixture was allowed to cool to room temperature and then di-tert-
butyl dicarbonate (0.393 g, 1.80 mmol) was added. The reaction mixture was 
stirred for a further 24 h. The reaction mixture was extracted with ethyl acetate (3 × 
5 mL), dried (MgSO4), filtered, and concentrated in vacuo. Purification by column 
chromatography (ethyl acetate/petroleum ether, 1:20) gave 5-tert-
butoxycarbonylamino-N-(p-toluenesulfonyl)-2,5-dihydro-1H-benzazepine (226) 
(0.108 g, 73%) as a white solid. Mp 149–151 °C (decomposition); Rf 0.28 (33% 
ethyl acetate/petroleum ether); max/cm
−1 (neat) 3393 (NH), 2978 (CH), 1698 (CO), 
1494, 1343, 1159, 908, 728; δH (400 MHz, CDCl3) 1.44 (9H, s, O
tBu), 2.45 (3H, s, 
CH3), 4.14 (1H, br s, 2-HH), 4.35 (1H, br s, 2-HH), 5.33 (1H, br t, J 7.2 Hz, 5-H), 
5.50 (1H, br s, NH), 5.61 (1H, br d, J 10.7 Hz, 3-H), 5.81 (1H, br s, 4-H), 7.05 (1H, 
d, J 7.6 Hz, 9-H), 7.21 (1H, td, J 7.6, 1.6 Hz, 8-H), 7.27–7.36 (4H, m, 6-H, 7-H and 
2 × ArH), 7.77 (2H, br d, J 8.2 Hz, 2 × ArH); δC (126 MHz, CDCl3) 21.6 (CH3), 28.4 
(3 × CH3), 48.9 (CH2), 51.3 (CH), 79.5 (C), 127.3 (2 × CH), 127.9 (CH), 128.5 (3 × 
CH), 128.7 (2 × CH), 129.9 (2 × CH), 137.6 (C), 138.0 (C), 141.4 (C), 143.8 (C), 
154.9 (C); m/z (ESI) 437.1486 (MNa+, C22H26N2NaO4S requires 437.1505). 
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5-tert-Butoxycarbonylamino-2,3,4,5-tetrahydro-1H-benzazepine (228)183 
 
Palladium on charcoal (20%, 0.017 g) was added to a solution of 5-tert-
butoxycarbonylamino-N-(p-toluenesulfonyl)-2,5-dihydro-1H-benzazepine (226) 
(0.057 g, 0.14 mmol) in ethyl acetate (4 mL). The mixture was stirred under an 
atmosphere of hydrogen at 60 °C for 17 h. The reaction mixture was filtered 
through a short pad of Celite® with diethyl ether (50 mL), concentrated in vacuo to 
give 5-tert-butoxycarbonylamino-N-(p-toluenesulfonyl)-2,3,4,5-tetrahydro-1H-
benzazepine (227) (0.050 g) as a white solid. 5-tert-Butoxycarbonylamino-N-(p-
toluene-sulfonyl)-2,3,4,5-tetrahydro-1H-benzazepine (0.050 g, 0.12 mmol) was 
dissolved in methanol (5 mL) and magnesium turnings (0.082 g, 3.36 mmol) were 
added. The mixture was heated under reflux for 4 h. The reaction mixture was 
cooled to 0 °C and 1M aqueous hydrochloric acid solution (10 mL) was added 
dropwise. The solution was extracted with ethyl acetate (3 × 10 mL), dried 
(MgSO4) and concentrated in vacuo. Purification by column chromatography using 
(ethyl acetate/petroleum ether, 1:20) gave 5-tert-butoxycarbonylamino-2,3,4,5-
tetrahydro-1H-benzazepine (228) (0.032 g, 88%) as a white solid. Mp 151–153 °C 
(lit.183 153–154 °C); Rf 0.45 (30% ethyl acetate/petroleum ether); δH (400 MHz, 
CDCl3) 1.42 (9H, s, O
tBu), 1.55–1.80 (2H, m, 3-HH and 4-HH), 1.94–2.21 (2H, m, 
3-HH and 4-HH), 2.83 (1H, td, J 12.8, 2.0 Hz, 2-HH), 3.21–3.35 (1H, m, 2-HH), 
3.61 (1H, br s, NH), 4.90 (1H, t, J 8.1 Hz, 5-H), 5.72 (1H, br d, J 8.1 Hz, NH), 6.73 
(1H, dd, J 7.3, 1.1 Hz, 9-H), 6.89 (1H, td, J 7.3, 1.1 Hz, 7-H), 7.08 (1H, td, J 7.3, 
1.6 Hz, 8-H), 7.23 (1H, br d, J 7.3 Hz, 6-H); δC (101 MHz, CDCl3) 25.5 (CH2), 28.5 
(3 × CH3), 30.9 (CH2), 49.1 (CH2), 55.1 (CH), 79.0 (C), 120.5 (CH), 121.9 (CH), 
128.0 (CH), 130.0 (CH), 133.7 (C), 149.1 (C), 155.2 (C); m/z (ESI) 285 (MNa+, 
100%), 185 (25), 146 (4). 
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2-Propargyloxybenzaldehyde (238a)244 
 
 
Propargyl bromide (3.34 mL, 30.0 mmol) was added to a stirred solution of 2-
hydroxybenzaldehyde (180a) (3.00 g, 25.0 mmol) and potassium carbonate (7.00 
g, 50.0 mmol) in N,N’-dimethylformamide (120 mL) and heated to 70 °C for 3 h. 
The reaction mixture was cooled to room temperature, diluted with 5% aqueous 
lithium chloride solution (20 mL) and extracted with diethyl ether (3 × 50 mL). The 
organic layer was washed with 5% aqueous lithium chloride solution (3 × 50 mL), 
brine (50 mL), dried (MgSO4), filtered and concentrated in vacuo. Purification by 
column chromatography (diethyl ether/petroleum ether, 1:4) gave 2-
propargyloxybenzaldehyde (238a) (3.94 g, quantitative) as a white solid. Mp 69–
70 °C (lit.244 69–70 °C); Rf 0.65 (50% diethyl ether/petroleum ether); δH (500 MHz, 
CDCl3) 2.57 (1H, t, J 2.5 Hz, 4’-H), 4.81 (2H, d, J 2.5 Hz, 2’-H2), 7.06 (1H, br t, J 
7.5 Hz, 5-H), 7.10 (1H, d, J 8.5 Hz, 3-H), 7.54 (1H, ddd, J 8.5, 7.5, 1.9 Hz, 4-H), 
7.83 (1H, dd, J 7.5, 1.9 Hz, 6-H), 10.46 (1H, br d, J 0.6 Hz, CHO); δC (126 MHz, 
CDCl3) 56.4 (CH2), 76.5 (CH), 77.7 (C), 113.2 (CH), 121.7 (CH), 125.4 (C), 128.5 
(CH), 135.7 (CH), 159.7 (C), 189.5 (CH); m/z (EI) 160 (M+, 30%), 131 (100), 121 
(49), 109 (40), 83 (47), 65 (30), 39 (34). 
 
5-Methoxy-2-propargyloxybenzaldehyde (238b)245  
 
The reaction was carried out as described for the synthesis of 2-
propargyloxybenzaldehyde (238a) using 2-hydroxy-5-methoxybenzaldehyde 
(180h) (0.152 g, 1.00 mmol). Purification by column chromatography (diethyl 
ether/petroleum ether, 1:4) gave 5-methoxy-2-propargyloxybenzaldehyde (238b) 
(0.190 g, quantitative) as a white solid. Mp 60–62 °C; Rf 0.91 (50% diethyl 
ether/petroleum ether); Spectroscopic data was consistent with literature.245 δH 
(500 MHz, CDCl3) 2.55 (1H, t, J 2.4 Hz, 4’-H), 3.81 (3H, s, 5-OCH3), 4.78 (2H, d, J 
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2.4 Hz, 2’-H2), 7.08 (1H, d, J 9.1 Hz, 3-H), 7.14 (1H, dd, J 9.1, 3.3 Hz, 4-H), 7.34 
(1H, d, J 3.3 Hz, 6-H), 10.44 (1H, s, CHO); δC (126 MHz, CDCl3) 55.8 (CH3), 57.4 
(CH2), 76.4 (CH), 77.9 (C), 110.4 (CH), 115.7 (CH), 123.2 (CH), 126.2 (C), 126.2 
(C), 154.5 (C), 189.4 (CH); m/z (ESI) 213 (MNa+, 75%), 206 (40), 174 (100). 
 
4-Methoxy-2-propargyloxybenzaldehyde (238c)245   
   
The reaction was carried out as described for the synthesis of 2-
propargyloxybenzaldehyde (238a) using 2-hydroxy-4-methoxybenzaldehyde (180i) 
(0.152 g, 1.00 mmol). Purification by column chromatography (diethyl 
ether/petroleum ether, 1:4) gave 4-methoxy-2-propargyloxybenzaldehyde (238c) 
(0.188 g, 99%) as a white solid. Mp 82–84 °C (lit.245 76–78 °C); Rf 0.41 (50% 
diethyl ether/petroleum ether); δH (500 MHz, CDCl3) 2.58 (1H, t, J 2.4 Hz, 4’-H), 
3.87 (3H, s, 4-OCH3), 4.80 (2H, d, J 2.4 Hz, 2’-H2), 6.58–6.61 (2H, m, 3-H and 5-
H), 7.81–7.84 (1H, m, 6-H), 10.29 (1H, br d, J 0.6 Hz, CHO); δC (126 MHz, CDCl3) 
55.7 (CH3), 56.4 (CH2), 76.6 (CH), 77.6 (C), 99.5 (CH), 106.9 (CH), 119.6 (C), 
130.6 (CH), 161.5 (C), 165.9 (C), 188.1 (CH); m/z (ESI) 213 (MNa+, 100%). 
 
5-Chloro-2-propargyloxybenzaldehyde (238d)245 
   
The reaction was carried out as described for the synthesis of 2-
propargyloxybenzaldehyde (238a) using 2-hydroxy-5-chlorobenzaldehyde (180j) 
(1.57 g, 10.0 mmol). Purification by column chromatography (diethyl 
ether/petroleum ether, 1:4) gave 5-chloro-2-propargyloxybenzaldehyde (238d) 
(1.93 g, 99%) as a white solid. Mp 74–75 °C (lit.245 74–76 °C); Rf 0.58 (50% diethyl 
ether/petroleum ether); δH (500 MHz, CDCl3) 2.59 (1H, t, J 2.4 Hz, 4’-H), 4.82 (2H, 
d, J 2.4 Hz, 2’-H2), 7.08 (1H, d, J 8.9 Hz, 3-H), 7.50 (1H, dd, J 8.9, 2.8 Hz, 4-H), 
7.80 (1H, d, J 2.8 Hz, 6-H), 10.40 (1H, s, CHO); δC (126 MHz, CDCl3) 56.8 (CH2), 
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76.9 (C), 77.2 (CH), 115.0 (CH), 126.5 (C), 127.5 (C), 128.1 (CH), 135.2 (CH), 
158.1 (C), 188.2 (CH); m/z (ESI) 217 (MNa+, 100%), 210 (4), 194 (4), 178 (8), 159 
(8), 131 (4). 
 
5-Nitro-2-propargyloxybenzaldehyde (238e)246 
  
The reaction was carried out as described for the synthesis of 2-
propargyloxybenzaldehyde (238a) using 2-hydroxy-5-nitrobenzaldehyde (180k) 
(2.75 g, 16.5 mmol). Purification by column chromatography (diethyl 
ether/petroleum ether, 1:4) gave 5-nitro-2-propargyloxybenzaldehyde (238e) (3.31 
g, 98%) as a white crystalline solid. Mp 90–91 °C (lit.246 91.5–93 °C); Rf 0.32 (50% 
diethyl ether/petroleum ether); δH (400 MHz, CDCl3) 2.71 (1H, t, J 2.4 Hz, 4’-H), 
5.01 (2H, d, J 2.4 Hz, 2’-H2), 7.32 (1H, d, J 9.2 Hz, 3-H), 8.45 (1H, dd, J 9.2, 2.9 
Hz, 4-H), 8.69 (1H, d, J 2.9 Hz, 6-H), 10.45 (1H, s, CHO); δC (101 MHz, CDCl3) 
57.2 (CH2), 76.3 (C), 77.9 (CH), 113.8 (CH), 124.5 (CH), 125.2 (C), 130.4 (CH), 
142.2 (C), 163.4 (C), 187.3 (CH); m/z (EI) 205 (M+, 16%), 176 (53), 167 (100), 137 
(34), 120 (36), 92 (27), 65 (46). 
 
Ethyl (2E)-3-(2’-propargyloxyphenyl)prop-2-enoate (239a)  
 
Lithium chloride (4.20 g, 98.4 mmol) was added to a solution of triethyl 
phosphonoacetate  (16.6 mL, 83.6 mmol) and 1,8-diazabicyclo[5.4.0]undec-7-ene 
(12.5 mL, 83.6 mmol) in acetonitrile (100 mL) and stirred at room temperature for 
0.5 h. 2-Propargyloxybenzaldehyde (238a) (3.94 g, 24.6 mmol) was added and the 
solution was stirred at room temperature for 3.5 h. The reaction was quenched by 
the addition of an aqueous saturated solution of ammonium chloride (10 mL), 
concentrated to half volume in vacuo and extracted with diethyl ether (3 × 50 mL). 
The combined organic layers were washed with water (100 mL), brine (100 mL), 
dried (MgSO4), filtered and concentrated in vacuo. Purification by column 
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chromatography (diethyl ether/petroleum ether, 1:10) yielded ethyl (2E)-3-(2’-
propargyloxyphenyl)prop-2-enoate (239a) (5.67 g, quantitative) as a colourless oil. 
Rf 0.70 (50% diethyl ether/petroleum ether); max/cm
−1 (neat) 2983 (CH), 1701 
(CO), 1632 (C=C), 1486, 1316, 1220, 1175, 1022, 750, 731; δH (400 MHz, CDCl3) 
1.34 (3H, t, J 7.1 Hz, OCH2CH3), 2.53 (1H, t, J 2.4 Hz, 4’’-H), 4.26 (2H, q, J 7.1 Hz, 
OCH2CH3), 4.78 (2H, d, J 2.4 Hz, 2’’-H2), 6.51 (1H, d, J 16.2 Hz, 2-H), 7.01 (1H, br 
t, J 7.6 Hz, 5'-H), 7.05 (1H, br d, J 8.3 Hz, 3’-H), 7.35 (1H, ddd, J 8.3, 7.6, 1.6 Hz, 
4'-H), 7.53 (1H, dd, J 7.6, 1.6 Hz, 6'-H), 8.00 (1H, d, J 16.2 Hz, 3-H); δC (101 MHz, 
CDCl3) 14.4 (CH3), 56.1 (CH2), 60.4 (CH2), 76.1 (CH), 78.2 (C), 112.7 (CH), 119.1 
(CH), 121.6 (CH), 124.1 (C), 128.8 (CH), 131.2 (CH), 139.6 (CH), 156.1 (C), 167.3 
(C); m/z (EI) 230.0944 (M+, C14H14O3 requires 230.0943), 201 (44%), 185 (39), 
157 (40), 147 (46), 118 (100), 103 (14), 91 (66). 
 
Ethyl (2E)-3-(5’-methoxy-2’-propargyloxyphenyl)prop-2-enoate (239b)  
 
The reaction was carried out as described for the synthesis of ethyl (2E)-3-(2’-
propargyloxyphenyl)prop-2-enoate (239a) using 5-methoxy-2-
propargyloxybenzaldehyde (238b) (0.167 g, 0.880 mmol). Purification by column 
chromatography (diethyl ether/petroleum ether, 1:10) gave ethyl (2E)-3-(5’-
methoxy-2’-propargyloxyphen-yl)prop-2-enoate (239b) (0.225 g, 99%) as a 
colourless oil. Rf 0.60 (50% diethyl ether/petroleum ether); max/cm
−1 (neat) 3020 
(CH), 1701 (CO), 1633 (C=C), 1494, 1288, 1214, 1179, 1043, 752; δH (400 MHz, 
CDCl3) 1.34 (3H, t, J 7.1 Hz, OCH2CH3), 2.51 (1H, t, J 2.4 Hz, 4’’-H), 3.80 (3H, s, 
5’-OCH3), 4.27 (2H, q, J 7.1 Hz, OCH2CH3), 4.72 (2H, d, J 2.4 Hz, 2’’-H2), 6.48 
(1H, d, J 16.2 Hz, 2-H), 6.91 (1H, dd, J 9.0, 3.1 Hz, 4'-H), 7.01 (1H, d, J 9.0 Hz, 3'-
H), 7.06 (1H, d, J 3.1 Hz, 6'-H), 7.98 (1H, d, J 16.2 Hz, 3-H); δC (126 MHz, CDCl3) 
14.4 (CH3), 55.7 (CH3), 57.0 (CH2), 60.4 (CH2), 75.8 (CH), 78.5 (C), 112.9 (CH), 
114.7 (CH), 116.9 (CH), 119.3 (CH), 125.0 (C), 139.4 (CH), 150.5 (C), 154.3 (C), 
167.2 (C); m/z (ESI) 283.0932 (MNa+, C15H16NaO4 requires 283.0941), 271 (5%), 
244 (35). 
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Ethyl (2E)-3-(4’-methoxy-2’-propargyloxyphenyl)prop-2-enoate (239c)  
 
The reaction was carried out as described for the synthesis of ethyl (2E)-3-(2’-
propargyloxyphenyl)prop-2-enoate (239a) using 4-methoxy-2-
propargyloxybenzaldehyde (238c) (1.73 g, 9.07 mmol). Purification by column 
chromatography (diethyl ether/petroleum ether, 1:10) gave ethyl (2E)-3-(4’-
methoxy-2’-propargyloxyphen-yl)prop-2-noate (239c) (2.35 g, quantitative) as a 
colourless oil. Rf 0.46 (50% diethyl ether/petroleum ether); max/cm
−1 (neat) 2984 
(CH), 1704 (CO), 1605 (C=C), 1258, 1161, 1021, 970; δH (400 MHz, CDCl3) 1.32 
(3H, t, J 7.1 Hz, OCH2CH3), 2.54 (1H, t, J 2.5 Hz, 4’’-H), 3.83 (3H, s, 4’-OCH3), 
4.24 (2H, q, J 7.1 Hz, OCH2CH3), 4.75 (2H, d, J 2.5 Hz, 2’’-H2), 6.40 (1H, d, J 16.1 
Hz, 2-H), 6.54 (1H, dd, J 8.6, 2.4 Hz, 5'-H), 6.60 (1H, d, J 2.4 Hz, 3'-H), 7.46 (1H, 
d, J 8.6 Hz, 6'-H), 7.90 (1H, d, J 16.1 Hz, 3-H); δC (101 MHz, CDCl3) 14.4 (CH3), 
55.5 (CH3), 56.4 (CH2), 60.2 (CH2), 76.2 (CH), 78.0 (C), 99.9 (CH), 106.4 (CH), 
116.5 (CH), 117.1 (C), 130.2 (CH), 139.5 (CH), 157.6 (C), 162.4 (C), 167.7 (C); 
m/z (ESI) 283.0935 (MNa+, C15H16NaO4 requires 283.0941), 247 (100%). 
 
Ethyl (2E)-3-(5’-chloro-2’-propargyloxyphenyl)prop-2-enoate (239d)  
  
The reaction was carried out as described for the synthesis of ethyl (2E)-3-(2’-
propargyloxyphenyl)prop-2-enoate (239a) using 5-chloro-2-
propargyloxybenzaldehyde (238d) (0.120 g, 0.620 mmol). Purification by column 
chromatography (diethyl ether/petroleum ether, 1:10) gave ethyl (2E)-3-(5’-chloro-
2’-propargyloxyphen-yl)prop-2-enoate (239d) (0.163 g, quantitative) as a 
colourless oil. Rf 0.60 (50% diethyl ether/petroleum ether); max/cm
−1 (neat) 3020 
(CH), 1705 (CO), 1635 (C=C), 1480, 1216, 1181, 1024, 747; δH (400 MHz, CDCl3) 
1.33 (3H, t, J 7.1 Hz, OCH2CH3), 2.54 (1H, t, J 2.4 Hz, 4’’-H), 4.26 (2H, q, J 7.1 Hz, 
OCH2CH3), 4.76 (2H, d, J 2.4 Hz, 2’’-H2), 6.47 (1H, d, J 16.4 Hz, 2-H), 6.99 (1H, d, 
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J 8.9 Hz, 3'-H), 7.29 (1H, dd, J 8.9, 2.6 Hz, 4'-H), 7.49 (1H, d, J 2.6 Hz, 6'-H), 7.90 
(1H, d, J 16.4 Hz, 3-H); δC (101 MHz, CDCl3) 14.3 (CH3), 56.4 (CH2), 60.6 (CH2), 
76.4 (CH), 77.8 (C), 114.2 (CH), 120.4 (CH), 125.7 (C), 126.8 (C), 128.2 (CH), 
130.6 (CH), 138.1 (CH), 154.6 (C), 166.9 (C); m/z (ESI) 287.0434 (MNa+, 
C14H13
35ClNaO3 requires 287.0445), 247 (17%), 227 (10), 159 (3). 
 
Ethyl (2E)-3-(5’-nitro-2’-propargyloxyphenyl)prop-2-enoate (239e)  
  
The reaction was carried out as described for the synthesis of ethyl (2E)-3-(2’-
propargyloxyphenyl)prop-2-enoate (239a) using 5-nitro-2-
propargyloxybenzaldehyde (238e) (0.140 g, 0.680 mmol). Purification by column 
chromatography (diethyl ether/petroleum ether, 1:10) gave ethyl (2E)-3-(5’-nitro-2’-
propargyloxyphen-yl)prop-2-enoate (239e) (0.183 g, 98%) as a white solid. Mp 
95–96 °C; Rf 0.45 (50% diethyl ether/petroleum ether); max/cm
−1 (neat) 2986 (CH), 
1701 (CO), 1581 (C=C), 1514, 1343, 1270, 1233, 1016, 750; δH (400 MHz, CDCl3) 
1.34 (3H, t, J 7.1 Hz, OCH2CH3), 2.61 (1H, t, J 2.4 Hz, 4’’-H), 4.28 (2H, q, J 7.1 Hz, 
OCH2CH3), 4.90 (2H, d, J 2.4 Hz, 2’’-H2), 6.60 (1H, d, J 16.4 Hz, 2-H), 7.15 (1H, d, 
J 9.2 Hz, 3'-H), 7.93 (1H, d, J 16.4 Hz, 3-H), 8.25 (1H, dd, J 9.2, 2.8 Hz, 4'-H), 8.43 
(1H, d, J 2.8 Hz, 6'-H); δC (101 MHz, CDCl3) 14.3 (CH3), 56.7 (CH2), 60.8 (CH2), 
76.7 (CH), 77.4 (C), 112.5 (CH), 121.9 (CH), 124.0 (CH), 124.9 (C), 126.4 (CH), 
137.1 (CH), 142.0 (C), 160.2 (C), 166.5 (C); m/z (ESI) 298.0672 (MNa+, 
C14H13NNaO5 requires 298.0686), 247 (17%), 227 (22). 
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(2E)-3-(2’-Propargyloxyphenyl)prop-2-en-1-ol (240a)  
 
Diisobutylaluminium hydride (54.0 mL, 54.0 mmol, 1 M in hexane) was added 
dropwise with stirring to a solution of ethyl (2E)-3-(2’-propargyloxyphenyl)prop-2-
enoate (239a) (5.66 g, 24.6 mmol) in dichloromethane (100 mL) at −78 °C. The 
solution was stirred at −78 °C for 2 h, and then allowed to return to room 
temperature over 2 h. The reaction was quenched with 10% aqueous potassium 
sodium tartrate solution (10 mL), extracted with diethyl ether (2 × 50 mL), washed 
with water (100 mL), brine (100 mL), dried (MgSO4), filtered and concentrated in 
vacuo. Purification by column chromatography (diethyl ether/petroleum ether, 1:2) 
gave (2E)-3-(2’-propargyloxyphenyl)prop-2-en-1-ol (240a) (4.30 g, 93%) as a 
colourless oil. Rf 0.25 (50% diethyl ether/petroleum ether); max/cm
−1 (neat) 3304 
(OH), 2870 (CH), 1598 (C=C), 1487, 1217, 1024, 974, 748; δH (400 MHz, CDCl3) 
2.02 (1H, br s, OH), 2.51 (1H, t, J 2.4 Hz, 4’’-H), 4.30 (2H, br d, J 5.7 Hz, 1-H2), 
4.70 (2H, d, J 2.4 Hz, 2’’-H2), 6.36 (1H, dt, J 16.2, 5.7 Hz, 2-H), 6.92 (1H, d, J 16.2 
Hz, 3-H), 6.95–6.99 (2H, m, 3’-H and 5’-H), 7.19–7.24 (1H, m, 4’-H), 7.44 (1H, dd, 
J 8.0, 1.3 Hz, 6’-H); δC (101 MHz, CDCl3) 56.2 (CH2), 64.1 (CH2), 75.7 (CH), 78.7 
(C), 112.7 (CH), 121.7 (CH), 125.8 (CH), 126.5 (C), 127.1 (CH), 128.6 (CH), 129.7 
(CH), 154.7 (C); m/z (EI) 188.0838 (M+, C12H12O2 requires 188.0837), 149 (46%), 
131 (100), 121 (55), 91 (84), 77 (43), 65 (13). 
 
(2E)-3-(5’-Methoxy-2’-propargyloxyphenyl)prop-2-en-1-ol (240b)  
 
The reaction was carried out as described for the synthesis of (2E)-3-(2’-
propargyloxyphenyl)prop-2-en-1-ol (240a) using ethyl (2E)-3-(5’-methoxy-2’-
propargyloxyphenyl)prop-2-enoate (239b) (1.87 g, 7.17 mmol). Purification by 
column chromatography (diethyl ether/petroleum ether, 1:2) gave (2E)-3-(5’-
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methoxy-2’-propargyloxyphenyl)prop-2-en-1-ol (240b) (1.39 g, 89%) as a 
colourless oil. Rf 0.13 (50% diethyl ether/petroleum ether); max/cm
−1 (neat) 3288 
(OH), 2920 (CH), 1583 (C=C), 1492, 1286, 1202, 1041, 1021, 970, 803, 751; δH 
(400 MHz, CDCl3) 1.59 (1H, br s, OH), 2.50 (1H, t, J 2.4 Hz, 4’’-H), 3.79 (3H, s, 5’-
OCH3), 4.34 (2H, dd, J 5.8, 1.6 Hz, 1-H2), 4.67 (2H, d, J 2.4 Hz, 2’’-H), 6.37 (1H, 
dt, J 16.0, 5.8 Hz, 2-H), 6.78 (1H, dd, J 8.9, 3.1 Hz, 4'-H), 6.92 (1H, dt, J 16.0, 1.6 
Hz, 3-H), 6.95 (1H, d, J 8.9 Hz, 3'-H), 7.02 (1H, d, J 3.1 Hz, 6'-H); δC (101 MHz, 
CDCl3) 55.7 (CH3), 57.3 (CH2), 64.1 (CH2), 75.4 (CH), 78.9 (C), 112.1 (CH), 113.7 
(CH), 114.9 (CH), 125.7 (CH), 127.7 (C), 129.9 (CH), 149.2 (C), 154.5 (C); m/z 
(ESI) 241.0829 (MNa+. C13H14NaO3 requires 241.0835), 236 (7%), 227 (5), 218 
(4), 202 (100), 199 (6), 161 (3). 
 
(2E)-3-(4’-Methoxy-2’-propargyloxyphenyl)prop-2-en-1-ol (240c)  
    
The reaction was carried out as described for the synthesis of (2E)-3-(2’-
propargyloxyphenyl)prop-2-en-1-ol (240a) using ethyl (2E)-3-(4’-methoxy-2’-
propargyloxyphenyl)prop-2-enoate (239c) (2.48 g, 9.40 mmol). Purification by 
column chromatography (diethyl ether/petroleum ether, 1:2) gave (2E)-3-(4’-
methoxy-2’-propargyloxyphenyl)prop-2-en-1-ol (240c) (1.99 g, 92%) as a white 
solid. Mp 66–68 °C; Rf 0.16 (50% diethyl ether/petroleum ether); max/cm
−1 (neat) 
3302 (OH), 2929 (CH), 1608 (C=C), 1503, 1258, 1194, 1161, 750; δH (500 MHz, 
CDCl3) 1.86 (1H, br s, OH), 2.53 (1H, t, J 2.4 Hz, 4’’-H), 3.80 (3H, s, 4’-OCH3), 
4.28 (2H, dd, J 6.1, 1.1 Hz, 1-H2), 4.69 (2H, d, J 2.4 Hz, 2’’-H2), 6.26 (1H, dt, J 
16.0, 6.1 Hz, 2-H), 6.51 (1H, dd, J  8.5, 2.4 Hz, 5'-H), 6.56 (1H, d, J 2.4 Hz, 3'-H), 
6.82 (1H, br d, J 16.0 Hz, 3-H), 7.36 (1H, d, J 8.5 Hz, 6'-H); δC (126 MHz, CDCl3) 
55.4 (CH3), 56.3 (CH2), 64.3 (CH2), 75.8 (CH), 78.5 (C), 100.0 (CH), 106.2 (CH), 
119.3 (C), 125.8 (CH), 127.4, (CH), 127.9 (CH), 155.8 (C), 160.3 (C); m/z (ESI) 
241.0830 (MNa+, C13H14NaO3 requires 241.0835), 224 (3%), 213 (16), 202 (13), 
185 (3), 175 (4), 162 (4). 
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(2E)-3-(5’-Chloro-2’-propargyloxyphenyl)prop-2-en-1-ol (240d)  
   
The reaction was carried out as described for the synthesis of (2E)-3-(2’-
propargyloxyphenyl)prop-2-en-1-ol (240a) using ethyl (2E)-3-(5’-chloro-2’-
propargyloxyphenyl)prop-2-enoate (239d) (2.48 g, 9.40 mmol). Purification by 
column chromatography (diethyl ether/petroleum ether, 1:2) gave (2E)-3-(5’-
chloro-2’-propargyloxyphenyl)prop-2-en-1-ol (240d) (1.95 g, 93%) as a white solid. 
Mp 67–68 °C; Rf 0.25 (50% diethyl ether/petroleum ether); max/cm
−1 (neat) 3285 
(OH), 2929 (CH), 1480, 1222, 1025, 963, 795; δH (500 MHz, CDCl3) 2.20 (1H, br s, 
OH), 2.53 (1H, t, J 2.5 Hz, 4’’-H), 4.30 (2H, br d, J 5.4 Hz, 1-H2), 4.68 (2H, d, J 2.5 
Hz, 2’’-H2), 6.34 (1H, dt, J 16.1, 5.4 Hz, 2-H), 6.84 (1H, dt, J 16.1, 1.5 Hz, 3-H), 
6.89 (1H, d, J 8.9 Hz, 3'-H), 7.15 (1H, dd, J 8.9, 2.7 Hz, 4'-H), 7.39 (1H, d, J 2.7 
Hz, 6'-H); δC (126 MHz, CDCl3) 56.5 (CH2), 63.7 (CH2), 76.1 (CH), 78.2 (C), 114.0 
(CH), 124.3 (CH), 126.8 (CH), 126.8 (C), 128.0, (CH), 128.2 (C), 131.0 (CH), 
153.2 (C); m/z (ESI) 245.0333 (MNa+, C12H11
35ClNaO2 requires 245.0340), 236 
(35%), 227 (13), 218 (11), 205 (13), 170 (11), 141 (7). 
 
(2E)-3-(5’-Nitro-2’-propargyloxyphenyl)prop-2-en-1-ol (240e)  
   
The reaction was carried out as described for the synthesis of (2E)-3-(2’-
propargyloxyphenyl)prop-2-en-1-ol (240a) using ethyl (2E)-3-(5’-nitro-2’-
propargyloxyphenyl)prop-2-enoate (239e) (1.25 g, 4.54 mmol). Purification by 
column chromatography (diethyl ether/petroleum ether, 1:2) gave (2E)-3-(5’-nitro-
2’-propargyloxyphenyl)prop-2-en-1-ol (240e) (1.02 g, 96%) as a white solid. Mp 
92–93 °C; Rf 0.16 (50% diethyl ether/petroleum ether); max/cm
−1 (neat) 3299 
(OH), 2917 (CH), 1584 (C=C), 1514, 1343, 1230, 1011, 747; δH (400 MHz, CDCl3) 
1.56 (1H, t, J 5.6 Hz, OH), 2.59 (1H, t, J 2.4 Hz, 4’’-H), 4.39 (2H, td, J 5.6, 1.7 Hz, 
1-H2), 4.85 (2H, d, J 2.4 Hz, 2’’-H2), 6.51 (1H, dt, J 16.1, 5.6 Hz, 2-H), 6.92 (1H, dt, 
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J 16.1, 1.7 Hz, 3-H), 7.08 (1H, d, J 9.1 Hz, 3'-H), 8.15 (1H, dd, J 9.1, 2.8 Hz, 4'-H), 
8.36 (1H, d, J 2.8 Hz, 6'-H); δC (101 MHz, CDCl3) 56.5 (CH2), 63.6 (CH2), 76.9 (C), 
77.1 (CH), 112.0 (CH), 122.6 (CH), 123.3 (CH), 124.2 (CH), 127.4 (C), 132.6 (CH), 
142.1 (C), 159.0 (C); m/z (ESI) 256.0570 (MNa+, C12H11NNaO4 requires 
256.0580), 227 (27%), 185 (4), 159 (7). 
 
3-(2’-Propargyloxyphenyl)-3-(2”,2’’,2’’-trichloromethylcarbonylamino)prop-1-
ene (241a) 
 
(2E)-3-(2’-Propargyloxyphenyl)prop-2-en-1-ol (240a) (0.200 g, 1.06 mmol) was 
dissolved in dichloromethane (16 mL) and cooled to 0 °C under argon with stirring. 
Trichloroacetonitrile (0.160 mL, 1.60 mmol) was added to the solution, followed by 
1,8-diazabicyclo[5.4.0]undec-7-ene (0.080 mL, 0.540 mmol) and the reaction 
mixture was allowed to warm to room temperature over 2 h. The reaction mixture 
was filtered through a short pad of alumina (neutral, Brockman V) with diethyl 
ether (150 mL) and concentrated in vacuo to yield the crude allylic 
trichloroacetimidate as a yellow oil which was used without further purification. The 
allylic trichloroacetimidate was transferred to a dry Schlenk tube containing a 
stirrer bar and potassium carbonate (15 mg, 3 mg/mL) to which p-xylene (5 mL) 
was then added. The tube was purged with argon, sealed and heated to 140 °C for 
18 h. The reaction mixture was concentrated in vacuo and purified by column 
chromatography (diethyl ether/petroleum ether, 1:20) to give 3-(2’-
propargyloxyphenyl)-3-(2’’,2’’,2’’-trichloromethylcarbonylamino)prop-1-ene (241a) 
(0.331 g, 97%) as a white solid. Mp 46–48 °C; Rf 0.72 (50% diethyl 
ether/petroleum ether); max/cm
−1 (neat) 3410 (NH), 3297 (CH), 1707 (CO), 1502, 
1489, 1223, 1020, 818, 751; δH (500 MHz, CDCl3) 2.53 (1H, t, J 2.4 Hz, 4’’’-H), 
4.77 (2H, d, J 2.4 Hz, 2’’’-H2), 5.16–5.26 (2H, m, 1-H2), 5.56–5.65 (1H, m, 3-H), 
6.06 (1H, ddd, J 17.1, 10.3, 5.4 Hz, 2-H), 6.98–7.07 (2H, m, 3'-H and 4’-H), 7.27 
(1H, dd, J 7.7, 1.6 Hz, 6'-H), 7.30–7.37 (1H, m, 5'-H), 7.93 (1H, br d, J 7.9 Hz, 
NH); δC (101 MHz, CDCl3) 56.0 (CH), 56.0 (CH2), 76.2 (CH), 77.8 (C), 92.9 (C), 
209 
 
112.6 (CH), 116.1 (CH2), 122.1 (CH), 127.1 (C), 129.5 (CH), 129.7 (CH), 135.8 
(CH), 155.1 (C), 160.8 (C); m/z (ESI) 330.9937 (M+, C14H12
35Cl3NO2 requires 
330.9934), 296 (90%), 260 (22), 186 (29), 171 (41), 131 (100), 114 (61), 103 (68), 
77 (75).
 
3-(5’-Methoxy-2’-propargyloxyphenyl)-3-(2’’,2’’,2’’-trichloromethylcarbonyl-
amino)prop-1-ene (241b) 
 
The reaction was carried out as described for the synthesis of 3-(2’-
propargyloxyphenyl)-3-(2’’,2’’,2’’-trichloromethylcarbonylamino)prop-1-ene (241a) 
using (2E)-3-(5’-methoxy-2’-propargyloxyphenyl)prop-2-en-1-ol (240b) (0.302 g, 
1.38 mmol). Flash column chromatography (diethyl ether/petroleum ether, 1:10) 
gave 3-(5’-methoxy-2’-propargyloxyphenyl)-3-(2’’,2’’,2’’-
trichloromethylcarbonylamino)prop-1-ene (241b) (0.441 g, 88%) as a yellow oil. Rf 
0.43 (50% diethyl ether/petroleum ether); max/cm
−1 (neat) 3404 (NH), 3298, 2917 
(CH), 1707 (CO), 1493, 1205, 1041, 817, 709; δH (400 MHz, CDCl3) 2.52 (1H, t, J 
2.4 Hz, 4’’’-H), 3.78 (3H, s, OCH3), 4.71 (2H, d, J 2.4 Hz, 2’’’-H2), 5.15–5.30 (2H, 
m, 1-H2), 5.52–5.61 (1H, m, 3-H), 6.04 (1H, ddd, J 17.1, 10.3, 5.4 Hz, 2-H), 6.78–
6.87 (2H, m, 4’-H and 3'-H), 6.92–6.99 (1H, m, 6'-H), 7.95 (1H, br d, J 8.4 Hz, NH); 
δC (101 MHz, CDCl3) 55.7 (CH3), 56.0 (CH), 56.7 (CH2), 76.0 (CH), 78.1 (C), 92.9 
(C), 113.7 (CH), 114.1 (CH), 115.5 (CH), 116.2 (CH2), 128.2 (C), 135.7 (CH), 
149.1 (C), 154.6 (C), 160.9 (C); m/z (CI) 362.0116 (MH+, C15H15
35Cl3NO3 requires 
362.0118), 328 (42%), 292 (10), 236 (11), 201 (100), 163 (5). 
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3-(4’-Methoxy-2’-propargyloxyphenyl)-3-(2’’,2’’,2’’-trichloromethylcarbonyl-
amino)prop-1-ene (241c) 
   
The reaction was carried out as described for the synthesis of 3-(2’-
propargyloxyphenyl)-3-(2’’,2’’,2’’-trichloromethylcarbonylamino)prop-1-ene (241a) 
using (2E)-3-(4’-methoxy-2’-propargyloxyphenyl)prop-2-en-1-ol (240c) (0.100 g, 
0.459 mmol). Flash column chromatography (diethyl ether/petroleum ether, 1:10) 
gave 3-(4’-methoxy-2’-propargyloxyphenyl)-3-(2’’,2’’,2’’-
trichloromethylcarbonylamino)prop-1-ene (241c) (0.142 g, 84%) as a yellow oil. Rf 
0.46 (50% diethyl ether/petroleum ether); max/cm
−1 (neat) 3416 (NH), 3305, 3018 
(CH), 1709 (CO), 1614, 1500, 1197, 1162, 1025, 820, 751; δH (400 MHz, CDCl3) 
2.54 (1H, t, J 2.4 Hz, 4’’’-H), 3.81 (3H, s, OCH3), 4.73 (2H, d, J 2.4 Hz, 2’’’-H2), 
5.17–5.22 (2H, m, 1-H2), 5.52–5.59 (1H, m, 3-H), 6.04 (1H, ddd, J 17.0, 10.4, 5.3 
Hz, 2-H), 6.53 (1H, dd, J 8.4, 2.4 Hz, 5'-H), 6.60 (1H, d, J 2.4 Hz, 3'-H), 7.17 (1H, 
d, J 8.4 Hz, 6'-H), 7.80 (1H, br d, J 8.3 Hz, NH); δC (101 MHz, CDCl3) 55.4 (CH3), 
55.5 (CH), 56.1 (CH2), 76.3 (CH), 77.7 (C), 93.0 (C), 100.6 (CH), 105.6 (CH), 
115.8 (CH2), 119.5 (C), 130.3 (CH), 136.1 (CH), 156.1 (C), 160.8 (C), 160.8 (C); 
m/z (ESI) 383.9914 (MNa+, C15H14
35Cl3NNaO3 requires 383.9931), 201 (18%). 
 
3-(5’-Chloro-2’-propargyloxyphenyl)-3-(2’’,2’’,2’’-trichloromethylcarbonyl-
amino)prop-1-ene (241d)  
 
The reaction was carried out as described for the synthesis of 3-(2’-
propargyloxyphenyl)-3-(2’’,2’’,2’’-trichloromethylcarbonylamino)prop-1-ene (241a) 
using (2E)-3-(5’-chloro-2’-propargyloxyphenyl)prop-2-en-1-ol (240d) (0.10 g, 0.45 
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mmol). The Overman rearrangement was heated to 140 °C for 48 h. Flash column 
chromatography (diethyl ether/petroleum ether, 1:10) gave 3-(5’-chloro-2’-
propargyloxyphenyl)-3-(2’’,2’’,2’’-trichloromethylcarbonylamino)prop-1-ene (241d) 
(0.161 g, 98%) as a white solid. Mp 64–66 °C; Rf 0.56 (50% diethyl 
ether/petroleum ether); max/cm
−1 (neat) 3422 (NH), 3306, 2931 (CH), 1713 (CO), 
1504, 1486, 1215, 1022, 749; δH (400 MHz, CDCl3) 2.54 (1H, t, J 2.2 Hz, 4’’’-H), 
4.75 (2H, d, J 2.2 Hz, 2’’’-H2), 5.15–5.35 (2H, m, 1-H2), 5.55–5.65 (1H, m, 3-H), 
6.03 (1H, ddd, J 17.0, 10.4, 5.3 Hz, 2-H), 6.96 (1H, d, J 8.6 Hz, 3'-H), 7.20–7.40 
(2H, m, 4'-H and 6'-H), 7.70 (1H, br d, J 8.3 Hz, NH); δC (101 MHz, CDCl3) 55.1 
(CH), 56.4 (CH2), 76.6 (CH), 77.3 (C), 92.8 (C), 113.9 (CH), 116.8 (CH2), 127.1 
(C), 128.9 (C), 129.1 (CH), 129.5 (CH), 135.0 (CH), 153.6 (C), 160.9 (C); m/z 
(ESI) 387.9424 (MNa+, C14H11
35Cl4NNaO2 requires 387.9436), 381 (14%), 353 
(11), 236 (4), 227 (6), 205 (4). 
 
3-(5’-Nitro-2’-propargyloxyphenyl)-3-(2’’,2’’,2’’-trichloromethylcarbonyl-
amino)prop-1-ene (241e) 
  
The reaction was carried out as described for the synthesis of 3-(2’-
propargyloxyphenyl)-3-(2’’,2’’,2’’-trichloromethylcarbonylamino)prop-1-ene (241a) 
using (2E)-3-(5’-nitro-2’-propargyloxyphenyl)prop-2-en-1-ol (240e) (0.100 g, 0.429 
mmol). The Overman rearrangement was heated to 140 °C for 72 h. Flash column 
chromatography (diethyl ether/petroleum ether, 1:10) gave 3-(5’-nitro-2’-
propargyloxyphenyl)-3-(2’’,2’’,2’’-trichloromethylcarbonylamino)prop-1-ene (241e) 
(0.155 g, 96%) as a white crystalline solid. Mp 140–142 °C; Rf 0.3 (50% diethyl 
ether/petroleum ether); max/cm
−1 (neat) 3422 (NH), 3305, 2926 (CH), 1708 (CO), 
1516, 1343, 1263, 1010, 821, 751; δH (400 MHz, CDCl3) 2.62 (1H, t, J 2.3 Hz, 4’’’-
H), 4.89 (2H, d, J 2.3 Hz, 2’’’-H2), 5.29 (1H, d, J 17.1 Hz, 1-HH), 5.33 (1H, d, J 10.3 
Hz, 1-HH), 5.70–5.85 (1H, m, 3-H), 6.06 (1H, ddd, J 17.1, 10.3, 5.4 Hz, 2-H), 7.15 
(1H, d, J 9.0 Hz, 3'-H), 7.51 (1H, br d, J 8.3 Hz, NH), 8.21 (1H, d, J 2.7 Hz, 6'-H), 
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8.25 (1H, dd, J 9.0, 2.7 Hz, 4'-H); δC (101 MHz, CDCl3) 54.1 (CH), 56.8 (CH2), 76.5 
(CH), 77.4 (C), 92.5 (C), 112.5 (CH), 117.9 (CH2), 124.7 (CH), 125.6 (CH), 128.6 
(C), 134.2 (CH), 142.1 (C), 159.7 (C), 161.0 (C); m/z (ESI) 398.9662 (MNa+, 
C14H11
35Cl3N2NaO4 requires 398.9677). 
 
8-[1’-(2”,2”,2”-Trichloromethylcarbonylamino)-2’-propenyl]-2H-chromene 
(242a)  
 
3-(2’-Propargyloxyphenyl)-3-(2’’,2’’,2’’-trichloromethylcarbonylamino)prop-1-ene 
(241a) (0.820 g, 2.48 mmol) was dissolved in p-xylene (10 mL) under argon 
followed by [bis(trifluoromethanesulfonyl)imidate](triphenylphosphine)gold(I) (2:1) 
toluene adduct (245) (0.097 g, 0.062 mmol) and the reaction was heated to 80 °C 
for 4 h. The reaction mixture was concentrated in vacuo and purified by column 
chromatography (diethyl ether/petroleum ether, 1:15) to give 8-[1’-(2”,2”,2”-
trichloromethylcarbonylamino)-2’-propenyl]-2H-chromene (242a) (0.820 g, 
quantitative) as a colourless oil. Rf 0.67 (50% diethyl ether/petroleum ether); 
max/cm
−1 (neat) 3418 (NH), 2930 (CH), 1707 (CO), 1700, 1507, 1215, 821, 747; 
δH (500 MHz, CDCl3) 4.86 (2H, dd, J 3.6, 1.9 Hz, 2-H2), 5.18–5.24 (2H, m, 3'-H2), 
5.55 (1H, ddt, J 8.2, 5.4, 1.7 Hz, 1'-H), 5.82 (1H, dt, J 9.9, 3.6 Hz, 3-H), 6.03 (1H, 
ddd, J 17.1, 10.4, 5.4 Hz, 2'-H), 6.45 (1H, dt, J 9.9, 1.9 Hz, 4-H), 6.88 (1H, t, J 7.6 
Hz, 6-H), 6.96 (1H, dd, J 7.6, 1.7 Hz, ArH), 7.06 (1H, dd, J 7.6, 1.7 Hz, ArH), 7.94 
(1H, br d, J 8.2 Hz, NH); δC (126 MHz, CDCl3) 55.4 (CH), 65.7 (CH2), 93.0 (C), 
116.0 (CH2), 121.8 (CH), 122.0 (CH), 123.1 (C), 124.5 (CH), 125.3 (C), 126.8 
(CH), 128.9 (CH), 135.9 (CH), 151.4 (C), 160.8 (C); m/z (EI) 330.9939 (M+, 
C14H12
35Cl3NO2 requires 330.9934), 296 (47%), 260 (22), 224 (10), 196 (7), 170 
(100), 128 (35), 115 (30), 77 (10). 
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6-Methoxy-8-[1’-(2”,2”,2”-trichloromethylcarbonylamino)-2’-propenyl]-2H-
chromene (242b)  
 
The reaction was carried out as described for the synthesis of 8-[1’-(2”,2”,2”-
trichloromethylcarbonylamino)-2’-propenyl]-2H-chromene (242a) using 3-(5’-
methoxy-2’-propargyloxyphenyl)-3-(2’’,2’’,2’’-trichloromethylcarbonylamino)prop-1-
ene (241b) (0.060 g, 0.165 mmol). Purification by column chromatography (diethyl 
ether/petroleum ether, 1:15) gave 6-methoxy-8-[1’-(2”,2”,2”-
trichloromethylcarbonylamino)-2’-propenyl]-2H-chromene (242b) (0.060 g, 
quantitative) as a colourless oil. Rf 0.6 (50% diethyl ether/petroleum ether); 
max/cm
−1 (neat) 3404 (NH), 2955 (CH), 1708 (CO), 1503, 1472, 1203, 818; δH 
(400 MHz, CDCl3) 3.75 (3H, s, 6-OCH3), 4.78 (2H, dd, J 3.6, 1.9 Hz, 2-H2), 5.18–
5.24 (2H, m, 3'-H2), 5.49 (1H, ddt, J 8.6, 5.4, 1.6 Hz, 1'-H), 5.86 (1H, dt, J 9.9, 3.6 
Hz, 3-H), 6.01 (1H, ddd, J 17.1, 10.3, 5.4 Hz, 2'-H), 6.41 (1H, dt, J 9.9, 1.9 Hz, 4-
H), 6.53 (1H, d, J 2.9 Hz, 5-H), 6.62 (1H, d, J 2.9 Hz, 7-H), 8.01 (1H, br d, J 8.6 
Hz, NH); δC (101 MHz, CDCl3) 55.7 (CH3), 55.7 (CH), 65.5 (CH2), 92.9 (C), 111.9 
(CH), 113.9 (CH), 116.1 (CH2), 123.1 (CH), 124.1 (C), 124.6 (CH), 126.0 (C), 
135.7 (CH), 145.1 (C), 154.2 (C), 160.8 (C); m/z (CI) 362.0113 (MH+, 
C15H15
35Cl3NO3 requires 362.0118), 328 (5%), 290 (4), 243 (4), 201 (100), 85 (4). 
 
 
5-Methoxy-8-[1’-(2”,2”,2”-trichloromethylcarbonylamino)-2’-propenyl]-2H-
chromene (242c)  
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The reaction was carried out as described for the synthesis of 8-[1’-(2”,2”,2”-
trichloromethylcarbonylamino)-2’-propenyl]-2H-chromene (242a) using 3-(4’-
methoxy-2’-propargyloxyphenyl)-3-(2’’,2’’,2’’-trichloromethylcarbonyl-amino)prop-1-
ene (241c) (0.025 g, 0.070 mmol). Purification by column chromatography (diethyl 
ether/petroleum ether, 1:15) gave 5-methoxy-8-[1’-(2”,2”,2”-
trichloromethylcarbonylamino)-2’-propenyl]-2H-chromene (242c) (0.025 g, 99%) 
as a colourless oil. Rf 0.53 (50% diethyl ether/petroleum ether); max/cm
−1 (neat) 
3421 (NH), 2928 (CH), 1707 (CO), 1492, 1215, 1109, 821, 747; δH (400 MHz, 
CDCl3) 3.82 (3H, s, 5-OCH3), 4.78 (2H, dd, J 3.6, 1.6 Hz, 2-H2), 5.16–5.22 (2H, m, 
3'-H2), 5.49 (1H, ddt, J 8.4, 5.3, 1.6 Hz, 1'-H), 5.77 (1H, dt, J 10.0, 3.6 Hz, 3-H), 
6.02 (1H, ddd, J 17.0, 10.4, 5.3 Hz, 2'-H), 6.44 (1H, d, J 8.6 Hz, 6-H), 6.77 (1H, dt, 
J 10.0, 1.6 Hz, 4-H), 7.02 (1H, d, J 8.6 Hz, 7-H), 7.86 (1H, br d, J 8.4 Hz, NH); δC 
(101 MHz, CDCl3) 55.3 (CH3), 55.7 (CH), 65.2 (CH2), 93.0 (C), 103.8 (CH), 112.5 
(C), 115.7 (CH2), 118.2 (C), 119.4 (CH), 119.9 (CH), 129.0 (CH), 136.2 (CH), 
152.1 (C), 155.3 (C), 160.7 (C); m/z (ESI) 383.9916 (MNa+, C15H14
35Cl3NNaO3 
requires 383.9931). 
 
6-Chloro-8-[1’-(2”,2”,2”-trichloromethylcarbonylamino)-2’-propenyl]-2H-
chromene (242d)  
  
The reaction was carried out as described for the synthesis of 8-[1’-(2”,2”,2”-
trichloromethylcarbonylamino)-2’-propenyl]-2H-chromene (242a) using 3-(5’-
chloro-2’-propargyloxyphenyl)-3-(2’’,2’’,2’’-trichloromethylcarbonyl-amino)prop-1-
ene (241d) (0.062 g, 0.169 mmol). Purification by column chromatography (diethyl 
ether/petroleum ether, 1:10) gave 6-chloro-8-[1’-(2”,2”,2”-
trichloromethylcarbonylamino)-2’-propenyl]-2H-chromene (242d) (0.061 mg, 98%) 
as a white solid. Mp 62–64 °C; Rf 0.68 (50% diethyl ether/petroleum ether); 
max/cm
−1 (neat) 3418 (NH), 2927 (CH), 1713 (CO), 1504, 1466, 1214, 821, 748; 
δH (400 MHz, CDCl3) 4.86 (2H, dd, J 3.6, 1.9 Hz, 2-H2), 5.20–5.26 (2H, m, 3'-H2), 
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5.52 (1H, ddt, J 8.6, 5.3, 1.6 Hz, 1'-H), 5.86 (1H, dt, J 9.9, 3.6 Hz, 3-H), 6.00 (1H, 
ddd, J 17.0, 10.4, 5.3 Hz, 2'-H), 6.38 (1H, dt, J 9.9, 1.9 Hz, 4-H), 6.94 (1H, d, J 2.5 
Hz, 5-H), 7.04 (1H, d, J 2.5 Hz, 7-H), 7.72 (1H, br d, J 8.6 Hz, NH); δC (101 MHz, 
CDCl3) 54.6 (CH), 65.9 (CH2), 92.8 (C), 116.7 (CH2), 123.4 (CH), 123.6 (CH), 
124.4 (C), 126.3 (CH), 126.5 (C), 127.0 (C), 128.2 (CH), 135.1 (CH), 149.9 (C), 
160.8 (C); m/z (ESI) 387.9419 (MNa+, C14H11
35Cl4NNaO2 requires 387.9436), 381 
(33%), 353 (33), 236 (9). 
 
6-Nitro-8-[1’-(2”,2”,2”-trichloromethylcarbonylamino)-2’-propenyl]-2H-
chromene (242e)  
 
The reaction was carried out as described for the synthesis of 8-[1’-(2”,2”,2”-
trichloromethylcarbonylamino)-2’-propenyl]-2H-chromene (242a) using 3-(5’-nitro-
2’-propargyloxyphenyl)-3-(2’’,2’’,2’’-trichloromethylcarbonyl-amino)prop-1-ene 
(241e) (0.150 g, 0.400 mmol). Purification by column chromatography (diethyl 
ether/petroleum ether, 1:10) gave 6-nitro-8-[1’-(2”,2”,2”-
trichloromethylcarbonylamino)-2’-propenyl]-2H-chromene (242e) (0.098 mg, 66%) 
as a yellow solid. Mp 138–140 °C; Rf 0.48 (50% diethyl ether/petroleum ether); 
max/cm
−1 (neat) 3418 (NH), 2924 (CH), 1710 (CO), 1518, 1338, 1216, 837, 754; 
δH (500 MHz, CDCl3) 5.05 (2H, dd, J 3.4, 2.0 Hz, 2-H2), 5.28 (1H, dd, J 17.2, 1.7 
Hz, 3'-HH), 5.33 (1H, dd, J 10.4, 1.7 Hz, 3'-HH), 5.68 (1H, ddt, J 8.3, 5.4, 1.7 Hz, 
1'-H), 5.93 (1H, dt, J 10.1, 3.4 Hz, 3-H), 6.03 (1H, ddd, J 17.2, 10.4, 5.4 Hz, 2'-H), 
6.47 (1H, dt, J 10.1, 2.0 Hz, 4-H), 7.41 (1H, br d, J 8.3 Hz, NH), 7.83 (1H, d, J 2.7 
Hz, ArH), 8.00 (1H, d, J 2.7 Hz, ArH); δC (126 MHz, CDCl3) 53.5 (CH), 67.1 (CH2), 
92.5 (C), 117.7 (CH2), 122.0 (CH), 122.6 (C), 123.0 (CH), 123.8 (CH), 124.1 (CH), 
126.5 (C), 134.3 (CH), 141.7 (C), 156.6 (C), 160.9 (C); m/z (ESI) 398.9665 (MNa+, 
C14H11
35Cl3N2NaO4 requires 398.9677). 
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8-[1’-(2”,2”,2”-Trichloromethylcarbonylamino)-2’-propenyl]-2H-chromene 
(242a)  
 
(2E)-3-(2’-Propargyloxyphenyl)prop-2-en-1-ol (240a) (0.050 g, 0.27 mmol) was 
dissolved in dichloromethane (4.0 mL) and cooled to 0 °C under argon with stirring. 
Trichloroacetonitrile (0.040 mL, 0.040 mmol) was added to the solution, followed 
by 1,8-diazabicyclo[5.4.0]undec-7-ene (0.020 mL, 0.130 mmol) and the reaction 
was allowed to warm to room temperature over 2 h. The reaction mixture was 
filtered through a short pad of alumina (neutral, Brockman V) with diethyl ether 
(100 mL) and concentrated in vacuo to yield the crude allylic trichloroacetimidate 
as a yellow oil which was used without further purification. The allylic 
trichloroacetimidate was transferred to a dry Schlenk tube containing a stirrer bar 
and potassium carbonate (12 mg, 3 mg/mL) to which p-xylene (4 mL) was then 
added. The tube was purged with argon, sealed and heated to 140 °C for 18 h. 
The reaction mixture was allowed to cool to room temperature and 
chloro(triphenylphosphine)gold(I) (243) (0.0040 g, 0.0070 mmol) and silver(I) 
hexafluoroantimonate (244) (0.0020 g, 0.0070 mmol) were added. The reaction 
mixture was heated to 80 °C for 4 h. The reaction mixture was concentrated in 
vacuo and purified by column chromatography (diethyl ether/petroleum ether, 
1:15) to give 8-[’-(2”,2”,2”-trichloromethylcarbonylamino)-2’-propenyl]-2H-
chromene (242a) (0.069 g, 80%) as a colourless oil. Spectroscopic data was as 
described above. 
 
 
 
 
 
 
 
217 
 
6-Methoxy-8-[1’-(2”,2”,2”-trichloromethylcarbonylamino)-2’-propenyl]-2H-
chromene (242b)  
 
The reaction was carried out as described for the synthesis of 8-[1’-(2”,2”,2”-
trichloromethylcarbonylamino)-2’-propenyl]-2H-chromene (242a) using (2E)-3-(5’-
methoxy-2’-propargyloxyphenyl)prop-2-en-1-ol (240b) (0.100 g, 0.460 mmol), 
chloro(triphenylphosphine)gold(I) (243) (0.017 g, 0.035 mmol) and silver(I) 
hexafluoroantimonate (244) (0.008 g, 0.035 mmol). The hydroarylation step was 
heated to 80 °C for 48 h. Purification by column chromatography (diethyl 
ether/petroleum ether, 1:15) gave 6-methoxy-8-[1’-(2”,2”,2”-
trichloromethylcarbonylamino)-2’-pro-penyl]-2H-chromene (242b) (0.152 g, 91%) 
as a colourless oil. Spectroscopic data was as described above. 
 
5-Methoxy-8-[1’-(2”,2”,2”-trichloromethylcarbonylamino)-2’-propenyl]-2H-
chromene (242c) 
 
The reaction was carried out as described for the synthesis of 8-[1’-(2”,2”,2”-
trichloromethylcarbonylamino)-2’-propenyl]-2H-chromene (242a) using (2E)-3-(4’-
methoxy-2’-propargyloxyphenyl)prop-2-en-1-ol (240c) (0.100 g, 0.460 mmol), 
chloro(triphenylphosphine)gold(I) (243) (0.017 g, 0.035 mmol) and silver(I) 
hexafluoroantimonate (244) (0.008 g, 0.035 mmol). The hydroarylation step was 
heated to 80 °C for 48 h. Purification by column chromatography (diethyl 
ether/petroleum ether, 1:15) gave 5-methoxy-8-[1’-(2”,2”,2”-trichloromethylcarbon-
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ylamino)-2’-propenyl]-2H-chromene (242c) (0.129 g, 78%) as a colourless oil. 
Spectroscopic data was as described above. 
 
6-Chloro-8-[1’-(2”,2”,2”-trichloromethylcarbonylamino)-2’-propenyl]-2H-
chromene (242d)  
  
The reaction was carried out as described for the synthesis of 8-[1’-(2”,2”,2”-
trichloromethylcarbonylamino)-2’-propenyl]-2H-chromene (242a) using (2E)-3-(5’-
chloro-2’-propargyloxyphenyl)prop-2-en-1-ol (240d) (0.105 g, 0.472 mmol), 
chloro(triphenylphosphine)gold(I) (243) (0.018 g, 0.035 mmol) and silver(I) 
hexafluoroantimonate (244) (0.009 g, 0.035 mmol). The Overman rearrangement 
was heated to 140 °C for 48 h. The hydroarylation step was heated to 80 °C for 48 
h. Purification by column chromatography (diethyl ether/petroleum ether, 1:15) 
gave 6-chloro-8-[1’-(2”,2”,2”-trichloromethylcarbonylamino)-2’-propenyl]-2H-
chromene (242d) (0.131 g, 76%) as a white solid. Spectroscopic data was as 
described above. 
 
6-Nitro-8-[1’-(2”,2”,2”-trichloromethylcarbonylamino)-2’-propenyl]-2H-
chromene (242e)  
 
The reaction was carried out as described for the synthesis of 8-[1’-(2”,2”,2”-
trichloromethylcarbonylamino)-2’-propenyl]-2H-chromene (242a) using (2E)-3-(5’-
nitro-2’-propargyloxyphenyl)prop-2-en-1-ol (240e) (0.085 g, 0.364 mmol), 
chloro(tri-phenylphosphine)gold(I) (243) (0.018 g, 0.036 mmol) and silver(I) 
hexafluoro-antimonate (244) (0.009 g, 0.036 mmol). The Overman rearrangement 
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was heated to 140 °C for 72 h. The isomerisation step was heated to 80 °C for 65 
h. Purification by column chromatography (diethyl ether/petroleum ether, 1:10) 
gave 6-nitro-8-[1’-(2”,2”,2”-trichloromethylcarbonylamino)-2’-propenyl]-2H-
chromene (242e) (0.074 g, 54%) as a white solid. Spectroscopic data was as 
described above. 
 
8-[1’-(2”,2”,2”-Trichloromethylcarbonylamino)-2’-propenyl]-2H-chromene 
(242a)  
 
(2E)-3-(2’-Propargyloxyphenyl)prop-2-en-1-ol (240a) (0.050 g, 0.27 mmol) was 
dissolved in dichloromethane (4 mL) and cooled to 0 °C under argon with stirring. 
Trichloroacetonitrile (0.040 mL, 0.040 mmol) was added to the solution, followed 
by 1,8-diazabicyclo[5.4.0]undec-7-ene (0.020 mL, 0.13 mmol) and the reaction 
was allowed to warm to room temperature over 2 h. The reaction mixture was 
filtered through a short pad of alumina (neutral, Brockman V) with diethyl ether 
(100 mL) and concentrated in vacuo to yield the crude allylic trichloroacetimidate 
as a yellow oil, which was used without further purification. The allylic 
trichloroacetimidate was transferred to a dry Schlenk tube containing a stirrer bar 
and bis(acetonitrile)palladium(II) chloride (0.0070 g, 0.027 mmol) to which toluene 
(4 mL) was then added. The tube was purged with argon, sealed and heated to 80 
°C for 16 h. The reaction mixture was allowed to cool to room temperature and 
chloro(triphenylphosphine)gold(I) (243) (0.0040 g, 0.0070 mmol) and silver(I) 
hexafluoroantimonate (244) (0.0020 g, 0.0070 mmol) were added. The reaction 
mixture was heated to 80 °C for 4 h. The reaction mixture was cooled to room 
temperature, concentrated in vacuo and purified by column chromatography 
(diethyl ether/petroleum ether, 1:15) to give 8-[1’-(2”,2”,2”-
trichloromethylcarbonylamino)-2’-propenyl]-2H-chromene (242a) (0.048 g, 56%) 
as a colourless oil. Spectroscopic data was as described above. 
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8-[1’-(2”,2”,2”-Trichloromethylcarbonylamino)-2’-propenyl]-2H-chrom-2-one 
(251a)  
 
Pyridinium dichromate (0.070 g, 0.186 mmol) was added to a stirred solution of 8-
[1’-(2”,2”,2”-trichloromethylcarbonylamino)-2’-propenyl]-2H-chromene (242a) 
(0.030 g, 0.090 mmol) in dichloromethane (1 mL) and stirred at room temperature 
for 6 days. The reaction mixture was concentrated in vacuo and purified by column 
chromatography (diethyl ether/petroleum ether, 1:1) to give 8-[1’-(2”,2”,2”-
trichloromethylcarbonylamino)-2’-propenyl]-2H-chrom-2-one (251a) (0.020 g, 65%) 
as a white solid. Mp 136–138 °C; Rf 0.13 (50% diethyl ether/petroleum ether); 
max/cm
−1 (neat) 3424 (NH), 2926 (CH), 1711 (CO), 1604, 1505, 1117, 907, 833, 
726; δH (400 MHz, CDCl3) 5.23–5.34 (2H, m, 3'-H2), 5.83 (1H, ddt, J 8.4, 5.7, 1.6 
Hz, 1'-H), 6.16 (1H, ddd, J 17.1, 10.3, 5.7 Hz, 2'-H), 6.44 (1H, d, J 9.6 Hz, 3-H), 
7.29 (1H, t, J 7.7 Hz, 6-H), 7.46 (1H, dd, J 7.7, 1.6 Hz, ArH), 7.52 (1H, dd, J 7.7, 
1.6 Hz, ArH), 7.73 (1H, d, J 9.6 Hz, 4-H), 7.80 (1H, br d, J 8.4 Hz, NH); δC (101 
MHz, CDCl3) 54.9 (CH), 92.5 (C), 116.8 (CH), 117.9 (CH2), 119.4 (C), 124.6 (CH), 
126.6 (C), 128.2 (CH), 131.4 (CH), 134.6 (CH), 143.7 (CH), 151.8 (C), 159.2 (C), 
161.1 (C); m/z (ESI) 367.9606 (MNa+, C14H10
35Cl3NNaO3 requires 367.9618). 
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(Z)-8-Methoxy-5-(2’,2’,2’-trichloromethylcarbonylamino)-3-vinyl-2,5-dihydro-
1-benzoxepine (253) 
 
 
3-(4’-Methoxy-2’-propargyloxyphenyl)-3-(2’,2’,2’-
trichloromethylcarbonylamino)prop-1-ene (241c) (0.030  g, 0.090 mmol) was 
dissolved in p-xylene (1.5 mL) and Grubbs first-generation catalyst (0.006 g, 0.007 
mmol) was added and the reaction mixture was heated for 24 h at 50 °C. A further 
portion of Grubbs 1st generation catalyst (0.0020 g, 0.0020 mmol) was added and 
the reaction mixture was stirred at 50 °C for 48 h. The reaction mixture was 
concentrated in vacuo and purified by column chromatography (diethyl 
ether/petroleum ether, 1:10) gave (Z)-8-methoxy-5-(2’,2’,2’-
trichloromethylcarbonylamino)-3-vinyl-2,5-dihydro-1-benzoxepine (253) (0.0060 g, 
18%) as a colourless oil. Rf 0.57 (50% diethyl ether/petroleum ether); δH (400 
MHz, CDCl3) 3.80 (3H, s, OCH3), 4.57 (1H, dd, J 16.4, 1.8 Hz, 2-HH), 5.04 (1H, d, 
J 16.4 Hz, 2-HH), 5.07 (2H, m, 2’’-H2), 5.42 (1H, t, J 8.3 Hz, 5-H), 6.10 (1H, br d, J 
8.3 Hz, 4-H), 6.24 (1H, dd, J 18.0, 11.3 Hz, 1’’-H), 6.65 (1H, dd, J 8.3, 2.5 Hz, 7-
H), 6.72 (1H, d, J 2.5 Hz, 9-H), 7.20 (1H, d, J 8.3 Hz, 6-H), 7.55 (1H, d, J 8.3 Hz, 
NH); δC (101 MHz, CDCl3) 50.6 (CH3), 55.5 (CH), 71.2 (CH2), 92.6 (C), 108.0 
(CH), 110.1 (CH), 113.8 (CH2), 126.5 (C), 127.0 (CH), 128.9 (CH), 136.7 (CH), 
139.1 (C), 158.4 (C), 160.6 (C), 161.0 (C). 
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(6S*,6aR*,6bR*,9aS*)-3-Methoxy-8-phenyl-6-(2’,2’,2’-
trichloromethylcarbonylamino)-1-benzoxepin[e]isoindol-7,9(2H)-dione (254) 
 
 
 
(Z)-8-Methoxy-5-(2’,2’,2’-trichloromethylcarbonylamino)-3-vinyl-2,5-dihydro-1-
benzoxepine (253) (0.0060 g, 0.016 mmol) was dissolved in p-xylene (0.27 mL) 
and N-phenylmaleimide (0.0040 g, 0.025 mmol) was added and the reaction 
mixture was heated at 50 °C for 24 h. The reaction mixture was concentrated in 
vacuo and purified by column chromatography (100% diethyl ether) gave 
(6S*,6aR*,6bR*,9aS*)-3-methoxy-8-phenyl-6-(2’,2’,2’-
trichloromethylcarbonylamino)-1-benzoxepin[e]isoindol-7,9(2H)-dione (254) 
(0.0060 g, 63%) as a white solid. Rf 0.03 (50% diethyl ether/petroleum ether); δH 
(400 MHz, CDCl3) 2.35–2.47 (1H, m, 10-HH), 2.66–2.80 (1H, m, 10-HH), 2.83 (1H, 
ddd, J 15.9, 6.3, 3.0 Hz, 9a-H), 3.37–3.46 (1H, m, 6a-H), 3.52–3.61 (1H, m, 6b-H), 
3.78 (3H, s, OCH3), 4.62 (1H, d, J 12.9 Hz, 12-HH), 4.77 (1H, d, J 12.9 Hz, 12-
HH), 5.80 (1H, t, J 8.8 Hz, 6-H), 6.10 (1H, t, J 4.1 Hz, 11-H), 6.47 (1H, d, J 2.6 Hz, 
2-H), 6.58 (1H, dd, J 8.8, 2.6 Hz, 4-H), 7.18 (2H, br d, J 7.5 Hz, 2 × ArH), 7.22 (1H, 
d, J 8.8 Hz, 5-H), 7.35–7.41 (1H, m, ArH), 7.43 (2H, br d, J 7.5 Hz, 2 × ArH), 7.61 
(1H, d, J 8.8 Hz, NH); δC (101 MHz, CDCl3) 24.1 (CH2), 40.0 (CH), 41.6 (CH), 42.4 
(CH), 53.3 (CH), 55.3 (CH3), 72.2 (CH2), 92.6 (C), 105.6 (CH), 109.0 (CH), 126.4 
(2 × CH), 126.8 (CH), 128.1 (CH), 128.7 (CH), 129.0 (2 × CH), 131.2 (C), 131.6 
(C), 137.3 (C), 156.4 (C), 160.6 (C), 161.0 (C), 175.9 (C), 177.9 (C). 
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